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ABSTRACT  
 
Medical expulsive therapy can be administered to treat ureteral calculi by 
relieving ureteral colic and increasing stone passage rate. It is vital to have 
a greater understanding of the mechanisms controlling ureteral 
contraction, as this may reveal novel mechanisms and identify targets for 
the development of more effective pharmacological agents for medical 
expulsive therapy. The overall aim of this thesis was to elucidate the 
mechanisms controlling contractility of the ureter. Functional organ bath 
studies with isolated porcine ureteral tissues were used to examine key 
systems involved in ureteral smooth muscle contraction. The findings 
demonstrate that G-protein coupled receptor-mediated contractile 
responses of ureteral tissues in response to muscarinic receptor, α1-
adrenoceptor and 5-HT receptor stimulation differ with age and the latter 
two appear to play more dominant roles in mediation of ureteral smooth 
muscle contraction. Muscarinic and α1-adrenoceptor-stimulated responses 
are increased in tissues from older animals compared to younger animals 
and vice versa in 5-HT-stimulated contractions. The 5-HT2A receptor 
subtype appears to be responsible for 5-HT-mediated contractile 
responses, although, this might be more complex with age. While it was 
clear that this is the sole functional receptor subtype in ureteral tissues 
from the younger animals, the findings suggested that this might not be 
the case in ureteral tissues from older animals. In the study of intracellular 
signalling pathways, it was observed that the Rho-kinase pathway plays a 
vital role in mediation of contractile responses in the ureter. Additionally, 
the inhibitory effect of urothelium and specifically, urothelium-derived 
inhibitory factor on contractile responses was evident in the isolated ureter 
and adenosine triphosphate was identified as a likely candidate for this 
inhibitory mediator. Conclusively, age-related changes are apparent in 
every mechanism that was investigated, indicating that ageing might an 
important factor to be considered in management of ureteral colic. 
ii 
 
 
  
iii 
 
DECLARATION 
 
This thesis is submitted to Bond University in fulfilment of the requirements 
of the degree of Doctor of Philosophy by Research. 
 
I declare that the research presented within this thesis is a product of my 
own original ideas and work, and contains no material which has 
previously been submitted for a degree at this or any other institution, 
except where due acknowledgement has been made. 
 
 
 
________________ 
Iris Lim 
7th October 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
  
v 
 
ACKNOWLEDGEMENTS 
 
Firstly, I would like to thank my supervisors, Donna Sellers and Russ 
Chess-Williams for their continual support and guidance in the 
development of my scientific skills. Donna, you always tell me I am very 
organised but the truth is, I learnt from the best – you! It will always be a 
wonder to me how you managed those meetings and teaching and still 
have time to constantly check on me. Russ, you are a special character 
that I have come to truly admire in these years and I will forever cherish 
our endless chats. You have both contributed so much in my PhD years, 
not just in research but also in my personal life and I will always be 
grateful. I would also like to thank all my colleagues in the Centre for 
Urology Research at Bond University for always being friends I can turn to 
when I run into any troubles in the lab and also for the weekly chats at our 
lab meeting on scientific and non-scientific topics.  
 
A big thank you also goes to the kindest couple I know, Joe and Cynthia. 
You both are my God-sent guardian angels on the Gold Coast. The 
biggest thank you, of course, goes to my family. Seventh year away from 
home, but still as tough as ever. To my siblings, Aline, Lenice, Daryl and 
Sheryl, thanks for keeping me sane by being insane with me throughout 
these years and making me feel less nerdy than I really am! Last but 
definitely not least, infinite thanks to my amazing parents. Dad (Anthony), 
for believing in me even when I didn’t and being the light that guides me to 
the right path. Mum (Celine), for the encouragement and nightly chats 
about my day despite how much more you had going on – no more 
complains about the 3-hour drive to the abattoir! I love you both endlessly 
and I dedicate this thesis to you. 
 
 
 
vi 
 
 
  
vii 
 
PUBLICATIONS 
 
Gold Coast Health and Medical Research Conference (GHMRC) 
Lim I, Sellers D & Chess-Williams R (2013) The difference in contractile 
responses of isolated porcine tissues to carbachol and phenylephrine in 
old and young pigs. GCHMRC, Gold Coast, Australia, November 2013. 
Available from proceedings of Gold Coast Health and Medical Research 
Conference 2013 (p 106) 
 
National Symposium on Advances in Gastrointestinal & Urogenital 
Research 
Lim I, Sellers D & Chess-Williams R (2013) The effect of age on 
contractile responses of the porcine ureter to carbachol and 
phenylephrine. 5th National Symposium on Advances in Gastrointestinal & 
Urogenital Research, Melbourne, Australia, November 2013. Available 
from proceedings of 5th National Symposium on Advances in 
Gastrointestinal & Urogenital Research 
 
Australasian Society of Clinical and Experimental Pharmacologists 
and Toxicologists (ASCEPT) Annual Scientific Meeting 
Lim I, Sellers D & Chess-Williams R (2013) The effect of age on 
contractile responses of the porcine ureter to carbachol and 
phenylephrine. ASCEPT, Melbourne, Australia, December 2013. Available 
online at http://www.asceptasm.com/wp-content/uploads/2013/06/ASCEP 
T-abstracts-403-493.pdf (Abstract No. 437) 
 
National Symposium on Advances in Gastrointestinal & Urogenital 
Research 
Lim I, Sellers D & Chess-Williams R (2014) The role of Rho-kinase in 
phenylephrine and 5-HT-induced contractile activity of the porcine ureter. 
6th National Symposium on Advances in Gastrointestinal & Urogenital 
viii 
 
Research, Gold Coast, Australia, September 2014. Available from 
proceedings of 6th National Symposium on Advances in Gastrointestinal & 
Urogenital Research (p 7) 
 
Gold Coast Health and Medical Research Conference (GHMRC) 
Lim I, Sellers D & Chess-Williams R (2014) The role of Rho-kinase in 
phenylephrine and 5-HT-induced contractile activity of the porcine ureter.  
GCHMRC, Gold Coast, Australia, December 2014. Available from 
proceedings of Gold Coast Health and Medical Research Conference 
2014 
 
Australasian Society of Clinical and Experimental Pharmacologists 
and Toxicologists (ASCEPT) Annual Scientific Meeting 
Lim I, Sellers D & Chess-Williams R (2014) The effect of age on 
contractile responses of the porcine ureter to carbachol and 
phenylephrine. ASCEPT, Melbourne, Australia, December 2014. Available 
online at http://www.asceptasm.com/wp-content/uploads/2014/01/ASCEP 
T-Poster-Program-Abstracts-FINAL1.pdf (Abstract No. 569) 
 
National Symposium on Advances in Gastrointestinal & Urogenital 
Research 
Lim I, Sellers D & Chess-Williams R (2015) Depressed effect of ageing on 
contractile response of porcine distal ureter to 5-hydroxytryptamine via 5-
HT2A receptor subtype. 7th National Symposium on Advances in 
Gastrointestinal & Urogenital Research, Adelaide, Australia, October 
2015. Available from proceedings of 7th National Symposium on Advances 
in Gastrointestinal & Urogenital Research (p 13) 
 
International Continence Society (ICS) Annual Meeting  
Lim I, Sellers D & Chess-Williams R (2015) Depressed effect of ageing on 
contractile response of porcine distal ureter to 5-hydroxytryptamine via 5-
ix 
 
HT2A receptor subtype. ICS, Montreal, Canada, October 2015. Available 
online at http://www.ics.org/Abstracts/Publish/241/000161.pdf  
 
Gold Coast Health and Medical Research Conference (GHMRC) (Best 
Digital Presentation Award) 
Lim I, Sellers D & Chess-Williams R (2015) The role of Rho-kinase in 
phenylephrine and 5-HT-induced contractile activity of the porcine ureter.  
GCHMRC, Gold Coast, Australia, December 2015. Available from 
proceedings of Gold Coast Health and Medical Research Conference 
2015 
 
International Continence Society (ICS) Annual Meeting  
Lim I, Sellers D & Chess-Williams R (2016) The role of rho-kinase in 
phenylephrine and 5-HT-induced contractile activity in the porcine ureter. 
ICS, Tokyo, Japan, September 2016. Available online at http://www.ics.or 
g/Abstracts/Publish/326/000642.pdf  
 
 
 
 
 
 
 
 
 
 
 
x 
 
 
  
xi 
 
TABLE OF CONTENTS 
 
ABSTRACT ..…………………………………………………………………... i 
DECLARATION ……..………………………………………………………... iii 
ACKNOWLEDGEMENTS ..…………………………………………………... v 
PUBLICATIONS ..……………………………………………………………. vii 
TABLE OF CONTENTS …..……………………………………...………..... xi 
 
CHAPTER 1: General introduction ……..……………………………..….. 1 
1.1 Ureteric Calculi …..……………………………………………..…………. 3 
1.2 Structure and Function of the Ureter ..……………………………….... 22 
1.3 Innervation of the Ureter …..………………………………………........ 27 
1,4 Intracellular Signalling Pathways ..…………………………………….. 38                
1.5 Summary …………………..…………………………………………...... 48 
1.6 Research Aims ………………………………………………………...… 49 
 
CHAPTER 2: Methods optimization ……………………………………... 51 
2.1 General Methods …..……………………………………………………. 53 
2.2 Optimization of Responses of Ureteral Tissue ……………………….. 58 
2.3 Optimization of Tissue Strips Orientation ……………………………... 62 
2.4 Reproducibility of Concentration-Response Curve ………………….. 68 
2.5 Effect of Age on Ureteral Responses …………………………………. 73 
2.6 Regional Differences in Responses of the Ureter ………………….... 86 
2.7 Effect of Indomethacin on Contractile Responses ………………..…. 95 
2.8 Effect of L-NG-Nitroarginine (L-NNA) on Responses ……………… 104 
 
CHAPTER 3: Characterization of the 5-HT receptor subtype in the 
porcine ureter …………………………………………………………….... 115 
3.1 Introduction ………………………………………………………...…… 117 
3.2 Method and Materials ………..………………………………………… 123 
3.3 Results …………………………………………………………...……… 125 
xii 
 
3.4 Discussion …………………………………………………………….… 155 
3.5 Conclusion ……………………………………………………………… 160 
 
CHAPTER 4: The role of Rho-kinase pathway in ureteral  
Responses …………………………………………………………………. 161 
4.1 Introduction …………………………………………………………...… 163 
4.2 Method and Materials ……………………………………………….…. 169 
4.3 Results …………………………………………………………...……… 171 
4.4 Discussion …………………………………………………………….... 194 
4.5 Conclusion …………………………………………………………...…. 198 
 
CHAPTER 5: The effect of urothelium-derived inhibitory factor and 
adenosine triphosphate on ureteral contractile responses ………. 199 
5.1 Introduction ………………………………………………………...…… 201 
5.2 Method and Materials ……………………………………………….…. 211 
5.3 Results ………………………………………………………………..…. 212 
5.4 Discussion ………………………………………………………………. 235 
5.5 Conclusion …………………………………………………………….... 241 
 
CHAPTER 6: General Discussion …………………………………….... 243 
6.1 General Discussion ……………………………………………………. 245 
 
REFERENCES ……………………………………………………………... 251 
APPENDICES …………………………………………………………….… 281 
 
 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1: 
General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
  
3 
 
1.1 Ureteric Calculi 
 
Urinary stones, also known as urinary calculi, are stones or calcifications 
developed by the aggregation of crystalline mineral deposits in the urine to 
form hard-rock crystals of various sizes and shapes. This condition is 
known as urolithiasis (Romero et al., 2010). Ninety percent of calculi are 
calcium stones and the remaining 10% are non-calcium stones, including 
struvite, uric acid, ammonium urate, and xanthine stones (Kijvikai and de 
la Rosette, 2011). While calculi can be found in various parts of the urinary 
tract, they are commonly lodged in the ureter as ureteric calculi (Canda et 
al., 2007) (Figure 1.1). The human adult ureter is a tube of smooth muscle, 
approximately 25 – 30 cm in length, responsible for propelling urine from 
the kidney to the bladder and can be anatomically divided into three parts: 
the proximal, mid and distal ureter. The proximal ureter is the section 
closest to the kidney whilst the distal ureter is the lower section 
approaching the bladder. Studies have shown that the most common 
location for lodgement of ureteral calculi is the distal ureter approaching 
the ureterovesical junction (also termed the intravesical ureter) where the 
ureter enters the bladder. This region accounts for 54% of calculi requiring 
surgical intervention (El-Barky et al., 2014). The second most common 
location, accounting for 34% of calculi, is just below the pelvi-ureteric 
junction where the proximal ureter leaves the kidney (El-Barky et al., 
2014). 
 
 
Pathogenesis 
Despite numerous studies aimed at understanding the pathogenesis of 
urinary calculi, the events that lead to stone formation are still unknown. 
This is partly because this disease is a polygenic and multifactorial 
disorder that is associated with involvement of an interrelationship 
between the kidney, bone and intestine (Gnessin, 2010).  
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However, tremendous progress has been made in recent years to 
delineate the exact processes that lead to calculi formation and a number 
of chemical theories including supersaturation, nucleation and crystal 
formation, crystal aggregation, crystal retention and crystal growth 
inhibitors are thought to be involved (Miller et al., 2007, Gnessin, 2010).  
 
 
 
 
Figure 1.1 Anatomical position of ureteric stones in relation to the 
structures of the urinary tract (El-Barky et al., 2014). 
 
 
Urinary supersaturation provides the driving force for a phase change from 
dissolved salt to solid phase and this occurs when the concentration of 
calculus-forming salt exceeds its solubility (Coe et al., 2005). It is possible 
to obtain supersaturation values by measuring ionic concentrations in 
urine tests. Calculated supersaturation values have been observed to 
correlate with stone composition and emphasize its importance in the 
pathogenesis of calculi formation (Parks et al., 1997).  
 
proximal region 
distal region 
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Nucleation is the establishment of the smallest units of crystal formation 
and occurs in the presence of high supersaturation values. The two types 
of nucleation are homogenous and heterogenous, where homogenous 
nucleation occurs in a pure solution and requires a much higher 
supersaturation level in comparison to the latter (Khan, 1997). However, in 
most cases, human urine has a diverse chemical environment causing 
nuclei to form on structures like cellular debris, urinary crystals and 
existing urinary membranes. This form of nucleation is called 
heterogenous nucleation and requires a lower level of supersaturation 
values, which suggest the possibility that this type of nucleation plays a 
greater role in calculi formation (Gnessin, 2010). Additionally, it has been 
observed that most calculi are comprised of more than one crystal type, 
thus, also supporting the predominance of heterogenous over 
homogenous nucleation (Khan, 1997).  
 
Crystal aggregation is the process where stone crystals bind to one 
another via chemical and electrical forces. Upon aggregation, these stone 
crystals are held in place and cannot be easily separated. This process is 
thought to have a vital role in calculi formation in the urinary tract, as a 
single crystal would not be large enough to be retained in the collecting 
system (Kok et al., 1990). In addition to this, crystal retention is also 
thought to be involved in calculi formation, as nucleation and crystal 
aggregation need to occur within the time frame of transit of urine through 
the nephron (Kok and Khan, 1994). 
  
Finally, crystal growth inhibitors might play an equally important role in 
calculi formation as supersaturation values. It was found that urine from 
non-calculus-formers contained high supersaturation values but calculus 
formation but did not occur in these individuals. This was explained by a 
number of substances found in the urine including citrate, magnesium, 
pyrophosphate and albumin, which prevent the formation of calculi (Coe et 
al., 2005, Gnessin, 2010).  
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While these theories on the physical chemistry of calculus formation are 
accepted to play significant roles, it is important to keep in mind that 
calculus formation could be due to different mechanisms in different 
patients. This is highly dependent on the clinical scenario of a certain 
patient and therefore, it is difficult to completely specify the pathogenesis 
of stone formation.  
 
 
Significance 
Urolithiasis is a common condition and is associated with considerable 
morbidity and a substantial economic impact. The incidence of urolithiasis 
is increasing in western countries, as well as in Australia, affecting 1 in 10 
people (Macneil and Bariol, 2011) and its prevalence is expected to 
escalate significantly in the following decades, as has been the case for 
obesity, diabetes and metabolic syndrome (Soucie et al., 1994, Lee et al., 
2002). In addition, the number of stone treatment procedures in Australia 
has increased in recent years (Figure 1.2). Although the financial burden 
of the disease is unknown for Australia, it was estimated at approximately 
$2.1 billion in 2000 in the United States, including $971 million allocated 
for inpatient services which reflects an increase of 50% since 1995 (Lotan 
and Pearle, 2011). In 2012, urolithiasis was associated with 25,000 
hospital admissions in England costing £11.6 million (Pickard et al., 2015).  
 
Another major problem associated with urolithiasis is recurrence of 
disease (Yuvanc et al., 2015). It has been reported that patients have 
recurrence rates of 10% in the first year, 35% in the next 5 years and 50% 
in 10 years following the first incidence (Yuvanc et al., 2015). With 
recurrence, patients may require further invasive or non-invasive surgical 
treatment and hospitalization, which subsequently leads to increased 
monetary costs (Yuvanc et al., 2015).   
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Risk Factors 
It is more likely for calculi to develop in men than in women, but the ratio 
has been shown to have declined from a 3:1 male-to-female 
predominance to now less than 1.3:1 since 1994 (Schade and Faerber, 
2010). The reason for this, and the slight predominance in males, are 
unexplained, although one interesting proposition is that females are more 
likely to hydrate than males, as dehydration is a major risk factor (Schade 
and Faerber, 2010). While this condition can affect all age groups, the first 
episode commonly occurs before reaching the age of 30 and then more 
frequently with increasing age (Hess, 2003).  
 
 
 
 
Figure 1.2 Number of procedures claimed under Medicare Australia for 
different stone treatment modalities between 1995 and 2010. The graph 
depicts a consistent increase in stone treatment procedures over the 16 
years (Lee and Bariol, 2011). No more recent accreditable data on urinary 
calculi was obtainable. 
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The highest prevalence and incidence rates of ureteral calculi are 
observed in Caucasians, followed by Hispanics, blacks and Asians 
(Romero et al., 2010). Additionally, a strong family history of urolithiasis 
and recurrent stone formation is also a risk factor (Macneil and Bariol, 
2011).  Environmental conditions and eating habits, such as high sodium 
and protein diets, including meat, fish and poultry, accompanied with low 
carbohydrate intake, have also been shown to result in a higher risk of 
stone formation. This diet composition has been shown to reduce the 
body’s ability to absorb calcium and therefore increases the chances of 
stones developing (Gottlieb, 2002). 
 
In addition to this, diabetes mellitus, gout and obesity are also major risk 
factors associated with urinary stone formation (Chung et al., 2011, 
Nowfar et al., 2011, Marchini et al., 2013). Those affected by diabetes, 
specifically, type 2 diabetes, have been shown to have urine with lower pH 
values than non-diabetic patients. While the reason for this is still unclear, 
the acidity of the urine is thought to increase the probability of uric acid 
calculi formation (Chung et al., 2011). The build-up of uric acid in the blood 
that occurs in gout also increases the risk of calculi formation (Marchini et 
al., 2013). Additionally, obesity is associated with an increase in insulin 
resistance and compensatory hyperinsulinemia which may contribute to 
the development of calcium stones by increasing the urinary excretion of 
calcium (Nowfar et al., 2011). Furthermore, it was also suggested that the 
obese population is more inclined to consume more salt and animal 
protein in their diet, and thus, predisposes them to calculus formation 
(Nowfar et al., 2011). Chronic kidney disease has also been suggested to 
be a significant health problem that could lead to urinary calculi formation 
and various studies have linked urolithiasis with varying degrees of renal 
insufficiency. It has been reported that 0.8% to 17.5% of patients with 
chronic kidney disease present with urinary stone disease (Kartha et al., 
2013). The potential causes of kidney failure in patients presenting with 
stones  include hydronephrosis (swelling of kidney/s due to build-up of 
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urine), infection, diabetes mellitus, hypertension, repeated stone surgeries, 
diet and genetic factors (Chou et al., 2011). It is also vital to note that 
besides being a risk factor for stone formation, kidney disease could also 
be a consequence of severe urolithiasis conditions (Chou et al., 2011). 
 
 
Symptoms and Diagnosis 
It is observed clinically that symptom manifestation in urolithiasis patients 
is highly dependent on the size of the calculus. Patients with smaller 
calculi are thought to pass stones asymptomatically in comparison to 
those with larger stones who could have severe symptoms (Kijvikai and de 
la Rosette, 2011). The most pressing symptom of urinary stones is urinary 
colic. Colic is an excruciating pain felt by patients at the location of the 
stone. The classic presentation of a ureteric colic is episodic acute colicky 
flank pain that radiates from the back to the groin. Physical examination 
usually shows a patient with ureteric colic writhing in distress, searching 
for a comfortable position, which is distinct from patients with peritoneal 
irritation who usually remain motionless to minimise discomfort (Masarani 
and Dinneen, 2007).  Colic occurs as a consequence of obstruction in the 
passageway of the urinary tract by calculi (Masarani and Dinneen, 2007). 
In patients with severe colic, nausea and vomiting might also occur (El-
Barky et al., 2014). It has been found that approximately 90% of patients 
presenting with colic also present with gross or microscopic haematuria 
(Masarani and Dinneen, 2007), while urine infection causing shivers, 
sweating and fever was observed in patients to a lesser extent (Steggall 
and Omara, 2008).  
 
A routine assessment consisting of an exhaustive history and physical 
examination is usually performed on patients presenting with symptoms 
related to urolithiasis. Preliminary diagnosis is confirmed with proper 
radiological imaging methods. This allows for the physician to rapidly and 
definitively diagnose the patient’s calculus/calculi and ensures substantial 
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knowledge, including size, location, composition and renal anatomy, to 
decide the most suitable treatment modalities (Mehmet and Ender, 2015). 
 
There is a wide array of imaging methods that are currently used in the 
diagnosis of calculus formation. Previously, abdominal plain films of the 
kidneys, ureters and bladder and intravenous urography (IVU) were the 
most effective radiological techniques for diagnosis of ureteral stones. The 
sensitivity of a plain radiograph of the kidney, ureter and bladder in 
evaluation of acute flank pain ranges from 45 – 60% (Mutgi et al., 1991). 
Calculi can be classified based on images on radiograms, where calcium 
calculi are radiopaque, and directly visible, and non-calcium calculi, 
including uric acid and xanthine stone, are radiolucent, and not directly 
visible. The disadvantages of abdominal plain films are that radiolucent 
stones (which make up approximately 10% of stones) cannot be 
visualised. Additionally, abdominal and pelvic calcifications and overlaying 
bowel gas or stool can make it difficult to identify a ureteral calculus 
effectively (Masarani and Dinneen, 2007). Furthermore, it has been shown 
that in some cases, image quality in obese patients is impaired and there 
has been difficulty in differentiating pelvic vascular calcifications from 
stones in the proximal ureter close to the kidneys (Mandeville et al., 2011).  
Despite the disadvantages, a plain film may be adequate to determine 
size, shape and location of urinary calculi in certain patients (Masarani and 
Dinneen, 2007) (Figure 1.3). 
 
Intravenous urography provides information on site, degree and nature of 
obstruction and has a detection rate of 70 – 90% (Figure 1.4), which is 
significantly higher than with plain films (Miller et al., 1998). However, it 
has been closely associated with undesirable characteristics including 
radiation exposure, risk of nephrotoxicity, contrast reaction and time period 
of the procedure. Also, similar to plain films, only radiopaque calculi are 
visible (Masarani and Dinneen, 2007). The incidence of contrast-induced 
renal failure is reported to be approximately 1% (Levy et al., 1996) while in 
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patients with pre-existing renal failure and diabetes mellitus, the risk of 
nephrotoxicity is 25% (Barrett and Carlisle, 1993). The incidence of 
contrast reactions with IVU is 5 – 10%, and these include vomiting, 
urticaria, bronchospasm and anaphylaxis (Shehadi and Toniolo, 1980). 
 
 
 
 
Figure 1.3 Kidney, ureter and bladder x ray of a patient presented with left 
loin pain showing 7mm radiopaque stone located lateral to the tip of 
transverse process of L2 (Masarani and Dinneen, 2007). 
 
 
With the rapid development in technologies such as ultrasound and non-
contrast computed tomography (NCCT), a much wider range of imaging 
studies are now available to physicians (Zilberman et al., 2011).  The main 
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advantage ultrasound has over other imaging techniques is that there is 
no radiation exposure, and therefore, it is commonly utilised for stone 
diagnosis in pregnant women and also in follow up procedures to ensure 
signs of ureteral obstruction have resolved after treatment (Macneil and 
Bariol, 2011). Ultrasound can be used to detect calculi located in the 
pelvis, calices, and specific locations of the ureter including the 
pelviureteric junction (where ureter leaves the kidney) and vesicoureteric 
junction (where ureter enter the bladder) (Sheafor et al., 2000, Ray et al., 
2010).  
 
 
 
 
Figure 1.4 Intravenous urography film showing left nephrogram and 
contrast coming down the ureters to the level of the stone, after 
administration of intravenous contrast medium (Miller et al., 1998). 
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IVU was previously the standard imaging modality for assessing stones, 
however, the advancement in NCCT recently has given this technique 
better specificity and sensitivity for stone detection (Shine, 2008) (Figure 
1.5). In comparison to IVU, NCCT not only has a higher sensitivity and 
specificity for detection of calculi, but also does not require intravenous 
contrast medium administration. Furthermore, NCCT has a shorter 
examination time and the ability to determine radiolucent stones, in 
addition to being able to define density and internal formation of the stone 
and the distance of stone from the skin (Masarani and Dinneen, 2007). 
The reliability of NCCT in detection of calculi is undeniable with sensitivity, 
specificity and positive predictive values being 96%, 100% and 100% 
respectively (Worster et al., 2002). Nonetheless, the most distinct 
advantage of NCCT is that it does not require administration of 
intravenous contrast medium and therefore, does not induce 
nephrotoxicity and contrast reactions (Masarani and Dinneen, 2007).  
 
 
 
 
Figure 1.5 Non-contrast computer tomography of a patient showing left 
ureteral calculus (Miller, 2003). 
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The most important limitation of NCCT is the lack of ability to assess 
degree of obstruction and functional evaluation of the kidney which could 
possibly compromise clinical management (Masarani and Dinneen, 2007). 
Another major drawback is the higher radiation exposure compared to 
other methods. Nevertheless, newer protocols requiring less radiation 
exposure without affecting efficacy are rapidly developing. These 
procedures are termed low-dose and ultra low-dose NCCT respectively 
and been shown to reduce radiation exposure by 50% and 95% compared 
to standard-dose NCCT, and this is without influencing calculi detection 
rates (Meagher et al., 2001, Kluner et al., 2006, Poletti et al., 2007). Other 
disadvantages of NCCT include its questionable 24-hour availability due to 
the demand for a radiologist to accurately interpret films and its 
significantly higher cost. However, it has been suggested that its 
advantages in terms of reduced time of diagnosis and manpower are 
enough to lower indirect costs when compared to other methods (Pfister et 
al., 2003). 
 
 
Current Treatments 
Choosing treatment modalities for urolithiasis is dependent upon stone 
size, location and composition, along with the patient’s symptoms and 
comorbidities. In addition to that, the degree of ureteral obstruction and 
ureteral colic presented in specific patients also contribute to the choice of 
treatment  (Steggall, 2002). In recent years, there has been a great 
improvement in the technology for minimally invasive treatment modalities 
utilised in the management of urinary stones.  
 
Intervention treatments involved in treating larger urinary stones include 
shock wave lithotripsy (SWL), ureteroscopy, open nephrolithotomy, and 
percutaneous nephrolithotomy. The SWL procedure involves the use of 
shock waves to fragment urinary stones (Figure 1.6). Ureteroscopy is 
performed with an endoscope passing through the urethra and bladder 
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and into the ureter for removal of the stone (Macneil and Bariol, 2011). 
Open nephrolithotomy is a surgical procedure, where the kidney is 
dissected to remove the stone, whereas in percutaneous nephrolithotomy 
the stone is removed by a small puncture wound through the skin. The 
nephrolithotomy procedures are more invasive in nature due to the 
requirement of skin penetration (Macneil and Bariol, 2011). 
 
 
 
 
Figure 1.6 Extracorporeal shock wave lithotripsy procedure. Shock waves 
are utilised to crush stones in both the kidney and ureter. In both 
circumstances, stone fragments are required to pass through the ureter in 
the urine to the bladder for expulsion (Aboumarzouk et al., 2012). 
 
 
As shown in Figure 1.7, the less invasive methods, including ureteroscopy, 
pyeloscopy and shock wave lithotripsy (SWL), are more popular compared 
to the invasive treatments including open and percutaneous 
nephrolithothotomy (Lee and Bariol, 2011). Since the introduction of SWL 
as a treatment for managing stone disease, it has been the most common 
first line treatment for patients (Preminger et al., 2007). Although SWL is 
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the least invasive method, its efficacy is highly dependent on stone 
burden, location, composition and the efficacy of different lithotripters. It is 
predominantly dependent on the size of stone, where the stone-free rate is 
excellent in stones of less than 1cm (Preminger et al., 2007). Stone 
clearance rates for larger stones are much better with ureteroscopy 
(Parker et al., 2004, Kijvikai et al., 2007, Salem, 2009, Aboumarzouk et al., 
2012). SWL is the least invasive treatment method, but nevertheless has 
been associated with complications including instances of tissue injury, 
bleeding, urinary tract obstruction, adjacent organ injury and urinary tract 
infections. However, it is notable that the increased risk of these 
complications is associated with comorbidities including hypertension, 
diabetes mellitus, obesity and coronary heart disease. Although these 
acute effects of SWL are known, it is established that treatment with this 
modality does not affect renal functions in the long term (Mehmet and 
Ender, 2015). There are contradicting results as to whether complication 
rates are higher in ureteroscopy than in SWL or if they are similar 
(Aboumarzouk et al., 2012, Parker et al., 2004).  
 
In the introductory years of ureteroscopy, the total cost for the procedure 
was higher than SWL (Bierkens et al., 1998). However, the evolvement of 
new model flexible ureteroscopies, laser fibers and baskets in the last 
decade has been tremendous and its total cost is currently less than the 
total charges for shock wave lithotripsy (Salem, 2009, Lotan et al., 2002). 
Physicians are inclined to recommend ureteroscopy for stones larger than 
2cm. It is considered an effective alternative for percutaneous 
nephrolithotomy in patients with significant comorbidities including 
anticoagulation, cardiopulmonary disease, advanced age, obesity and 
renal malformations (Palmero et al., 2012, Akman et al., 2012). 
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Figure 1.7 Number of procedures claimed under Medicare Australia for 
different stone treatment modalities between 1995 and 2010 (Lee and 
Bariol, 2011). 
 
 
Medical Expulsive Therapy 
The likelihood of spontaneous calculus passage within 4 weeks ranges 
between 50% - 95% and this has been shown to be highly dependent on 
stone size, where stones that are less than 3mm in diameter are expected 
to pass spontaneously while stones greater than 6mm generally do not 
(Simon et al., 1997, Miller and Kane, 1999). Thus, in cases of 
asymptomatic and smaller stones, ‘watchful’ waiting might be 
recommended and might be extended by addition of medical expulsive 
therapy to improve passing and expulsion of stones (Canda et al., 2007).  
 
The primary purposes of medical expulsive therapy are to increase the 
rate of stone expulsion along the ureter to avoid ureteral obstruction and 
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reduce ureteral colic, the excruciating pain in the ureter frequently 
accompanying stone expulsion (Michel and de la Rosette, 2006). 
Furthermore, effective medical expulsive therapy is also expected to 
benefit patients, as it will reduce the need for hospitalization and surgical 
procedures. While the pathophysiology of this disease is still not fully 
understood, several drugs are currently used clinically in patients with 
ureteric stones. These act by relaxation of the ureter and augmentation of 
the hydrostatic physical force proximal to the calculus (Sivula and 
Lehtonen, 1967). Currently, the two most common drug classes used in 
medical expulsive therapy are calcium channel blockers and α1-
adrenoceptor antagonists. Both these drug classes are thought to act by 
inducing smooth muscle relaxation in the ureters to allow stone passage. 
 
The most commonly used α1-adrenoceptor antagonist is tamsulosin, and 
results from various studies suggest that tamsulosin displays a significant 
efficacy in stone expulsion rate and colic episodes in comparison to 
untreated patients (Hollingsworth et al., 2006, Michel and de la Rosette, 
2006, Parsons et al., 2007, Seitz et al., 2009, Al-Ansari et al., 2010, 
Kaneko et al., 2010). While these studies indicate the efficacy of 
tamsulosin, other investigations suggested that tamsulosin does not 
increase the rate of stone expulsion over placebo (Hermanns et al., 2009, 
Wang et al., 2009). Documented side effects due to administration of 
tamsulosin include dizziness, nausea and vomiting, headache and 
transient hypotension, with the latter being the most commonly reported 
(Hollingsworth et al., 2006, Singh et al., 2007, Seitz et al., 2009). The 
incidence of side effects by tamsulosin in urolithiasis patients is 
approximately 4% (Hollingsworth et al., 2006, Singh et al., 2007, Seitz et 
al., 2009). 
 
While the use of tamsulosin in medical expulsive therapy is the most 
studied α1-adrenoceptor antagonist, a randomised control trial 
demonstrated equal efficacy between tamsulosin, terazosin and doxazosin 
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in comparison to the trial groups (Yilmaz et al., 2005). The use of 
silodosin, a selective α1A-adrenoceptor antagonist, as a substitute for 
tamsulosin has also received increasing attention and has been reported 
to significantly increase calculus expulsion rate (Gupta et al., 2013, 
Dell'Atti, 2015). While no severe complications with silodosin 
administration were recorded, it was associated with a significantly higher 
incidence of retrograde ejaculation as an adverse effect (Gupta et al., 
2013, Dell'Atti, 2015).  
 
The only calcium channel blocker studied in association with urolithiasis is 
nifedipine, which has demonstrated some benefit in calculus expulsion 
and relieving colic (Dellabella et al., 2005, Porpiglia et al., 2006, Osorio et 
al., 2008, Seitz et al., 2009). However, multiple studies have reported 
superior efficacy of tamsulosin in comparison to nifedipine in calculus 
passage facilitation (Saita et al., 2004, Dellabella et al., 2005, Ye et al., 
2011).  Furthermore,  the occurrence of adverse effects including nausea 
and vomiting, asthenia, dyspepsia, headache, drowsiness and euphoria, 
appears to be higher with administration of nifedipine (15.2%) than 
tamsulosin (4%) (Singh et al., 2007). Hence, the focus of medical 
expulsive therapy is predominantly on α1-adrenoceptor antagonists, 
despite promising results of calcium channel blockers. 
  
The majority of the randomized studies performed on α1-adrenoceptor 
antagonists and calcium channel blockers were not blinded and had 
unclear allocation concealment, which leads to the probability of an 
overestimation of treatment efficacy and limits the strength of final 
conclusions regarding their benefits. Additionally, these studies were 
predominantly small and based on single clinical centres. Interestingly, a 
recent study which took into account these limitations reported that 
administration of neither tamsulosin nor nifedipine affected the number of 
patients requiring further intervention for clear calculus passage after 4 
weeks, suggesting similar rates of spontaneous calculus passage between 
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trial groups (tamsulosin, nifedipine, placebo) (Pickard et al., 2015). 
Consequently, the current guidelines for medical expulsive therapy by both 
European (EAU) and American (AUA) Urological Associations outline the 
role of tamsulosin as the most viable option in clinical settings. Medical 
expulsive therapy is not as commonly administered in Australia in 
comparison to the United States and in European countries due to its 
inefficacy. The most common pharmacological treatment prescribed to 
patients with urolithiasis are pain killers. However, there have been reports 
where tamsulosin (Floxamatra) was prescribed to patients with smaller 
stones in Australia. 
 
In addition to these agents, non-steroidal anti-inflammatory drugs 
(NSAIDs) are often used for relief of pain from inflammation and therefore 
also sometimes administered to patients with ureteric stones with 
accompanying colic (Holmlund and Sjodin, 1978). NSAIDs are thought to 
relieve pain by inhibiting the formation of inflammatory mediators. 
Diclofenac is the most commonly used NSAID in ureteral colic and has 
been shown to be efficient in reducing pain with no or very few side effects 
in multiple clinical trials (Basar et al., 1991, Vignoni et al., 1983, Sommer 
et al., 1989, Walden et al., 1993). However, NSAIDs are useful only in 
relieving pain and do not alter stone expulsion rate in ureteral colic 
patients (Laerum et al., 1995, Hermanns et al., 2009). Additionally, most 
studies only involved a short-term prescription of NSAIDs to avoid many of 
the adverse effects associated with prolonged treatment (Bos and Kapoor, 
2014). Therefore, although many studies have shown that NSAIDs in 
combination with either α1-antagonists or calcium channel blockers can be 
effective (Porpiglia et al., 2006, Yilmaz et al., 2005, Hwang et al., 2012), 
their efficacy in reducing calculus expulsion time as a monotherapy is still 
yet to be manifested.  
 
A novel candidate in medical expulsive therapy is PDE5 inhibitors, which 
can cause smooth muscle relaxation in the ureter (Gratzke et al., 2007). 
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However, the potential value of this class of drugs, particularly in clinical 
settings, is still in its infancy. In one study, it was reported that there is no 
significant difference in calculus expulsion rate between patients 
administered with only tamsulosin and patients who were treated with 
combined tamsulosin and the PDE5 inhibitor tadalafil (Kumar et al., 2014). 
Further clinical investigations are required to assess the efficacy of PDE5 
inhibitors in medical expulsive therapy. Another novel medical expulsive 
therapy drug that has emerged in clinical trials is β3-adrenoceptor 
antagonist, mirabegron (Tabner et al., 2016) but similar to PDE5 inhibitors, 
its efficacy has not been thoroughly investigated.    
 
In summary, the efficacy of currently used pharmacological agents, 
namely tamsulosin, nifedipine and NSAIDs, in increasing stone expulsion 
rate, is still questionable. Additionally, while their adverse effects are 
considered mild, there are still significant factors to be considered in the 
choice of treatment as they can affect patients’ quality of life. Based on 
current findings, it is evident that medical expulsive therapy is most 
advantageous for patients with smaller calculi. Additionally, it has been 
shown that administration of both tamsulosin and nifedipine can benefit 
patients who undergo the shock wave lithotripsy procedure, by facilitating 
the passage of fragmented stones along the ureter (Kupeli et al., 2004, 
Micali et al., 2007). Therefore, the development of a more effective 
medical expulsive therapy agent, that can both increase stone expulsion 
rate and relieve colic. will be advantageous for patients with smaller 
ureteral stones by avoiding more invasive procedures. In order to achieve 
this aim, a greater understanding of the mechanisms involved in the 
contractility of the ureter is required. 
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1.2 Structure and Function of the Ureter 
 
Ureteral Structure 
The right and left ureters are attached to the renal pelvis of the right and 
left kidneys and together, these organs, the ureters and kidneys, compose 
the upper urinary tract. The main, and possibly only, function of the ureter 
is the unidirectional transport of urine from the kidneys to the bladder 
(Santicioli and Maggi, 1998). The mammalian ureter consists of two main 
cell types: a multilayered water-tight transitional epithelium called the 
urothelium, which is surrounded by subepithelial connective tissues and 
smooth muscle cells (Woolf and Davies, 2013). There are two distinct 
layers of smooth muscle cells: an inner longitudinal layer and an outer 
circular layer, surrounded by fibrous tissues, as shown in Figure 1.8. The 
longitudinal smooth muscle is responsible for ureteral  shortening  and 
plays  a  role  in  movement  of  urine, while circular  smooth  muscle that 
coats the ureteral walls contracts to generate pressure (Vargiu et al., 
2015). 
 
 
Pyeloureteral Motility 
Ureteral peristalsis is the propagation of smooth muscle contraction and 
relaxation waves down the ureteric muscular tube to propel urine from the 
kidneys to the bladder. The basic process of ureteral peristalsis has long 
been thought to be myogenic in nature, where it is initiated by renal 
pacemaker cells and conducted to the ureters. This mechanism requires 
both the kidneys and the ureters and is therefore known as the 
pyeloureteral complex (Santicioli and Maggi, 1998, Lang et al., 1998). 
 
Spontaneous ureteral contractility originates at the renal pelvis, due to 
electrical activity at the pacemaker sites. Electrical activity is propagated in 
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a cell-to-cell manner distally to the otherwise inactive smooth muscle cells 
in the ureter, creating a contractile wave and the ability for urine propulsion 
to the bladder (McHale et al., 2006). Although the pathophysiology of renal 
colic is not completely understood, it is propose that increased luminal 
pressure and volume in the ureter that occur due to the obstruction can 
induce an increase in peristaltic wave amplitude and frequency (Rose and 
Gillenwater, 1973).  This can significantly amplify pain, and therefore 
cause ureteral colic (Rose and Gillenwater, 1973).   
 
 
 
Figure 1.8 Microscopic image of transverse section of the human ureter. 
Smooth muscle tissues are surrounded by fibrous tissues and lined with a 
layer of transitional epithelium. 
 
 
According to current literature, the most likely candidate for the renal 
pacemaker cells of the pyeloureteral complex are ‘atypical’ smooth muscle 
cells, which are not to be confused with the ‘typical’ smooth muscle cells 
200µM 
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that compose the ureter (Lang and Klemm, 2005). The pacemaker sites 
are located at the border where the calyces attach to the base of the 
papilla, called the pelvi-calyceal junction. This region is very weakly 
contractile with few ‘typical’ smooth muscle cells (McHale et al., 2006). 
These ‘atypical’ smooth muscles were identified by neurobiotin injection 
and it was observed that they have similar morphological and electrical 
characteristics to cardiac sino-atrial cells, which are responsible for 
cardiac excitation (Berridge, 2008). This results in a loose resemblance 
between the regulation of cardiac and pyeloureteral excitation. Electrical 
and mechanical activities are initiated by these spontaneously active cells 
in the pelvi-calyceal region of the renal pelvis and conducted to distal 
regions in the ureter that are not normally active unless driven by 
pacemakers (Berridge, 2008). Therefore, it is only when the electrical 
impulse is conducted to the ureter that there is an initiation of contractions 
that propagates along the ureter to the uretero-vesical junction as a 
peristaltic wave (McHale et al., 2006).  
 
As shown in the microelectrode recordings by Klemm and colleagues in 
Figure 1.9, the ‘atypical’ smooth muscle cells, which account for 
approximately 10% of cells in the pyeloureteral complex, display 
spontaneous activity characterized by slow rising and repolarizing phases 
called ‘pacemaker’ potentials. On the contrary, the action potentials in the 
ureters are ‘driven’, consisting of a rapidly rising initial spike and followed 
by a period of membrane oscillations and a plateau phase (Klemm et al., 
1999). The pacemaker potentials have been shown to be resistant to 
cholinergic, noradrenergic and neuronal blockers, suggesting a purely 
myogenic origin. Additionally, it has been shown that peristalsis occurs 
normally in isolated pyeloureteral complex, further indicating its myogenic 
origin (Santicioli and Maggi, 1998).  
 
Under conditions of normal diuresis, a conduction block appears to exist 
between the renal pelvis and the ureter. Every pacemaker contraction of 
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the renal pelvis does not necessarily propagate to the ureter (Santicioli 
and Maggi, 1998). A urine flow-dependent mechanism triggers ureteral 
peristalsis, where stretching forces exerted by increasing volume of urine 
on the pyeloureteral region increase the coupling strength to enable an 
incoming pacemaker wave to pass to the ureter (Constantinou and 
Yamaguchi, 1981). 
 
 
 
Figure 1.9 Typical intracellular microelectrode recordings of ‘pacemaker’ 
potentials in the renal pelvis and ‘driven’ action potentials in the ureter 
(Klemm et al., 1999). 
 
 
In the past decade, it was discovered that there is a third population of 
electrically-active cells which play a fundamental role in pyeloureteric 
autorythmicity. These cells display numerous similar morphological 
features to the interstitial cells of Cajal (ICC) present in the intestinal tract 
and thereby are called ICC-like cells. ICC-like cells have been observed in 
the lamina propria of the guinea pig renal pelvis and pelvi-calyceal 
junction, but not identified in the ureter (Klemm et al., 1999). While both 
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‘atypical’ smooth muscle cells and ICC-like cells display spontaneous 
electrical activity, ‘atypical’ smooth muscle cells show high frequency 
oscillations of the membrane potential, while the ICC-like cells slow 
frequency oscillations. Therefore, it was suggested that in the absence of 
‘atypical’ smooth muscle cells, ICC-like cells provide a compensatory 
pacemaker mechanism to maintain peristaltic waves in ‘typical’ SMCs, but 
are not normally involved in setting the pace (Lang and Klemm, 2005). It 
was also proposed that these ICC-like cells could be responsible for 
conducting and amplifying pacemaker signals to initiate action potentials in 
the ‘typical’ smooth muscle cells of the ureter (McHale et al., 2006). 
 
The ‘typical’ smooth muscle cells in the ureter propagate proximal to distal 
peristaltic waves from the pacemaker cells in the pelvi-calyceal junction, 
pumping urine from the renal pelvis to the bladder for storage and 
micturition (Woolf and Davies, 2013). Smooth muscle cells play an integral 
part in most mammalian organ systems, including the ureters. Clinical 
disorders including hypertension, bronchial asthma and preterm birth are 
results of altered smooth muscle contractility by a change in balance 
between contractile and relaxing agents, and so it is highly likely that this 
mechanism is involved, to some extent, in lodgement of ureteric stones 
(Lang and Klemm, 2005).   
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1.3 Innervation of the Ureter 
 
Until the last couple of decades, neurogenic control of smooth muscle cell 
contraction in the ureter has remained elusive. While it is known that the 
myogenic properties of the pyeloureteral complex are sufficient for normal 
ureteral peristalsis, stimulation of sensory nerves by neurotransmitters 
released in the presence of stone or infections can excite latent 
pacemakers present in the smooth muscle, giving rise to antiperistaltic 
waves or urine backflow (Santicioli and Maggi, 1998). Additionally, the 
primarily inactive distal regions of the ureter have also been shown to be 
dependent on neurogenic mechanisms for the modulation of contractility 
(Santicioli and Maggi, 1998). 
 
The mammalian ureter is innervated mainly by unmyelinated fibers 
originating from the renal, ovarian or spermatic and sympathetic plexuses 
(Wharton et al., 1981). It has also been suggested that the lower part of 
the ureter in cat and guinea pigs may receive a pelvic innervation 
(Wharton et al., 1981). In humans, the distal ureter receives a greater 
density of innervation compared to the proximal ureter, suggesting the 
possibility of a major contribution from the pelvic plexus (Edyvane et al., 
1992). The ureters have both an efferent and afferent innervation including 
adrenergic, cholinergic and non-adrenergic non-cholinergic components 
(Gray, 1918).  
 
 
Adrenergic Innervation 
Adrenoceptors are responsible for mediating responses to endogenous 
catecholamines, namely noradrenaline and adrenaline. The two types of 
adrenoceptors are α-adrenoceptor and β-adrenoceptor. α-adrenoceptors 
were initially thought to be involved mostly in excitatory functions including 
vasoconstriction, uterine and urethral smooth muscle contraction and pupil 
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dilation. A group of α-adrenoceptors responsible for inhibitory responses 
were discovered and these were termed α2-adrenoceptors, while the 
excitatory receptors were labelled α1-adrenoceptors. β-adrenoceptors, on 
the other hand, mediate inhibitory functions including vasodilation, uterine 
and urethral smooth muscle relaxation and bronchodilation but are also 
involved in excitatory effects in the cardiac system (Civantos Calzada and 
Aleixandre de Artinano, 2001). 
 
There are currently four known α1-adrenoceptor subtypes: α1A-, α1B-, α1D-, 
and α1L-adrenoceptors, the latter representing a functional phenotype of 
the α1A-adrenoceptor (Civantos Calzada and Aleixandre de Artinano, 
2001). α1-adrenoceptors are coupled predominantly by G-proteins of the 
Gq/11 family to activate the phospholipase C mechanism (Docherty, 2010) 
whose effect on smooth muscle contraction will be discussed in detail 
later. α1-adrenoceptor antagonists are most well-known for their use in 
benign prostatic hyperplasia patients as this receptor type is widely 
distributed in the prostatic smooth muscle. The blockade of these 
receptors also reduces urethral constriction and enhances urine flow 
(Pinheiro and Martins Pisco, 2012).  
 
The net result of noradrenaline application on the isolated human ureter is 
generally contraction, indicating the functional dominance of α1-
adrenoceptors over β-adrenoceptors (Hernandez et al., 1992). Molecular 
characterisation and immunohistochemical staining for α1-adrenoceptors 
in the human ureter showed that α1D and α1A-adrenoceptor subtypes were 
prevalent over the α1B-adrenoceptor subtype (Figure 1.10) (Sigala et al., 
2005, Itoh et al., 2007, Park et al., 2007). Radioligand binding studies 
indicated a heterogenous distribution of all three subtypes with the 
greatest density of α1-adrenoceptors at the distal ureter in comparison to 
the proximal and mid ureters (Sigala et al., 2005).  
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Although the expression of α1D-adrenoceptors is observed to be the 
greatest of the subtypes, a functional study performed on isolated human 
ureter suggested that the α1A-adrenoceptor is the subtype that plays the 
major functional role in mediating contractions (Sasaki et al., 2011). In this 
study, it was found that the α1A-selective antagonist silodosin had a 
greater affinity than the α1D-selective antagonist, BMY-7378 and the non-
selective α1-adrenoceptor antagonist, prazosin (Sasaki et al., 2011). 
These results support the efficacy of the current drug used in medical 
expulsive therapy, tamsulosin, which is an α1A-adrenoceptor selective 
antagonist, in increasing the expulsion rate of ureteral stones in patients   
(Dellabella et al., 2003, Autorino et al., 2005, Yilmaz et al., 2005, Agrawal 
et al., 2009). 
 
 
Figure 1.10 α1-adrenoceptor subtypes mRNA density in the human ureter. 
α1D-adrenoceptor has the highest mRNA expression followed by α1A-
adrenoceptor then α1B-adrenoceptor (Itoh et al., 2007). 
 
 
α2-adrenoceptors are involved in various physiological functions, 
particularly in the cardiovascular system and central nervous system. They 
are linked to Gi-proteins which inhibit adenylyl cyclase, causing a decrease 
in cAMP concentration upon activation and thereby, results in smooth 
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muscle contraction (Gyires et al., 2009). Additionally, they are found on 
the sympathetic nerve terminals where they inhibit noradrenaline release. 
This acts as a negative feedback mechanism for noradrenaline release 
(Gyires et al., 2009). There are currently three recognised α2-adrenoceptor 
subtypes and these are α2A-, α2B-, and α2C-adrenoceptors. α2A-
adrenoceptors are thought to be responsible for most classical effects of 
α2-adrenoceptors including antihypertensive effects, bradycardia, 
antinociception and also regulation of the gastrointestinal tract (Gyires et 
al., 2009). On the other hand, the activation of α2B- and α2C-adrenoceptors 
are likely to modify the α2A-adrenoceptor-mediated effect by either 
contributing or negating these reactions (Gyires et al., 2009).  
 
There is limited data on α2-adrenoceptors in the ureter but a study 
performed on porcine ureteric tissues suggested that there could be a 
possible role for these receptors in the maintenance of ureteral wall tone 
(Macneil and Bariol, 2011). Rauwolscine, the α2-adrenoceptor selective 
antagonist, blocked tone of the ureter without affecting the phasic activity 
induced upon a submaximal dose of noradrenaline addition. However, in 
this same study, B-HT920, B-HT933 and clonidine, all α2-adrenoceptor 
agonists failed to elicit contractions, even in the presence of low potassium 
and phenylephrine concentrations to induce initial depolarisation 
(Hernandez et al., 1992).  Thus, the effect of raulwolscine may have been 
due to a non-selective action on α1-adrenoceptors. 
 
There are three well-known β-adrenoceptor subtypes: β1-, β2- and β3-
adrenoceptor (Michel, 2011). The stimulation of β-adrenoceptors induces 
an increase in cAMP via adenylate cyclase and therefore, causes smooth 
muscle relaxation (Michel, 2011). β1-adrenoceptors are mainly involved in 
cardiac excitation as they are present in cardiac pacemakers and the 
myocardium. β2- and β3-adrenoceptors have both been observed to 
induce relaxation in the detrusor muscle of the urinary bladder (Michel, 
2011).  
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The two outcomes of β-adrenoceptor agonist application on the ureter are 
pacemaker activity alteration and smooth muscle relaxation (Michel, 
2011). Functional studies involving β-adrenoceptors are mostly organ bath 
experiments involving isolated ureteric smooth muscle tissues, hence 
alteration of pacemaker activity by β-adrenoceptor stimulation has not 
been well characterised. Although there is generally a functional 
dominance of α1-adrenoceptors in the ureter, it has been suggested that 
there is a stronger component of β-adrenoceptor expression in the distal 
ureter (Michel, 2011). MRNA for all three β-adrenoceptor subtypes are 
expressed in the human ureter and the existence of β2-adrenoceptors has 
been clearly demonstrated by receptor-binding assay (Park et al., 2000). 
While there are no radio-ligand binding data on β3-adrenoceptors, the co-
existence of this subtype with β2-adrenoceptors has been well 
characterised through pharmacological functional experiments.  
 
A study performed on porcine isolated ureteral smooth muscle cells 
showed that CGP-12177A and CL-316243, β2- and β3-selective agonists, 
produced a greater relaxation effect on potassium chloride-induced 
contractions in comparison to dobutamine, a β1-adrenoceptor selective 
agonist (Wanajo et al., 2004). In addition to that, isoprenaline-induced 
relaxations were antagonized by the β2-selective antagonist ICI-118,551 
and the β3-selective antagonist SR 58894A but not by the β1-adrenoceptor 
antagonist CGP20712A (Wanajo et al., 2004). Furthermore, it was 
demonstrated in a different study that the β2/β3-adrenoceptor agonist KUL-
7211, was more potent and has a more selective effect on the pig ureter in 
vitro and in vivo in comparison to the non-selective β-agonists isoprenaline 
and CL-316243 or the β2-adrenoceptor selective agonist terbutaline 
(Wanajo et al., 2011). KUL-7211 also potently and selectively relaxed 
isolated human ureteric tissues (Tomiyama et al., 2003a). In a study on 
human ureter, the relaxant effects of procaterol, a β2-adrenoceptor 
selective agonist, and TRK-380, a β3-selective agonist were greater in 
comparison to β1-selective agonists (Matsumoto et al., 2013). These 
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results suggest that the subtypes mediating relaxation in pig and human 
ureter are β2- and β3-adrenoceptors.  
 
 
Cholinergic Innervation 
There are five currently known subtypes of muscarinic receptors that have 
been cloned and defined pharmacologically: M1, M2, M3, M4 and M5. 
Muscarinic receptor subtypes M1, M3 and M5 receptors are coupled to 
Gq/11 guanine nucleotide binding proteins and cause contraction through 
phospholipase C activation in smooth muscle cells (Uchiyama and Chess-
Williams, 2004). M2 and M4 receptor subtypes, on the other hand, are 
coupled to Gi proteins to attenuate smooth muscle relaxation responses 
through inhibition of adenylate cyclase (Uchiyama and Chess-Williams, 
2004). In the majority of smooth muscle studies, M3 receptors have been 
shown to mediate contraction (Eglen et al., 1994). 
 
Immunocytochemical analysis of human ureters detected the presence of 
all five known subtypes of muscarinic receptors, whereas reverse 
transcription polymerase chain reaction analysis was only able to detect 
mRNA for M2, M3 and M5 subtypes (Sakamoto et al., 2006). In this same 
study, it was found that M5 receptor expression was greater than other 
subtypes (Sakamoto et al., 2006). Functional studies performed on the 
isolated pig ureter showed that the M1 receptor mediates the tonic 
response while phasic activity could involve M1, M2, M3 or M4 (Hernandez 
et al., 1993). Therefore, the functional role of muscarinic receptors in the 
ureter is still not clearly understood, especially in the human ureter.  
 
 
5-Hydroxytryptamine 
The major source of 5-HT in human is found is from the gastrointestinal 
tract (Barnes, 2001). There are currently six known classes of G protein-
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coupled 5-HT receptors present in mammals, namely 5-HT1, 5-HT2, 5-HT4, 
5-HT5, 5-HT6 and 5-HT7. There is an amazing diversity of signalling 
mechanisms for each 5-HT receptor class as they are each divided into 
different subtypes (Roth, 1994). The general signalling mechanisms of 
each 5-HT class are shown in the table below (Table 1.1). 
 
 
Table 1.1 5-HT receptor classes and their general signalling 
mechanisms (Roth, 1994). 
Receptor Class Signalling Mechanism/s 
5-HT1 Inhibits adenylate cyclase 
5-HT2 Activates phospholipase C 
5-HT3 Ligand-gated ion channel 
5-HT4 
Activates adenylate cyclase 
Activates protein kinase A 
5-HT5 Inhibits adenylate cyclase 
5-HT6 Activates adenylate cyclase 
5-HT7 Activates adenylate cyclase 
 
 
In isolated strips of human ureter, 5-HT induced concentration dependent 
contractions (Barnes, 2001, Gidener et al., 1999). The 5-HT induced effect 
was antagonised by the 5-HT2 antagonist, ketanserin and the mixed 5-
HT1/5-HT2 receptor antagonist methysergide, but was unaltered by the 
blockage of 5-HT3 and 5-HT4 receptors (Gidener et al., 1995).  
 
Intravenous and topical administration of the 5-HT2A antagonist ritanserine 
resulted in an inhibition of contractions in the pig isolated intravesical 
ureter (Hernandez et al., 2003). In addition, the 5-HT2A agonist DOI, 
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increased the frequency of ureteral contractions in pig ureter in vivo in a 
dose-dependent manner (Hauser et al., 2002). These outcomes suggest a 
possible role of the 5-HT2A receptor in mediating contractility of porcine 
ureter, although further studies are required to clearly determine the 
receptor type responsible for these 5-HT-induced contractile responses. 
 
 
Nitric Oxide 
There is ample evidence that nitric oxide (NO) is a major inhibitory 
neurotransmitter in many tissues of the urogenital tract and acts via an 
increase in cGMP (Andersson and Arner, 2004). Neuronal NO synthase 
(NOS)-positive neuronal axons have been detected in human and porcine 
isolated ureters and in vitro findings suggest a possible role for NO in 
ureteral relaxation (Stief et al., 1996, Iselin et al., 1996). NOS-reactive 
nerves were also detected via immunohistochemistry in the both human 
and pig distal and intravesical ureter and NO was suspected to have a 
possible role regulating the valve of the ureterovesical junction, where the 
ureter enters the bladder (Hernandez et al., 1995, Iselin et al., 1997, Iselin 
et al., 1998). Besides its effect on the ureterovesical junction, in vitro 
studies on mice and dog have also suggested that NO production is 
decreased in ureteral obstruction, and have shown its importance in 
reducing intra-ureteral pressure (Chang et al., 2002, Felsen et al., 2003, 
Xingyu et al., 2012). 
 
 
Histamine 
Histamine is an inflammatory mediator released by basophils and mast 
cells. The two histamine receptor subtypes that have been found in 
smooth muscle cells are the H1 and H2 histamine receptors. The H1 
receptor has been shown to stimulate bronchial smooth muscle 
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contraction and causes bronchoconstriction while stimulation of H2 
receptors is primarily involved in vasodilation (Marquardt, 1983).  
 
Electron microscopy of human ureters has demonstrated that urine can 
penetrate subepithelially in ureteral damage as observed with ureteral 
stones, and induce mast cell degranulation with the release of histamine 
(Ugaily-Thulesius and Thulesius, 1988, Ugaily-Thulesius et al., 1988). This 
process is likely one of the mechanisms of renal colic. A functional study 
showed that in human ureteral smooth muscle, the H1-receptor was 
predominant, as contraction induced by histamine stimulation completely 
masks the relaxation effect of H2-receptors (Bertaccini et al., 1983). In 
animal models, H1-receptor stimulation caused excitation in dog and 
sheep ureter, while H2 receptor stimulation initiated relaxation in dog and 
buffalo ureters (Dodel et al., 1996, Benedito et al., 1991, Phadnis et al., 
1995). The association between histamine and inflammation suggests that 
histamine receptors could play a significant role in ureteral colic in patients 
with ureteral stones.  
 
 
Prostaglandins 
Prostaglandins are lipid compounds derived from fatty acids which have 
various roles including regulation of contraction and relaxation of smooth 
muscle. The formation of prostaglandins requires cyclooxygenase (COX) 
enzymes. The COX enzyme converts arachidonic acid to an intermediate 
PGH2 which is metabolised to PGD2, PGE2, PGF2α and PGI2 (Matsuoka 
and Narumiya, 2007). The seven prostaglandin G-protein coupled 
receptors and their corresponding prostaglandin types are: DP receptors 
(PGD), EP1, EP2, EP3 and EP4 receptors (PGE), FP receptors (PGF) and 
IP receptors (PGI) (Matsuoka and Narumiya, 2007). There are two 
isoforms of the COX enzyme: COX-1, a constitutive form expressed in 
many tissue and organs, and COX-2, an inducible form induced by various 
stimuli including stretching of muscle, mucosal injuries and inflammatory 
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mediators, and nerve stimulation (Norregaard et al., 2006, Nakada et al., 
2002).  
 
A study performed on isolated human ureteric tissues showed that 
administration of PGE2 and PGF2α increased phasic and tonic activity 
(Cole et al., 1988). However, another study showed that PGE1 and PGE2 
caused inhibition of contractile activity in normal human ureter in vitro, 
while PGF1α and PGF2α caused increased contraction (Abrams and 
Feneley, 1975). Additionally, studies have shown that PGE2 increased 
contractility in ureteral obstruction and relaxed normal and non-obstructed 
ureters in pigs through the subtype EP3 receptor (Lowry et al., 2005, 
Ankem et al., 2005).  
 
The drug class NSAIDs, that is currently used for pain relief in ureteral 
colic, act by inhibiting the COX enzyme. Indomethacin, a non-selective 
COX inhibitor has been shown to dose-dependently inhibit ureteral 
contractility in isolated human and sheep ureters (Angelo-Khattar et al., 
1985, Al-Ugaily et al., 1986). Diclofenac, also a COX inhibitor, was shown 
to cause relaxation in human ureters (Sivrikaya et al., 2003). COX-2 
enzyme expression is up-regulated in human and rat ureter following 
ureteral obstruction, a complication that could accompany ureteric stones 
(Norregaard et al., 2006, Nakada et al., 2002). The increase of this isoform 
has led to investigations as to whether COX-2 selective inhibitors will be 
effective, with fewer side effects, in managing ureteral colic. NS-398 and 
celecoxib, COX-2 selective inhibitors, have been shown to be equipotent 
with non-selective inhibitors indomethacin and diclofenac, at reducing 
agonist-induced contractions and inhibiting prostaglandin release in pig 
and human ureters (Mastrangelo et al., 2000, Nakada et al., 2000, Jerde 
et al., 2005, Lee et al., 2010). These analyses indicate the importance of 
prostaglandins in regulation of ureteral smooth muscle contraction 
although clinical studies have been focused on the ability of COX inhibitors 
to relieve pain, and not in increasing stone expulsion rate. 
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Neuropeptides  
The role of neuropeptides in the ureter have not been thoroughly 
investigated. However, it has been reported that the release of calcitonin 
gene-related peptide (CGRP) inhibits ureteral motility in the guinea pig 
ureter in vitro and in vivo (Hua and Lundberg, 1986, Maggi et al., 1994). 
However, CGRP-positive nerve density was reported to be significantly 
lower in the human ureter compared to other species and these were 
detected mainly around blood vessel and submucosa and not at the 
smooth muscle (Edyvane et al., 1992, Tainio et al., 1992). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
1.4 Intracellular Signalling Pathways in 
Smooth Muscle Contraction 
 
Many organs in the body possess layers of smooth muscle cells and 
smooth muscle contraction is vital for most bodily functions and 
abnormalities can contribute to a wide range of diseases. The change in 
intracellular Ca2+ concentration, [Ca2+]i is currently thought to be the 
principal foundation that initiates contraction and relaxation in smooth 
muscle cells of the ureter (Somlyo and Somlyo, 1994). Figure 1.11 depicts 
a brief overview of intracellular mechanisms controlling general smooth 
muscle contraction and the different, but not necessarily independent, 
intracellular pathways thought to be involved in mediation of smooth 
muscle contraction are discussed below. 
 
 
Phospholipase C Pathway 
Agonists that act on G-protein coupled receptors (GPCR) can induce both 
Ca2+ sensitization and activation of phospholipase C (PLC) via the Gq/11 
family of GPCR to induce contraction (Somlyo and Somlyo, 1994). 
Receptors that are suggested to activate the PLC pathway in the ureter 
are α1-adrenoceptor, muscarinic receptor subtypes M1, M3 and M5, 5-HT2 
receptor, histamine H1 receptor and prostaglandin receptors. 
 
PLC activation catalyses the breakdown of phosphatidylinositol-4,5-
biphosphate (PIP2) into intracellular second messengers inositol-1,4,5-
triphosphate (IP3) and diacylglycerol (DAG). IP3 induces Ca2+ release from 
the sarcoplasmic reticulum, increasing [Ca2+]i available for binding 
calmodulin. The association of calcium-calmodulin complex with the 
catalytic subunit of myosin light chain kinase (MLCK) activates this kinase 
to phosphorylate the myosin light chain (MLC20) (Matsumura and 
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Hartshorne, 2008). Phosphorylated MLC20 activates myosin to form cross-
bridges with actin filaments (Sweeney et al., 1994). Myosin utilizes 
adenosine triphosphate (ATP) hydrolysis as the chemical energy source to 
facilitate its attachment and interaction with actin filaments. The formation 
of these cross-bridges is the mediator for motor responses in smooth 
muscle cells (de Godoy and Rattan, 2011).  
 
 
 
 
Figure 1.11 Intracellular mechanisms involved in smooth muscle contraction. 
CaM, calmodulin; DAG, diacylglyerol; GPCR, G protein-couple receptor; IP3, 
inositol triphosphate; MLCK, myosin light chain kinase; MLCP, myosin light 
chain phosphatase, PIP2, phosphatidylinositol 4,5-biphosphate; PKC, protein 
kinase C; PLC, phospholipase C; RhoGEF, Rho-specific guanine nucleotide 
exchange factor; ROCK, Rho-associated protein kinase; SR, sarcoplasmic 
reticulum 
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The other product of PIP2 breakdown, DAG, activates protein kinase C 
(PKC). PKC is a constitutively active protein kinase that phosphorylates 
CPI-17, a potent inhibitor of myosin light chain phosphatase (MLCP). The 
activated form of MLCP in the smooth muscle binds phosphorylated 
MLC20 at its myosin-binding site and dephosphorylates it to terminate 
smooth muscle contraction (MacDonald et al., 2001). Therefore, the final 
consequence of DAG is enhancement of contractions at constant [Ca2+]i. It 
has been found that Ca2+ release can be dissociated from Ca2+ 
sensitization hence, although IP3 induces Ca2+ release, it does not 
necessarily initiate Ca2+ sensitization which is an important process to 
maintain smooth muscle contraction (Kobayashi et al., 1991). 
 
 
Role of Calcium Channels 
Smooth muscle contraction is highly dependent on the release of Ca2+ 
from the sarcoplasmic reticulum to the cell cytoplasm. This depletes the 
intracellular Ca2+ store and replenishment of Ca2+ from the extracellular 
space is required (McFadzean and Gibson, 2002). The best characterised 
Ca2+ entry pathway is via the L-type calcium channel which is a voltage-
dependent channel. This channel is sensitive to depolarization of the 
smooth muscle cells, allowing Ca2+ entry (McFadzean and Gibson, 2002). 
However, non-voltage-gated channels permeable to Ca2+ are also present 
in smooth muscle cells including receptor-operated channels (ROCs) and 
store-operated channels (SOCs). 
 
ROCs are proposed to have the properties of non-selective cation 
currents, with varying degrees of Ca2+ selectivity (McFadzean and Gibson, 
2002). ROCs can be activated by agonists that act on GPCR (McFadzean 
and Gibson, 2002). Multiple extensive studies have been performed in 
various smooth muscle cell types and have suggested promising ROC 
activators. These include noradrenaline, acetylcholine and histamine 
acting via α1-adrenoceptors, M2 muscarinic and H1 receptors respectively 
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(Wang and Large, 1991, Komori et al., 1992, Zholos and Bolton, 1997). 
Although IP3-mediated release of Ca2+ from the sarcoplasmic reticulum is 
not necessary for activation of ROC, the increase in [Ca2+]i  has been 
observed to augment the channel current, and hence, calcium entry 
(Pacaud and Bolton, 1991). 
 
Intracellular Ca2+ store depletion stimulates Ca2+ influx across the plasma 
membrane to maintain [Ca2+]i during prolonged agonist application and 
also aids refilling of stores upon agonist withdrawal (Putney et al., 2001). 
SOCs are currently thought to be the pathway of this calcium entry from 
the extracellular space into the smooth muscle, occurring via a family of 
non-selective cation channels. Reduced intracellular stores of calcium, 
regardless of the cause, activate SOC to allow Ca2+ current across the cell 
membrane (McFadzean and Gibson, 2002). It was suggested that the 
single spanning membrane protein, STIM1, acts as the Ca2+ sensor to 
trigger SOC activation (Minke, 2006).   
 
 
Rho/Rho-kinase/Calcium Sensitization Pathway 
RhoA is a monomeric G-protein that belongs to the family of GTPases that 
include RhoA, RhoB and RhoC isoforms. It is the best understood isoform 
due to its significant roles in smooth muscle motility (de Godoy and 
Rattan, 2011). RhoA acts like a molecular switch, changing between the 
active guanosine triphosphate (GTP)-bound and inactive guanosine 
diphosphate (GDP)-bound state (Gidener et al., 1995). The activation of 
RhoA protein is through the Rho-specific guanine nucleotide exchange 
factor (RhoGEF) which is known to catalyse the switch between GDP and 
GTP on RhoA. Activated GTP-bound RhoA interacts with multiple 
effectors including Rho-associated protein kinase (ROCK), protein kinase 
N, rhotekin, rhophilin, citron and phospholipase D (Wettschureck and 
Offermanns, 2002).  
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ROCK is one of the most investigated RhoA effectors and exists in two 
isoforms; ROCK1 and ROCK2, with both present in smooth muscle (Yoshii 
et al., 1999). ROCK, when activated by RhoA, inactivates MLCP by 
phosphorylation of the myosin binding subunit. ROCK has also been 
shown to directly phosphorylate MLC20 to induce actin-myosin cross-
bridging which is the motor response for smooth muscle contraction 
(Amano et al., 1996, Somlyo and Somlyo, 2000). Hence, ROCK induces 
Ca2+ sensitization and enhances smooth muscle contraction independent 
of [Ca2+]i. Although the second messenger DAG also plays a similar role 
via PKC as a regulator of MLCP activity, it only plays a minor role in 
comparison to ROCK, as shown in the rabbit trachea (Iizuka et al., 1999). 
There have been suggestions of the possibility of cross-talk between the 
PKC and Rho/Rho-kinase pathways. The attenuation of PKC-induced 
contraction in the internal anal sphincter was observed not only in the 
presence of a PKC inhibitor but also by a ROCK inhibitor (Patel and 
Rattan, 2007). 
 
There are several levels where regulation of the Rho/Rho-kinase pathway 
can occur. Figure 1.9 shows a brief overview of RhoA regulation. At the 
GPCR, the activating agonist or antagonist will activate or inhibit the 
pathway respectively. As mentioned previously, RhoGEF is responsible for 
the activation of Rho by exchanging GDP with GTP on the protein. 
RhoGEF activity is controlled by protein kinases, phosphatidylinositol 
kinases and dimerization (Zheng, 2001). The next level of regulation is at 
the RhoA protein. It is well established that G-proteins, including G12-
family, G12 and G13 which seem to be ubiquitously expressed, couple to 
GPCRs and activate Rho (Buhl et al., 1995, Fromm et al., 1997). Though 
not fully understood, there is increasing evidence that Rho can be 
activated by Gq and the G11 families too (Katoh et al., 1998, Mao et al., 
1998). One of the negative regulatory mechanisms of Rho activity is via 
GTPase activating proteins (GAPs). GAPs inactivate the GTP-bound Rho 
by increasing RhoA intrinsic GTPase activity (Olofsson, 1999).  GTPase-
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dissociation inhibitor (GDI) inhibits GAP-stimulated GTP hydrolysis and is 
therefore a positive regulator for RhoA (Olofsson, 1999). 
 
 
 
 
 
Figure 1.12 Regulation of RhoA protein activity. Various G-protein 
receptor classes activate RhoA through Rho-specific guanine nucleotide 
exchange factor (RhoGEF). GTPase activating protein (GAP) and 
GTPase-dissociation inhibitor (GDI) are negative and positive regulators 
respectively. 
 
 
The ROCK pathway has been shown to be upregulated in 
pathophysiological conditions involving bladder smooth muscle 
dysfunction and in response to ureteral outlet obstruction (Zhang and 
DiSanto, 2011). Immunohistochemistry and Western blotting experiments 
in ureteric tissues have indicated the presence of both ROCK isoforms, 
ROCK-1 and ROCK-2, in human and sheep (Ferguson et al., 1998, Levent 
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and Buyukafsar, 2004). The presence of ROCK in the ureter suggests that 
it could have a significant functional role in smooth muscle contraction. 
The role of ROCK in ureteric obstruction was recently shown, where Y-
27632, a specific ROCK inhibitor, suppressed contraction in obstructed 
rabbit ureter and a greater ROCK expression was also seen via Western 
blotting (Turna et al., 2007). Y-27632 was also shown to attenuate both 
spontaneous and electrical field stimulated contractile responses in the 
human ureter (Zhang and DiSanto, 2011). However, no studies have 
linked the role of Rho/Rho-kinase pathway to the stimulation of α1-
adrenoceptors, muscarinic, histamine, prostaglandin and 5-HT receptors 
in the ureter. 
 
 
Cyclic Nucleotides 
Smooth muscle relaxation occurs either as a consequence of the removal 
of a contractile stimulus or by a direct action of a substance that stimulates 
inhibitory mechanisms (Webb, 2003). Nevertheless, the relaxation process 
requires a decrease in [Ca2+]i and increase in MLCP activity. The two main 
intracellular second messengers involved in smooth muscle relaxation are 
the cyclic nucleotides, cyclic adenosine monophosphate (cAMP) and 
cyclic guanosine monophosphate (cGMP) (Carvajal et al., 2000).  
 
As shown in Figure 1.13, the conversion of ATP to cAMP is catalysed by 
adenylate cyclase. Adenylate cyclase is activated by the α subunit of the 
Gs protein. cAMP generated by adenylate cyclase activate cAMP-
dependent protein kinase A (PKA) (Sassone-Corsi, 2012). PKA causes a 
decrease in [Ca2+]i and thereby induces smooth muscle cell relaxation 
through a number of mechanisms. PKA activates Ca2+-activated K+ (KCa) 
channels where the efflux of K+ is related to the concentration of Ca2+. 
Upon activation, these channels act as a negative feedback mechanism, 
hyperpolarizing the cell membrane and inhibiting Ca2+ entry through 
voltage-gated channels and thereby inactivating the PLC pathway, which 
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causes inhibition of smooth muscle contraction. Additionally, PKA also 
decreases the activity of RhoA and hence, the Rho/Rho-kinase pathway 
which stimulates smooth muscle contraction (Sanborn et al., 2005). 
 
 
 
 
Figure 1.13 Cyclic adenosine monophosphate pathway. GPCR 
stimulation causes activation of adenylate cyclase by Gαs subunit. 
Adenylyl cyclase converts adenosine triphosphate to cAMP which 
stimulates protein kinase A (PKA) to activate and inhibit mechanisms that 
induce SMC relaxation. 
 
 
The cyclic guanosine monophosphate (cGMP) relaxation pathway is 
summarised in Figure 1.14. cGMP is generated by the activity of guanylate 
cyclases. Nitric oxide is responsible for the activation of soluble guanylate 
cyclase (sGC) which catalyses the conversion of guanosine triphosphate 
(GTP) to cGMP. cGMP triggers the relaxation of SMC via the activation of 
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protein kinase G (PKG). Through the activation and inhibition of several 
proteins, PKG decreases [Ca2+]i (Carvajal et al., 2000).  
 
 
 
 
Figure 1.14 Cyclic guanosine monophosphate pathway. Nitric oxide (NO) 
stimulates soluble guanylate cyclase (sGC) which converts guanosine 
triphosphate (GTP) to cyclic guanosine monophosphate (cGMP). cGMP 
then activates protein kinase G (PKG) which triggers a reduction in [Ca2+]i 
via several mechanisms. 
 
 
Firstly, PKG activates KCa channels where K+ entry causes 
hyperpolarization and inhibition of Ca2+ entry through voltage-gated 
channels (Kannan and Johnson, 1995). Besides that PKG also inhibits 
membrane Ca2+ channel activity preventing the entry of Ca2+ (Horowitz et 
al., 1996). PKG also inhibits PKC and blocks IP3 receptors which have 
been discussed previously as important pathways for contraction of 
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smooth muscle cells. It may also activate MLCP which is responsible for 
dephosphorylating the MLC20, causing relaxation of smooth muscle cells 
(Carvajal et al., 2000). The relaxing effect of KATP channels was also 
reported in the isolated human ureter in vitro and also in intact ureters of 
anesthetized pigs in vivo (Weiss et al., 2002) which suggest that KATP 
channels have a role in the intracellular mechanism of smooth muscle 
contraction in the ureter.  In addition to this, it is suggested that hydrogen 
disulphide is a potent inhibitory neurotransmitter in the pig intravesical 
ureter via the activation of KATP channels (Fernandes et al., 2014). 
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1.5 Summary 
 
Ureteral colic is a common symptom presented clinically in patients 
affected by ureteral calculi which causes significant discomfort. The ureter 
is perhaps the least researched organ of the urinary tract. Although 
numerous molecular and functional studies have been performed on 
receptors at the membrane level of ureteric smooth muscle cells, there are 
many gaps in the knowledge of the control of ureteric smooth muscle 
contractile activity, and particularly, in the intracellular signal transduction 
modulating these responses. It is important to have a greater 
understanding of the intracellular mechanisms controlling ureteral smooth 
muscle contraction, as this may reveal novel mechanisms and identify 
targets for development of more effective pharmacological agents for 
expulsion of ureteral calculi and the treatment of ureteral colic.  
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1.6 Research Aims 
 
The overall aim of this study was to elucidate the mechanisms controlling 
ureteral motility by filling the gaps of current research, with a view to 
identify novel targets for the development of suitable drugs for medical 
expulsive treatment of ureteral stones.  
 
Specifically, isolated pig ureteral tissues were utilised in this study with the 
aims to:  
1) Optimise in vitro methodology for use of the pig model in studies of 
ureteral contractility (regions of ureter, tissue orientation, age groups). 
2) Functionally characterise agonist-mediated responses of the ureter, 
particularly those mediated via adrenoceptors, muscarinic, histamine, 
and 5-HT receptors. 
3) Functionally and molecularly characterise the intracellular signalling 
pathways linked to these receptors, in particular the Rho-kinase 
pathway / calcium sensitisation. 
4) Functionally investigate the effect of the urothelium and adenosine 
triphosphate (ATP) on agonist-mediated contractile activity. 
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CHAPTER 2: 
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2.1 General Methods 
 
Tissue Preparation 
Female pig urinary bladders, with ureters and urethra attached, were 
obtained from the local abattoir (Highchester Meats, Beau-Dessert, 
Queensland). These were immediately placed in ice-cold Krebs 
bicarbonate solution (4ºC) and transported on ice to Bond University for 
experimental procedures. Both right and left ureters were detached from 
the bladders and peri-ureteric fat was removed with care to avoid 
disruption of the smooth muscle layer of the ureter. The ureters were 
divided into proximal and distal segments, where proximal ureter was 
determined as the first 5cm of tube leaving the kidneys, and distal ureter 
was determined as the 5cm just before entering the bladder. These were 
dissected into 4mm long tissue strip sections. The tissue strips were 
mounted in 8ml organ baths (EZ-baths, Global Towns, CA) containing 
Krebs-bicarbonate solution, which was maintained at 37ºC and 
continuously gassed with 95% O2 and 5% CO2 (Figure 2.1). 
 
 
 
Figure 2.1 Set-up of four 8ml organ baths (EZ-baths, Global Towns, CA) 
with isometric transducers attached. 
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The ends of each tissue strip were attached with suture to an isometric 
transducer and tissue holder. A resting tension of 1 - 1.5g was set on the 
tissues and they were allowed to equilibrate for 45 minutes before the 
experimental protocol was commenced. During this resting period, tissues 
were washed with fresh Krebs solution every 15 minutes. Isometric 
tension generated by the tissues was measured using the isometric 
transducers connected to a PC and recorded using Powerlab LabChart® 6 
software (AD Instruments). At the end of all experiments, wet tissue 
weights were measured and recorded after removing moisture by dabbing 
with tissue paper.  
 
 
Buffers and Drugs 
Krebs-bicarbonate solution was used for all experiments. The composition 
is shown in the following table (Table 2.1). 
 
 
Table 2.1 Composition of Krebs bicarbonate 
solution 
Compound  Molarity 
Sodium chloride 118.4mM 
D(+)Glucose 11.7mM 
Sodium bicarbonate 25.0mM 
Potassium chloride 4.6mM 
Magnesium sulphate 2.4mM 
Potassium dihydrogen phosphate 1.2mM 
Calcium chloride 1.9mM 
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The chemicals and drugs used in the experiments are listed in the table 
below (Table 2.2). Stock solutions were made up in distilled water (dH2O) 
where possible, and if not, in dimethyl sulfoxide (DMSO) or ethanol. 
Further dilutions were made in distilled dH2O. Where stock solutions were 
made up with DMSO or ethanol, vehicle controls were incorporated into 
the experimental design. 
 
 
Table 2.2 List of Drugs and Chemicals (continued on following page) 
Compound  
Molecular 
Weight 
Supplier 
Catalogue 
Number 
Sodium chloride 58.44 Sigma-Aldrich S9888 
D-(+) Glucose 180.16 Sigma-Aldrich G8270 
Sodium bicarbonate 84.01 Sigma-Aldrich S5761 
Potassium chloride 74.55 Sigma-Aldrich P9541 
Magnesium sulphate 120.37 Sigma-Aldrich M7506 
Potassium dihydrogen 
phosphate 
136.09 Sigma-Aldrich P9791 
Calcium chloride solution 
(1M) 
110.98 Sigma-Aldrich 21115 
Phenylephrine 
hydrochloride  
203.67 Sigma-Aldrich P6126 
Carbamoylcholine chloride 182.65 Sigma-Aldrich C2409 
5-hydroxytryptamine 
hydrochloride 
212.68 Abcam 153-98-0 
Histamine dihydrochloride 184.07 Sigma-Aldrich H7250 
Indomethacin 357.79 Sigma-Aldrich I7378 
N-Nitro-L-arginine 219.20 Sigma-Aldrich N5501 
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Table 2.2 List of Drugs and Chemicals (continued from previous page) 
Compound  
Molecular 
Weight 
Supplier 
Catalogue 
Number 
Methiothepin mesylate salt 452.65 Sigma-Aldrich M149 
Ketanserin (+)-tartrate salt 545.51 Sigma-Aldrich S006 
RS-102221 649.08 Tocris 1050 
Ondansetron hydrochloride 
dihydrate 
365.85 Sigma-Aldrich O3639 
GR-113808 393.50 Tocris 1322 
SB 699551 584.66 Sigma-Aldrich SML0853 
SB-399885 hydrochloride 482.81 Sigma-Aldrich SML0604 
SB-269970 hydrochloride 388.95 Sigma-Aldrich S7389 
α-methyl-5-
hydroxytryptamine maleate 
306.32 Tocris 0557 
Y-27632 dihydrochloride 320.26 Tocris 1254 
Fasudil hydrochloride  327.83 Tocris 0541 
Adenosine 5’-triphosphate 
disodium salt hydrate 
551.14 Sigma-Aldrich A2383 
Apyrase from potatoes 
3.0-40.0 
Units/mg 
Sigma-Aldrich A6132 
Suramin sodium salt 1429.17 Sigma-Aldrich S2671 
1,3-Dimethyl-8-
phneylxanthine (8-
phenyltheophylline)  
256.26 Sigma-Aldrich P2278 
Dimethyl sulfoxide ACS 
reagent 
78.13 Sigma-Aldrich 472301 
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Data Analysis 
In preliminary experiments, in response to phenylephrine and other 
agonists, isolated ureteral strips from pigs develop spontaneous phasic 
contractions (Figure 2.2). Figure 2.2 showing the raw trace of contractile 
response to phenylephrine is the typical trace seen in response to all 
agonists including 5-HT and carbachol. The appearances of the phasic 
activities in response to all agonists are similar. The increase in amplitude 
of contractions in this spontaneous contractility did not necessarily 
correlate with increasing concentrations of agonist. Therefore, contractile 
activities of these tissues were expressed as area under the curve (AUC), 
by weight in grams seconds (g s) and frequency in Hertz (Hz), the number 
of phasic contractions in a second (see Appendix 1 for calculation of AUC 
using LabChart software). For all experiments within this thesis, the n 
number of preparations stated represents the number of different animals 
that were used. 
 
Appropriate statistical analyses for each set of data were performed and 
these will be discussed in detail in their respective chapters. In this 
methods optimization chapter, paired or unpaired (Chapter 2.5) Student’s 
t-tests were performed to identify statistically significant differences, where 
p<0.05 was deemed a significant difference. 
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2.2 Optimization of Responses of Ureteral 
Tissue 
 
When subjected to phenylephrine and other agonists (listed in later 
sections), tissue strips from the porcine ureter produced bursts of 
spontaneous contractile activity with increasing frequency of contraction 
that was dependent on increasing concentrations of the agonist. However, 
the amplitude of phasic contraction was independent of agonist 
concentration, and there was no consistent pattern of increase or 
decrease of amplitude at various concentrations of phenylephrine. Basal 
tension was not significantly increased with increased agonist 
concentrations. While amplitude appears to increase with concentration in 
Figure 2.2, this was not necessarily concentration-dependent in the 
majority of experiments. Additionally, within one concentration of agonist, 
the amplitude of the phasic contractions varied. This was apparent for all 
agonists that induced any contractile response. 
 
In preliminary investigations of cumulative concentration-response curves, 
it was notable that the tissues were desensitised at pre-maximal 
concentrations of phenylephrine following cumulative addition of agonist 
(Figure 2.2 and 2.4). Therefore, in order to produce accurate and 
consistent results, responses to single concentrations of agonist were 
performed in all subsequent experiments with porcine ureters, where each 
concentration of agonist was added for 5 minutes and washed for 10 
minutes before the following concentration was added. This allowed for 
accurate measurement of contractile activity to each agonist 
concentration, as a proper baseline was exhibited before each burst of 
phasic contractions (Figure 2.3). 
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Figure 2.4 Comparison of responses of pig distal ureter following 
cumulative vs single concentrations of phenylephrine. Responses are 
expressed as AUC in g s (a) and frequency in Hz (b). 
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2.3 Optimization of Tissue Strip Orientation 
 
Introduction 
The technique of in vitro isolated tissues is a useful and important method 
to investigate the physiology and pharmacology of various animal and 
human tissues, including the ureter. However, in previous studies of the in 
vitro function of isolated ureter, different laboratories have utilised various 
methods for preparing and mounting ureteral tissues. Thus, this prevents a 
valid comparison of data.   
 
As discussed in the Chapter 1, transverse sections of ureter have been 
studied previously and it has been shown that muscular bundles occur in 
two layers within the ureter, the outer muscular bundles that are orientated 
in a circular manner and the inner orientated longitudinally (Hanna et al., 
1976). Due to these findings, some reports suggest that a spiral-cut 
segment of the ureter preserves more continuous muscular bundles and 
can generate more powerful spontaneous contractions (Morita et al., 
1995). Despite this proposition, in a previous study, intact ring segments, 
open longitudinal tubes, closed longitudinal tubes and open spiral cut 
segments of porcine isolated ureter, as shown in Figure 2.5, were 
compared and it was found that responses did not vary (Jerde et al., 
1999). Therefore, most studies have utilised the open longitudinal tissue 
preparation, as spiral preparations utilise a greater amount of tissue and 
are not ideal for studies involving limited human or animal tissues.  
 
However, a circular preparation, as shown in Figure 2.6, has not been 
previously examined. Therefore, as part of the methods optimization, the 
aim was to compare the contractile responses between the following two 
types of ureteral preparations, longitudinal and circular, to determine which 
method was most optimal for the study of agonist-mediated contractile 
responses. 
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Figure 2.5 Preparations of ureteral tissues used in previous studies (Jerde 
et al., 1999).  
 
 
Methods and Materials 
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. The tissue strip orientations that were compared in 
this study are longitudinal and circular preparations and these were 
dissected and prepared as shown in Figure 2.6. The agonist used in this 
study was phenylephrine (7.48 x 10-8 – 7.48 x 10-4 M). Adjacent tissue 
strips were set-up in adjacent organ baths for comparison of contractile 
responses between circular and longitudinal segments. Contractile 
responses were expressed as AUC (g s) and frequency (Hz). 
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Figure 2.6 The two different methods used for preparation of ureteral 
segments. The lumen of ureteral segments was dissected open and 
attachments of suture for recording were positioned longitudinally 
(longitudinal preparation) or transversely (circular preparation) across the 
tissue strip. 
 
 
Results 
All porcine ureteral strips were allowed to equilibrate to a passive tension 
of 1.05g ± 0.04g (n=8). Spontaneous contractions developed in 3 of 8 
ureteral strips. When quiescent tissue strips were subjected to increasing 
concentrations of phenylephrine, both longitudinal and circular segments 
of porcine ureter developed bursts of phasic contractions. Also, increasing 
concentrations of phenylephrine induced increases in frequency of phasic 
activity in all porcine distal ureteral strips. However, the amplitude of 
phasic activity was not concentration-dependent. 
 
The potency (pEC50) of phenylephrine in the longitudinal segments was 
significantly greater than in the circular segments (p<0.05, paired t-test, 
n=4, Table 2.3). In addition, the maximum AUC of the contractile 
responses was also greater in the longitudinal strips (p<0.05, paired t-test, 
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n=4, Fig 2.7a). Maximum frequency was also greater in longitudinal 
segments (p<0.05, paired t-test, n=4, Fig 2.7b). 
    
          
       
   
 Figure 2.7 Concentration-response curves for phenylephrine in the distal 
pig ureter in longitudinal and circular preparations. Responses are 
expressed as AUC by tissue weight (a) and frequency (b). Data are 
presented as mean ± SEM of 4 preparations in each group. (*p<0.05, 
**p<0.01, ***p<0.001 vs circular) 
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Discussion 
A previous study reported that different preparations of pig ureteral tissue, 
including open longitudinal (similar to the longitudinal preparations in our 
study), closed longitudinal, closed ring and spiral cut segments all 
produced contractile responses that were similar in spontaneous 
contraction rates and maximum amplitude, in response to electrical field 
stimulation (EFS) and muscarinic stimulation with carbachol (Jerde et al., 
1999). However, no studies have investigated the open circular segment 
utilised in the present study. 
 
The longitudinal smooth muscle layer in the ureter is responsible for the 
shortening of the ureter while the circular smooth muscle contracts to 
generate lumen pressure and coapting of the ureteral walls. The present 
results indicate that the potency of phenylephrine, maximal AUC 
responses and maximal frequency are significantly greater in the 
longitudinal segments compared to the circular segments of ureter. This 
could be due to the greater amount of longitudinal smooth muscle 
compared to circular smooth muscle. However, there is no histological 
data on quantification of different smooth muscle types of the ureter 
available currently in the literature. Additionally, another explanation for 
Table 2.3 pEC50 values for AUC for 
phenylephrine responses in the pig ureter. Data 
are expressed as mean ± SEM (* vs circular 
segments). 
Orientation n pEC50 
Longitudinal 4 5.08 ± 0.27* 
Circular 4 4.54 ± 0.22 
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the results obtained could be that longitudinal smooth muscles cells of the 
ureter are more powerful compared to the circular smooth muscle cells 
and therefore were able to produce greater contractile responses. A recent 
mechanical study on the human ureter smooth muscle showed that the 
longitudinal smooth muscle possessed a significantly higher rate of myosin 
cross bridge interactions in comparison to the circular layer (Vargiu et al., 
2015). Therefore, this could likely result in a stronger contraction within the 
longitudinal layer of smooth muscle in comparison to the circular layer.  
 
It has been suggested that an increase in contractility and stretching of 
both circular and longitudinal smooth muscles surrounding a stone 
significantly amplifies pain, causing ureteral colic (Rose and Gillenwater, 
1973). Most studies on the isolated ureter in vitro utilise longitudinal tissue 
preparations.  In light of these results, longitudinal segments were used in 
all subsequent experiments in this thesis. This also allowed for a more 
reliable comparison between reported results of ureteric study in the 
literature and our results. 
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2.4  Reproducibility of Concentration-
Response Curves 
 
Introduction 
The desensitization of isolated ureteral smooth muscle strips was 
observed in preliminary experiments to cumulative concentrations of 
agonists. In addition to this, there have been numerous reports of 
desensitization of agonist-mediated responses in the urinary tract.  In 
order to investigate the effects of antagonists on responses of isolated 
ureteral smooth muscle, we aimed to determine the reproducibility of 
concentration-response curves to various agonists.  
 
 
Methods and Materials 
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. The agonist used in this study was phenylephrine 
(7.48 x 10-8 – 7.48 x 10-4 M). Tissue strips were subjected to increasing 
concentrations of phenylephrine and washed with Krebs solution until 
contractile responses returned to baseline, before the strips were 
subjected to increasing single concentrations of phenylephrine again. 
Contractile responses were expressed as a percentage of the maximal 
response in AUC (g-1 s) and frequency (Hz). 
 
 
Results 
All porcine ureteral strips were allowed to equilibrate to a passive tension 
of 1.18g ± 0.09g (n=6). No spontaneous contractions developed in any 
tissues strips. Increasing concentrations of phenylephrine triggered bursts 
of phasic contractions in quiescent tissue strips. Increasing single 
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concentrations of phenylephrine induced increases in frequency of phasic 
activity in all porcine distal ureteral strips, while amplitude of phasic activity 
was not concentration-dependent.   
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Figure 2.8 Comparison of first and second concentration-response curves 
for phenylephrine in the distal pig ureter. Responses are expressed as 
percentage of the maximal AUC (a) and frequency (b). Results are 
presented as mean ± SEM of 6 preparations. (*p<0.05, **p<0.01, 
***p<0.001 vs second curve) 
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The potency (pEC50) of phenylephrine was similar for first and second 
curves (Table 2.4). Maximum AUC of the contractile responses was 
reduced by 33% in the second curve (p<0.001, paired t-test, n=6, Figure 
2.8a). Maximum frequency was also depressed by 40% in the second 
phenylephrine concentration-response curve (p<0.001, paired t-test, n=6, 
Figure 2.8b). This reduction was not only observed at maximal 
concentrations of phenylephrine but also at submaximal concentrations. 
 
 
Discussion 
Our findings have shown that maximum contractile responses expressed 
as AUC and frequency were diminished in the subsequent phenylephrine 
concentration-response curve (Figure 2.8). The inability of the same 
isolated pig ureteral strip to contract to its full potential for the second time 
to increasing concentrations of phenylephrine is likely due to the 
desensitization of the α1-adrenoceptors in the smooth muscle cells.  
 
Receptor desensitization occurs when a diminished response to an 
agonist is obtained when compared to the initial response (Collins et al., 
1990). This is usually considered as a pharmacological event caused by 
prolonged stimulation by an agonist or by stimulation with a high agonist 
concentration. It is thought that in GPCRs like α1-adrenoceptors, a self-
Table 2.4 pEC50 values for AUC of 
phenylephrine responses in the pig ureter. 
Results are expressed as mean ± SEM. 
Curve n pEC50 
First 6 4.85 ± 0.07 
Second 6 4.65 ± 0.12 
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limited signal is produced when exposed to continuous stimulation by an 
agonist (Ferguson et al., 1998). Studies have shown that desensitization 
can involve various processes including changes in cellular receptor 
compartmentalization, receptor number and downstream signal 
transduction machinery (Thompson et al., 2005). In a previous study, it 
was reported that among three human α-adrenoceptor subtypes, only α1A- 
and α1B-adrenoceptors were downregulated with prolonged phenylephrine 
exposure while α1D-adrenoceptors were in fact, upregulated (Yang et al., 
1999). These effects were observed as soon as 2 hours of phenylephrine 
exposure (Yang et al., 1999). In this same study, it was also observed that 
these treatment conditions also caused a downregulation in inositol 
phosphate formation via α1A- and α1B-adrenoceptors but not in α1D-
adrenoceptors (Yang et al., 1999). However, mRNA expression was 
reduced only for α1B-adrenoceptors and not for α1A-adrenoceptors upon 
phenylephrine treatment, suggesting that desensitization of α1A-
adrenoceptor may occur independent of changes in corresponding mRNA 
(Yang et al., 1999). In the human and pig isolated ureter, it was found that 
although expression of α1D-adrenoceptor subtype is the greatest (Itoh et 
al., 2007), the subtype that plays the dominant functional role in smooth 
muscle contraction is α1A-adrenoceptor and not other adrenoceptor 
subtypes (Sasaki et al., 2011). Therefore, it is most likely that the 
desensitization observed in the present study is due to downregulation of 
inositol phosphate formation via α1A-adrenoceptors over prolonged 
exposure to agonist phenylephrine. While further molecular studies are 
required, alteration in mRNA expression of adrenoceptors is less likely. 
 
In conclusion, the depressed response in the smooth muscle cells of the 
ureter upon phenylephrine treatment in the present study could be due to 
α1A-adrenoceptor desensitization. For this reason, in all further 
experiments, paired adjacent ureteral tissue strips were utilised and only 
one concentration-response curve was constructed on each tissue, to 
avoid the variable of desensitization in antagonist experiments. 
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2.5 Effect of Age on Ureteral Responses 
 
Introduction 
Ageing has been shown to be a risk factor for urinary stone formation and 
is associated with declining function in almost every physiological system 
(Hess, 2003). Thus, it is vital to investigate how physiological function 
alters as we age, to aid in drug discovery and treatment of disease in the 
ageing society. However, it is often difficult to distinguish between 
dysfunction caused by disease and modifications that are solely age-
related.  
 
In the lower urinary tract, there have been many studies that have 
investigated how bladder function and neural activity are affected by 
ageing. Morphological studies demonstrate that there is an age-dependent 
decrease in numbers of unmyelinated afferents innervating the bladder, 
but the general innervation pattern seems to be preserved in rats (Aizawa 
et al., 2011, Mohammed and Santer, 2002, Nakayama et al., 1998). In 
addition to this, functional and histological investigations have produced 
contradicting results, where some found a decrease in detrusor muscle 
thickness, collagen deposition and contractility with age in the rat bladder 
(Lluel et al., 2000) while others have reported no change in the mouse 
bladder (Smith et al., 2012). 
 
Very little research has been directed towards the effects that ageing has 
on the normal functioning system of the ureter. α1-adrenoceptor-mediated 
contractions in the ureteral smooth muscle have been described in human 
(Park et al., 2007), canine (Wanajo et al., 2005), mouse and hamster 
(Kobayashi et al., 2009).  It has been shown that the receptor subtype 
responsible for contraction to noradrenaline is the α1A-adrenoceptor in 
human ureteral tissues, but the most abundant subtype at the mRNA level 
is the α1D-adrenoceptor (Sasaki et al., 2011).  Although no studies have 
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investigated α1-adrenoceptor-mediated responses in ureter with age, age-
related changes in α-adrenoceptor-mediated responses have been 
investigated in other tissues of the lower urinary tract, where increased 
contractile responses to phenylephrine were observed in the rat bladder 
with age (Ordway et al., 1986b). In other systems besides the urinary tract, 
ageing has also been shown to produce changes in α-adrenoceptor 
responses and these include the rat vas deferens (Yono et al., 2008, 
Docherty and O'Malley, 1983), rat isolated trachea (Preuss et al., 1998), 
and vascular preparations from rats (Docherty, 1988, Docherty and 
O'Malley, 1983) and dog (Toda and Shimizu, 1987). In contrast, it has 
been reported that there was no age-related change in α-adrenoceptor-
mediated response in human vascular tissue (Stevens et al., 1982, Scott 
and Reid, 1982) or rat tail arteries (Tsai et al., 1993). 
 
Although it has been shown that the α-adrenergic system plays the major 
role in contractility of the ureter, some studies have demonstrated the 
distribution of acetylcholinesterase-positive fibres at the distal ureter 
(Schulman, 1975, Prieto et al., 1990). Additionally, stimulation by 
muscarinic agonists has been shown to induce contractile responses in 
the isolated ureter of various species including  pig (Hernandez et al., 
1993), dog (Tomiyama et al., 2003b) and horse (Prieto et al., 1994). In the 
bladder, the effects of ageing on contractile responses induced by 
muscarinic agents are contradictory (Munro and Wendt, 1993, Lieu et al., 
1997, Ordway et al., 1986a). Nevertheless, changes were observed with 
ageing and this suggests that modifications with age in muscarinic 
receptors could also occur in the ureter. 
 
5-hydroxytyptamine (5-HT) has been shown to have a variety of actions on 
many cell types including smooth muscle cells. Pharmacological studies 
have shown that 5-HT evokes contractions in the ureter in vivo (Fetissof et 
al., 1983) and in vitro (Hernandez et al., 2003, Gidener et al., 1999, 
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Gidener et al., 1995). In one study, the detrusor muscle was shown to 
have altered contractile responses to 5-HT with ageing (Saito et al., 1993).  
 
Histamine is an inflammatory mediator released by basophils and mast 
cells that could be involved in the mediation of smooth muscle 
contractions.  Although very little research has been directed at histamine-
stimulated responses in the ureter, studies on the human and dog ureter 
have shown that contraction was induced by histamine (Bertaccini et al., 
1983, Dodel et al., 1996). There was no effect of age on histamine-
induced contractions in the male rat bladder (Chun et al., 1989) but 
contractions were greater in the young rabbit in comparison to the older 
group (Zderic et al., 1990). 
 
In our preliminary experiments, we noticed different responses in tissues 
from two different age groups of pigs available at the abattoir (old: 24 
months, young: 3 months). Therefore, it was of interest to compare the 
responses of the ureters between the age groups. The aim of the present 
study was to investigate the effect of age on smooth muscle contractility in 
the porcine ureter. 
 
 
Methods and Materials 
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. The agonists in this study were phenylephrine (7.48 
x 10-8 – 7.48 x 10-4 M), carbachol (6.84 x 10-8 – 6.84 x 10-4 M), 5-HT (5.88 
x 10-8 – 5.88 x 10-4 M), and histamine (1.12 x 10-7 – 1.12 x 10-3 M). 
Contractions to agonists were expressed as AUC by weight (g-1 s) and 
frequency (Hz). 
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Results 
The ureteral strips were allowed to equilibrate at a passive tension of 
1.01g ± 0.12g (n=56) and spontaneous contractions developed during 
equilibration period in 16 of 56 (29%) ureteral strips. When subjected to 
increasing single concentrations of phenylephrine and 5-HT, porcine 
ureteral tissues from both age groups developed bursts of phasic 
contractions and increasing concentrations caused increased frequency of 
phasic activity (Figures 2.9 and 2.11). In the presence of increasing 
concentrations of carbachol, only isolated ureteral strips from the older 
age group produced contractile responses, which were of a similar pattern 
(Figure 2.10). Increasing concentrations also resulted in an increase of 
frequency in phasic activity. No ureteral strips responded to stimulation by 
histamine (not shown).  
 
The potency (pEC50) of agonists was similar for tissues from both age 
groups, where comparison was possible (phenylephrine and 5-HT) (Table 
2.5). However, the maximum contractile responses to phenylephrine 
expressed in AUC (p<0.001, unpaired t-test, n=8, Figure 2.9a) and 
frequency were significantly enhanced in tissues from the the older group 
(p<0.05, unpaired t-test, n=8, Figure 2.9b). In contrast, for 5-HT, maximum 
AUC responses (p<0.001, unpaired t-test, n=8, Figure 2.11a) were 
depressed in tissues from older animals. However, the maximum 
frequency was similar in tissues from both age groups (Figure 2.11b).    
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Figure 2.9 Concentration-response curves for phenylephrine in distal 
ureteral tissues from old and young pigs. Responses are expressed as 
AUC by weight in g s (a) and frequency in Hz (b). Results are presented 
as mean ± SEM  of 8 preparations for each (*p<0.05, **p<0.01, ***p<0.001   
vs young) 
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Figure 2.10 Concentration-response curves for carbachol in distal ureteral 
tissues from old and young pigs. Responses are expressed as AUC by 
weight in g s (a) and frequency in Hz (b). Results are presented as mean ± 
SEM of 8 preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs 
young) 
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Figure 2.11 Concentration-response curves for carbachol in distal ureteral 
tissues from old and young pigs. Responses are expressed as AUC by 
weight in g s (a) and frequency in Hz (b). Results are presented as mean ± 
SEM of 8 preparations for each group. (*p<0.05, **p<0.01, ***p<0.001vs 
young) 
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Discussion 
In the present study, it was observed that isolated porcine ureteral smooth 
muscle demonstrates age-related changes in contractions in response to 
α-adrenoceptor, muscarinic and 5-HT receptor stimulation. Maximal 
contractile responses to the α-adrenoceptor agonist phenylephrine and the 
muscarinic receptor agonist carbachol were greater in older animals, 
whereas contractile responses to 5-HT were greater in younger animals. 
There were no changes in potency for any of the agonists, where possible 
comparison was permitted (phenylephrine and 5-HT). Therefore, changes 
observed in the maximal contractions are unlikely to be caused by an 
increase or decrease in the number of functional receptors expressed with 
age or affinity of the receptors for the agonist, as a decrease in receptor 
expression should produce a rightward shift of concentration curves. 
Additionally, it is also unlikely that these age-related changes are due to a 
general modification of smooth muscle contraction capability with age, as 
Table 2.5 pEC50 values for AUC in responses to 
various agonists in the distal ureters from old and 
young pigs. Results are expressed as mean ± SEM. 
Agonist Group n pEC50 
Phenylephrine 
Young 8 4.42 ± 0.18 
Old 8 4.83 ± 1.43 
Carbachol 
Young 8 - 
Old 8 4.77 ± 0.11 
5-HT 
Young 8 5.16 ± 0.09 
Old 8 5.43 ± 0.16 
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phenylephrine and carbachol induced greater contractions with age whilst 
5-HT-stimulated contractions were reduced with age. 
 
 
Increase in Phenylephrine-Induced Contractile Responses with Age  
The findings with regards to α-adrenoceptor stimulation in the ureter 
support previous findings demonstrating an increase in contractile 
responses to norepinephrine with age in the isolated rat urinary bladder, 
where no change in potency was observed with age (Saito et al., 1993, 
Ordway et al., 1986b).  Likewise, it was found that norepinephrine-induced 
contractile responses were greater in the bladders of older rats (Ordway et 
al., 1986b). Besides the lower urinary tract, studies on the effect of ageing 
on α-adrenoceptor-mediated contractile responses in other physiological 
systems have also been shown. Isolated rat tracheal strips elicited 
increased maximal contractions to noradrenaline in older animals, where 
pEC50 values were unaffected (Preuss et al., 1998). In this same study, 
ageing did not affect maximal contraction or pEC50 values for 
noradrenaline in isolated trachea from guinea-pig, indicating that age-
dependent α-adrenoceptor stimulation may be species-dependent (Preuss 
et al., 1998).  
 
In the human and porcine ureter, the dominant functional α1-adrenoceptor 
subtype is the α1A-adrenoceptor subtype (Sasaki et al., 2011). To our 
knowledge, there are currently no studies on the effect of ageing ureteral 
contractile responses. While mRNA studies of the various α-adrenoceptor 
subtypes have shown that there is a possible change of receptor subtype 
expression dominance from the α1A-adrenoceptor subtype to α1B-
adrenoceptor with maturation in aortic tissues of rats (Gurdal et al., 1995), 
this is unlikely to be the case to explain the present findings in the pig 
ureter. A change in receptor number might be evident in the case where 
maximal response to a partial agonist is altered or pEC50 values for full 
agonist are changed.  However, the present results show that the pEC50 
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value for phenylephrine, a full agonist, was not altered with age, which 
suggests that the increased contractile responses are not due to 
modification of α1A-adrenoceptor expression, but a change in the efficacy 
of the agonist. Alteration of receptor efficacy could be due to changes the 
intracellular signalling pathway/s resulting in the contractile responses. 
 
It is thought that the preferential intracellular pathway of α1-adrenoceptors 
is via Gq subunit coupling, activating the phospholipase C pathway which 
elevates levels of inositiol (1,4,5)-triphosphate and intracellular Ca2+, and 
releasing diacylglycerol that in turns allows protein kinase C activation. In 
addition to this, it has been reported that activation of α1-adrenoceptors 
also caused the activation of phospholipase A2, phospholipase D, 
adenylate cyclase and mitogen-activated protein kinases (Perez et al., 
1993, Graham et al., 1996, Zhong and Minneman, 1999, Piascik and 
Perez, 2001). The discovery of these multiple signalling pathways 
produces the possibility for activation of one subtype of α1-adrenoceptor 
producing different outcomes in the cell. In an investigation measuring the 
capacity of α1A-adrenoceptor stimulation to activate various signalling 
pathways, phenylephrine showed significant bias towards extracellular 
acidification rate versus Ca2+ release and cAMP accumulation (Evans et 
al., 2011). While there are currently no studies to our knowledge that have 
investigated these intracellular signalling pathways in the ureter, the 
possibility of an increase in extracellular acidification rate in the isolated 
porcine ureter with age alteration in functional intracellular cellular 
pathways may explain the increase in contractile response to 
phenylephrine with age in the present study. 
 
 
Increase in Carbachol-Induced Contractile Responses with Age  
In the bladder, contractions in response to cholinergic receptor stimulation 
by acetylcholine in denuded detrusor muscle strips were enhanced in 
tissues from aged mice (Daly et al., 2014) and older rats (Longhurst et al., 
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1992, Ordway et al., 1986a). The present study supports these findings in 
the lower urinary tract given that isolated ureters from younger animals did 
not respond to carbachol, whereas tissues from older animals did.  
 
While no molecular studies have been performed on muscarinic receptors 
in the ureter, a previous study suggested that the M1 receptor subtype 
regulated tonic responses in the pig intravesical ureter and phasic 
responses involved M2, M3 and M4 muscarinic receptors (Hernandez et al., 
1993). However, the age group of the animals used in the stated study 
was not reported and therefore, it is difficult to draw conclusions about 
expression with age.  In the present study, it was observed that there is no 
phasic nor tonic response to carbachol in isolated ureter from younger 
animals, suggesting the possibility that these muscarinic receptor 
subtypes may not be expressed before a certain age in the ureter. 
However, most studies on the lower urinary tract, particularly the bladder, 
suggest a decrease in muscarinic receptor expression with age. A study 
using quantitative competitive RT-PCR demonstrated a selective age-
related decrease in mRNA for muscarinic M3 receptors in detrusor of 
human bladder (Mansfield et al., 2005). However, RT-PCR showed that 
expression of mRNA of M2 and M3 muscarinic receptor subtypes were 
similar in isolated detrusor from juvenile and old pigs (Wuest et al., 2008). 
Thus the effect of age in the lower urinary tract is still not clear, and while it 
is not possible to directly compare the bladder with the ureter, these 
reports present the potential for a change in muscarinic receptor-mediated 
expression with age in the porcine isolated ureter. It is also possible that 
alterations in intracellular signalling pathways contribute to these changes. 
 
 
Decrease in 5-HT-Induced Contractile Responses with Age  
Whilst a few studies have examined the effects of ageing on responses of 
smooth muscle within lower urinary tract to 5-HT, results have been 
inconsistent. In studies of the rat urinary bladder, in vitro detrusor strips 
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have shown an increase in contractile response to 5-HT with age, while 
another study showed that responses were unaffected (Saito et al., 1993, 
Chun et al., 1989). Outside of the lower urinary tract, generally age does 
not appear to affect smooth muscle responses to 5-HT. Contractile 
responses to 5-HT in the guinea-pig and rat isolated trachea were shown 
not to differ in potency or maximal response between age groups (Cox 
and Cohen, 1994, Preuss and Goldie, 1998). Similarly, changes observed 
in rat vascular contractions to α-adrenoceptor stimulation due to age were 
not observed for 5-HT-mediated contractile responses (Cai et al., 1994). 
Although most studies of smooth muscle indicate that contractile activity to 
5-HT is not dependent on age, a similar finding to the present study was 
observed in the human basilar artery, where maximal contractions 
stimulated by 5-HT decreased with age (Hatake et al., 1992). 
 
Similar to pEC50 values of phenylephrine, pEC50 values for 5-HT were also 
unaffected by age. Because 5-HT is a full agonist for its receptors, it is 
also unlikely that the decrease in maximal 5-HT-induced contraction with 
age is due to changes in receptor expression but instead is due to altered 
efficacy of receptor stimulation. It is suggested that the differences in 5-
HT-stimulated contractile responses with age presented here could be due 
to alterations in the involvement of other receptor subtypes to contractility 
with age. This is further discussed in the following chapter, where the 5-HT 
receptor subtype/s responsible for 5-HT-stimulated contractile responses 
were pharmacologically characterised in ureteral tissues from old and 
young animals (Chapter 3). 
 
 
Summary 
In conclusion, contractile responses mediated by adrenergic, muscarinic 
and 5-HT receptors are altered with age in the porcine ureter. It is 
suggested that these age-related modifications in adrenergic responses 
may be due to changes in the intracellular signalling pathways stimulated 
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by receptor activation, while in muscarinic receptor mediated contractions, 
the alterations may be due to changes in receptor expression. However, 
further molecular and pharmacological studies are required. With regard to 
5-HT-mediated contractions, the following chapter investigates in more 
detail the possible cause for age-related changes in responses to 5-HT.  
 
For the purpose of this thesis, these findings were crucial, as it is clear that 
animal age must be a consideration when studying the pharmacology of 
smooth muscle tissues, including the ureter. All subsequent experiments 
in this thesis were performed in both age groups to determine whether 
there were any further age-related changes where all figures for tissues 
from young animals are presented in pink and figures for tissues from old 
animals in blue. 
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2.6  Regional Difference in Responses of the 
Ureter 
 
Introduction 
The ureter can be divided into three regions: the proximal, mid and distal 
ureter. The proximal ureter is the part closer to the kidney and the distal 
ureter is the lower part approaching the bladder. Studies have shown that 
the most common location for lodgement of ureteral calculi is in the distal 
ureter, approaching the ureterovesical junction, where the ureter enters 
the bladder, with this region accounting for 54% of stones requiring 
surgical intervention (El-Barky et al., 2014). The second most common 
location, accounting for 34% of stones, is just below the pelvi-ureteric 
junction where the proximal ureters leave the kidneys (El-Barky et al., 
2014). 
 
It is proposed that electrical activity arises at the renal pelvis where 
atypical smooth muscle cells act as the primary pacemakers and conduct 
peristaltic waves to the ureter (McHale et al., 2006).  In addition to this, 
studies have shown that the innervation density of the autonomic nervous 
system progressively increases from the renal pelvis to the bladder, and 
therefore the distal ureter will be more richly innervated than the proximal 
(Edyvane et al., 1992). The purpose of this study was to compare 5-HT 
and phenylephrine-induced contractile activity in the two different regions 
of the pig isolated ureter. 
 
 
Methods and Materials  
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. The proximal region of the ureter close to the 
kidneys and the distal region close to the bladder were isolated. The 
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agonists used in this study were phenylephrine (7.48 x 10-8 – 7.48 x 10-4 
M) and 5-HT (5.88 x 10-8 – 5.88 x 10-4 M). Contractions to agonists were 
expressed as percentage of maximal response in AUC (g s) and 
frequency (Hz). 
 
 
Results 
Porcine ureteral strips equilibrated to a passive tension of 0.98 ± 0.09 
(n=46). Spontaneous contractions developed during the equilibration time 
in 20 of 23 proximal ureteral strips (87%) and 6 of 23 distal ureteral strips 
(26%).  
 
The potency (pEC50) of agonists was similar between tissues from the two 
different regions and between the tissues from young and old animals 
(Table 2.6). While maximum AUC to phenylephrine was similar (Figure 
2.12a) in tissues from the two regions in the young group, maximum 
frequency was greater in the proximal strips from young animals 
compared to distal (p<0.005, paired t-test, n=6, Figure 2.12b). In contrast, 
in the older animals, maximum contractile responses to phenylephrine 
expressed as AUC were significantly greater in the distal region of the 
isolated ureter compared to proximal (p<0.05, paired t-test, n=5, Figure 
2.13a), although maximum frequency was similar in both regions (Figure 
2.13b).  
 
Maximum contractile responses to 5-HT expressed as AUC were smaller 
in the proximal region than in the distal region in both age groups 
(p<0.001, paired t-test, n=6, Figures 2.14a and 2.15a). Maximum 
frequency in response to 5-HT was not different between the proximal and 
distal regions in tissues from both age groups (Figures 2.14b and 2.15b).  
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Figure 2.12 Concentration-response curves for phenylephrine in the 
proximal and distal ureter from young pigs. Responses are expressed as 
percentage of maximal AUC (a) and frequency (b). Results are presented 
as mean ± SEM (*p<0.05, **p<0.01, ***p<0.001 vs distal) of 6 preparations 
for each group. 
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Figure 2.13 Concentration-response curves for phenylephrine in the 
proximal and distal ureter from old pigs. Responses are expressed as 
percentage of maximal AUC (a) and frequency (b). Results are presented 
as mean ± SEM (*p<0.05, **p<0.01, ***p<0.001 vs distal) of 5 preparations 
for each group. 
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Figure 2.14 Concentration-response curves for 5-HT in the proximal and 
distal ureter from young pigs. Responses are expressed as percentage of 
maximal AUC (a) and frequency (b). Results are presented as mean ± 
SEM (*p<0.05, **p<0.01, ***p<0.001 vs distal) of 6 preparations for each 
group. 
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Figure 2.15 Concentration-response curves for 5-HT in the proximal and 
distal ureter from old pigs. Responses are expressed as percentage of 
maximal AUC (a) and frequency (b). Results are presented as mean ± 
SEM (*p<0.05, **p<0.01, ***p<0.001 vs distal) of 6 preparations for each 
group. 
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Discussion 
The results indicate that there are differences in contractile responses 
between the proximal and distal ureter in specific age groups with specific 
agonists. A previous study in the isolated human ureter showed that 
maximum contraction to phenylephrine was significantly greater in the 
distal ureter in comparison to the proximal ureter (Sasaki et al., 2011). In a 
receptor-binding study, it was also shown that α1-adrenoceptor density 
was significantly greater in the distal human ureter than in the proximal 
ureter, which may explain why ureteral stones are more frequently lodged 
in the distal ureter (Sigala et al., 2005). A novel finding from our study 
shows that the larger phenylephrine-induced contractions in the pig 
isolated distal ureter compared to proximal ureter only occurs in older 
animals. Previous studies have not examined animals from different age 
groups. This result together with our previous finding where older animals 
Table 2.6 Mean pEC50 (±SEM) values for phenylephrine and 5-HT 
(AUC) in proximal and distal segments of pig ureter. 
Agonist Group Segment n pEC50 
Phenylephrine 
Young 
Proximal 6 5.01 ± 0.61 
Distal 6 4.90 ± 0.20 
Old 
Proximal 5 5.15 ± 0.12 
Distal 5 5.14 ± 0.11 
5-HT 
Young 
Proximal 6 5.67 ± 0.32 
Distal 6 5.39 ± 0.27 
Old 
Proximal 6 5.61 ± 0.36 
Distal 6 5.43 ± 0.59 
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had increased maximal response to α1-adrenoceptor stimulation, could 
indicate that the adrenergic system plays an increased role in older 
animals in comparison to the younger animals, in the distal region of the 
ureter. This may be linked with increased reports of ureteral stones with 
age and the efficacy of α1-adrenoceptor antagonist, tamsulosin in 
increasing stone expulsion rate. 
 
It was also observed that the number of ureteral strips from the proximal 
region that developed spontaneous contractions before addition of 
agonists was greater in comparison to strips from the distal ureter. This 
finding was as expected, due to the proximal ureter being located closer to 
the atypical smooth muscle cells located at the renal pelvis that initiate the 
peristaltic wave down the ureteral tube.  
 
It is established that 5-HT induces ureteral contractions in isolated ureter 
preparations from various species including  human (Hertle and Nawrath, 
1986), pig (Hernandez et al., 2003) and dog (Dodel et al., 1996). However, 
this is the first study to compare contractile responses to 5-HT between 
the proximal and distal regions of the ureter. Isolated distal ureter from 
both animal age groups showed enhanced 5-HT-induced contractile 
responses in comparison to the proximal ureter, although frequency was 
similar. The difference in maximum AUC between the two regions was 
similar in both age groups. This indicates that 5-HT plays a greater role in 
contractility of the distal region of the ureter, independent of age. 
 
In the isolated rat ureter, it has been reported that distal segments 
generate greater luminal pressures than proximal segments in response to 
acetylcholine (Rasidovic et al., 2010). Compared with distal segments, 
proximal segments were associated with a greater frequency of 
contraction and a lower magnitude of contraction (Rasidovic et al., 2010). 
Our findings partly support this, where maximum frequency of phasic 
contractions to phenylephrine of the isolated proximal ureter was greater 
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that distal segments in the younger animals. Additionally, isolated distal 
ureteral strips were able to achieve greater maximum AUC contractile 
responses in most cases which are indicative of increased magnitude of 
contractile responses.  
 
As the distal ureter produced greater contractile responses, and it is also 
where most ureteral stones are lodged, we utilised the distal ureter in all 
subsequent experiments.  
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2.7  Effect of Indomethacin on Contractile 
Responses in the Ureter 
 
Introduction 
NSAIDs including indomethacin, ketorolac, and ibuprofen have in some 
clinical trials been shown to be effective for relief of pain during treatment 
of renal colic. In addition, many studies have suggested that prostanoids 
including prostaglandins, thromboxanes and prostacyclins are involved in 
contractile responses mediated by the ureter (Al-Ugaily et al., 1986, 
Mastrangelo et al., 2000, Davidson and Lang, 2000). The synthesis of 
prostanoids from arachidonate involves cyclo-oxygenase (COX), which 
exists in two isoforms: COX-1 and COX-2. Both isoforms have been 
identified in the ovine ureteral smooth muscle and urothelium by 
radioimmunoassay (Ali et al., 1998). COX-1 is expressed in most tissues 
and is responsible for most of the physiological prostaglandin synthesis 
and COX-2 is expressed at low levels in most cells but can be up-
regulated locally by an inflammatory stimulus. Although this is the general 
understanding of these two different isoforms, the delineation of their 
individual roles is not as clear cut (Vane and Botting, 1995).  
 
It is believed that NSAIDs relieve ureteral colic through their anti-diuretic 
and analgesic effects. However, it is likely that NSAIDs may have further 
therapeutic effects by inhibiting smooth muscle contractions in the ureter. 
Several studies have reported that there is a decrease in spontaneous, 
electrically-evoked and agonist-induced contractions in the ureter in 
various species in the presence COX inhibitors (Al-Ugaily et al., 1986, 
Mastrangelo et al., 2000, Davidson and Lang, 2000, Lee et al., 2010). 
However, the influence of age on the effect of COX inhibitor in the ureters 
has not been investigated. In this study, the aim was to determine the role 
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of COX in phenylephrine and 5-HT-induced contractile responses of the 
isolated pig distal ureter with age. 
 
 
Methods and Materials 
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. The agonists used were phenylephrine (7.48 x 10-8 – 
7.48 x 10-4 M) and 5-HT (5.88 x 10-8 – 5.88 x 10-4 M). Contractile 
responses to these agonists were compared in the presence and absence 
of 10μM indomethacin which was introduced to the tissues before the first 
agonist concentration was added and allowed to incubate for 30 minutes. 
Contractions to agonists were expressed as maximum contractile 
responses in AUC and frequency of phasic contractions developed. 
 
 
Results 
A baseline of 1.23g ± 0.15g (n=48) was achieved in tissues during the 
equilibration period and spontaneous contractions developed in 10 of 48 
(21%) ureteral tissue strips. Indomethacin had no effect on potency 
(pEC50) of either agonist in the isolated ureteral strips from both age 
groups (Table 2.7). Maximum AUC and frequency responses to 
phenylephrine were similar in the presence and absence of indomethacin 
(10µM) in ureteral tissues from both age groups (Figure 2.16 and 2.17). 
Maximum contractility to 5-HT stimulation expressed as AUC was 
decreased in the presence of indomethacin (p<0.05, paired t-test, n=6, 
Figure 2.18a) in the younger animals but not in the older animals (Figure 
2.19a). The maximum frequency of phasic contractions in response to 5-
HT was unaffected by indomethacin in both age groups (Figure 2.18b and 
2.19b). 
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Figure 2.16 Concentration-response curves for phenylephrine in the distal 
ureter from young pigs in the absence and presence of indomethacin 
(10µM). Responses are expressed as percentage of maximal AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Figure 2.17 Concentration-response curves for phenylephrine in the distal 
ureter from old pigs in the absence and presence of indomethacin (10µM). 
Responses are expressed as percentage of maximal AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Figure 2.18 Concentration-response curves for 5-HT in the distal ureter 
from young pigs in the absence and presence of indomethacin (10µM). 
Responses are expressed as percentage of maximal AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Figure 2.19 Concentration-response curves for 5-HT in the distal ureter 
from old pigs in the absence and presence of indomethacin (10µM). 
Responses are expressed as percentage of maximal AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Discussion 
To investigate the role of COX in responses of the isolated ureter to 
phenylephrine and 5-HT, the non-selective COX-1 and COX-2 inhibitor 
indomethacin (10µM), was used. Previous studies of prostaglandins in the 
ureter have generally shown that COX inhibitors have a depressant effect 
on ureteral contractility. In the isolated human proximal ureter, NS-398, a 
selective COX-2 inhibitor induced dose-dependent relaxation of tonic and 
phasic contractions to KCl and Bay K 8644 (calcium channel agonist), 
whereas indomethacin and SC-650 (COX-1 inhibitor) had no effect (Lee et 
al., 2010). Diclofenac and NS-398 had similar depressant effects on pig 
ureteral contractions induced by various agonists including noradrenaline, 
5-HT and neurokinin A (Mastrangelo et al., 2000).   
 
Table 2.7 Mean pEC50 (±SEM) values (AUC) for phenylephrine and 5-
HT in the pig distal ureter in the presence and absence of 10µM 
indomethacin.  
Agonist Group n pEC50 
Phenylephrine 
Young 
Control 6 4.25 ± 0.15 
10µM indomethacin 6 4.46 ± 0.15 
Old 
Control 6 4.69 ± 0.14 
10µM indomethacin 6 4.89 ± 0.13 
5-HT 
Young 
Control 6 5.18 ± 0.09 
10µM indomethacin 6 5.04 ± 0.18 
Old 
Control 6 5.03 ± 0.22 
10µM indomethacin 6 4.83 ± 0.18 
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Although the influence of age on the effects of prostaglandins have not 
been studied in the ureter, one previous study showed that both diclofenac 
and NS-398 caused a reduction in contractions to noradrenaline and 5-HT 
in isolated ureteral strips from young pigs (3 – 6 months) (Mastrangelo et 
al., 2000). Interestingly, this depressant effect of COX inhibitors was also 
observed in the present study for 5-HT-stimulated contractile responses in 
younger animals, but there was no effect of indomethacin on 5-HT-
stimulated contractile responses in tissues from older animals. While that 
same study showed that response to norepinephrine was also attenuated 
by indomethacin (Mastrangelo et al., 2000), our result indicated otherwise. 
Outside of the urinary tract, a recent study on rat renal and femoral veins 
showed that indomethacin caused a statistically lower suppression of 
phenylephrine-induced responses in comparison to responses to 
noradrenaline (de Souza Rossignoli et al., 2015). It was suggested that 
this difference may be due to noradrenaline acting simultaneously on both 
α1- and α2-adrenoceptors and that local modulatory mechanisms such as 
prostanoid release affect contractile responses with a synergism between 
the α1-adrenoceptor subtypes (de Souza Rossignoli et al., 2015). 
However, because phenylephrine stimulates only α1-adrenoceptor, it could 
possibly explain our observation where phenylephrine-induced contractile 
responses were not affected by indomethacin as was observed in 5-HT-
stimulated contractile responses. Therefore, it is suggested that in the 
younger animals, indomethacin plays a role in the inhibition of contractile 
responses induced by 5-HT. 
 
While the effects of ageing on the activity of COX in the urinary tract have 
not been clearly elucidated, studies have suggested that in pig pulmonary 
artery indomethacin caused a rightward shift of the phenylephrine 
concentration-response curve in young (5 weeks old) piglets but not in 
older (26 weeks old) pigs (Gustin et al., 1993). However, in a separate 
study, neither cyclo-oxygenase nor phospholipase A2 activity was altered 
as a function of age in guinea-pig whole blood (Spaethe et al., 1992). 
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There was also no influence of age on cyclo-oxygenase activity in rat 
aortic smooth muscle cells (Chang et al., 1980).  
 
We conclude that the impact of ageing on the effect of COX inhibitors on 
contractile responses to phenylephrine and 5-HT of smooth muscle cells 
might vary between different physiological systems. In the ureter, they 
appear to have an inhibitory effect in younger animals but no effect on 
older animals. This is an interesting finding as it proposes that prostanoids 
might only play a role in modulation of ureteral motility in younger animals, 
but not in the older animals. 
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2.8  Effect of L-NG-Nitroarginine (L-NNA) on 
Responses in the Ureter 
 
Introduction 
Nitric oxide (NO) is a gaseous molecule mediating relaxation or inhibition 
in many biological processes, acting as a second messenger and 
neurotransmitter. The enzyme NO synthase (NOS) is responsible for NO 
synthesis from L-arginine and this only occurs in the presence of co-
factors, such as nicotinamide adenine dinucleotide phosphate (NADPH)-
diaphorase  (Fernandes and Hernandez, 2016). NO induces relaxation in 
smooth muscle cells of the lower urinary tract via soluble guanylate 
cyclase (sGC). The binding of NO with sGC causes a change in the 
enzyme conformation which increases the catalytic rate of conversion of 
guanosine triphosphate to the second messenger, cyclic guanosine 
monophosphate (cGMP). This has been shown to induce relaxation via 
the opening of potassium channels in the human ureter (Miyaoka et al., 
2014).  
 
NO has been observed in nerve fibres in the lower urinary tract and plays 
a prominent role in non-adrenergic, non-cholinergic neurotransmission in 
efferent pathways to the lower urinary tract (Andersson and Persson, 
1995). Additionally, it has been demonstrated that NOS-immunoreactive 
nerves have an inhibitory effect on trigonal, bladder neck and urethral 
smooth muscle tone (Andersson and Persson, 1995). There is evidence 
suggesting that in the ureter, NO is released from the urothelium and is a 
major inhibitory transmitter involved in ureteral peristalsis, urinary flow 
resistance and local blood flow (Iselin et al., 1997). It has also been found 
that NO donors reduce the frequency of spontaneous rhythmic 
contractions in the renal pelvis and proximal ureter and could be a 
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potential strategy for treatment of ureteral calculi (Mastrangelo et al., 
2003). 
 
In the pig intravesical ureter, addition of L-NNA, abolished electrically 
induced relaxation which was significantly reversed by addition of L-
arginine (Hernandez et al., 1995). This effect by L-NNA was also observed 
for electrically-induced responses of sheep ureter (Levent and Buyukafsar, 
2004). It was therefore proposed that NO synthase is present in the nerve 
fibres and they seem to be involved in the mediation of inhibitory 
neurotransmission. However, in the sheep urinary tract, NO-mediated 
relaxation of the ureter could not be detected (Garcia-Pascual et al., 
1996). Studies involving NO in the ureter have mostly focused on 
electrically induced contractile responses (Hernandez et al., 1995, 
Fernandes and Hernandez, 2016). In addition to this, the effect NO has on 
contractile activity in different age groups has also not previously been 
investigated. We aimed to investigate the effects of L-NNA on 
phenylephrine and 5-HT-induced contractile activity in old and young pigs. 
  
 
Methods and Materials 
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. The agonists used in this study were phenylephrine 
(7.48 x 10-8 – 7.48 x 10-4 M) and 5-HT (5.88 x 10-8 – 5.88 x 10-4 M). 
Contractile responses to these agonists were compared in the presence 
and absence of L-NNA (100µM) which was incubated for 30 minutes 
before addition of agonist. Contractions to agonists were expressed as 
percentage of maximal response in AUC and frequency of phasic 
contractions developed. 
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Results 
Spontaneous contractions developed in 8 of 48 (17%) isolated distal 
ureteral strips during equilibration to a passive tension of 1.15g ± 0.10g 
(n=48). L-NNA (100µM) had no effect on potency (pEC50) of both agonists 
in ureteral strips from both age groups (Table 2.8). Additionally, maximum 
AUC and frequency responses to phenylephrine and 5-HT were 
unaffected in the presence L-NNA (100µM) in both age groups (Figure 
2.13 and 2.14). 
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Figure 2.20 Concentration-response curves for phenylephrine in the distal 
ureter from young pigs in the absence and presence of L-NNA (100µM). 
Responses are expressed as percentage of maximum AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Figure 2.21 Concentration-response curves for phenylephrine in the distal 
ureter from old pigs in the absence and presence of L-NNA (100µM). 
Responses are expressed as percentage of maximum AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Figure 2.22 Concentration-response curves for 5-HT in the distal ureter 
from young pigs in the absence and presence of L-NNA (100µM). 
Responses are expressed as percentage of maximum AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 6 preparations for 
each group. 
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Figure 2.23 Concentration-response curves for 5-HT in the distal ureter 
from old pigs in the absence and presence of L-NNA (100µM). Responses 
are expressed as percentage of maximum AUC (a) and frequency (b). 
Results are presented as mean ± SEM of 6 preparations for each group. 
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Discussion 
In this study, we examined the effect of the NOS inhibitor L-NNA, on 
phenylephrine and 5-HT-induced contractile responses of ureter from two 
age groups. We demonstrated that NO was not involved in responses of 
the pig distal ureter to phenylephrine and 5-HT.  
 
Many studies have suggested that NO plays an important inhibitory effect 
on electrical field-stimulated contractions. However, our results indicate 
that there is no α1-adrenoceptor-stimulated or 5-HT receptor-stimulated 
release of NO in these tissues. Evidence showing localisation of NO 
synthase at the porcine intravesical ureter suggests that NO is a non-
adrenergic, non-cholinergic transmitter involved in the inhibitory system 
(Hernandez et al., 1995). However, in this same study, it was shown that 
Table 2.8 Mean pEC50 values (±SEM) for phenylephrine and 5-HT in 
the pig distal ureter in the presence and absence of L-NNA (100µM). 
Results are expressed as mean ± SEM. 
Agonist Group n pEC50 
Phenylephrine 
Young 
Control 6 4.68 ± 0.11 
100µM L-NNA 6 4.64 ± 0.28 
Old 
Control 6 4.23 ± 0.05 
100µM L-NNA 6 4.14 ± 0.06 
5-HT 
Young 
Control 6 5.24 ± 0.07 
100µM L-NNA 6 5.00 ± 0.15 
Old 
Control 6 5.33 ± 0.06 
100µM L-NNA 6 5.17 ± 0.08 
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NANC responses were only observed in the presence of guanethidine and 
atropine, which inhibit adrenergic and cholinergic transmission 
respectively (Hernandez et al., 1995). This could explain the lack of effect 
of L-NNA in the present study since we did not inhibit adrenergic or 
cholinergic transmission. 
 
One study has shown that exogenous NO (SIN-1) temporarily abolishes 
contractions of the isolated pig distal ureter to 5-HT  (Iselin et al., 1996). 
However, at maximum concentrations of SIN-1, 5-HT responses were 
attenuated by less than 50% (Iselin et al., 1996). It is possible that in the 
presence of NO donors, ureteral contractile responses to phenylephrine 
will also be attenuated, as this effect was also shown for isolated pig 
bladder tissue responses to muscarinic receptor stimulation (Moro et al., 
2012). It was shown in the rat, that urothelial muscarinic receptors induce 
NO release but only after the induction of inducible NO synthase in 
conditions such as bladder inflammation (Giglio et al., 2005).   
 
A study examining the distribution of NOS-immunoreactive nerves in the 
rat distal ureter showed that aged animals had a lower density of nerves  
compared to the younger animals (Mohammed and Santer, 2001). In 
addition, it was also shown that NOS-immunoreactive nerves and NADPH-
diaphorase in the extramural ganglion complex that provides autonomic 
innervation to the distal ureter, ureterovesical junction and bladder trigone 
are also downregulated with age (Mohammed and Santer, 2001, Bergman 
et al., 1999).  This raises the possibility that the relaxation function of NO 
and the transmission of sensory information may be compromised with 
increasing age in the ureter and bladder.   
 
In conclusion, several studies in the literature suggest that the responses 
of the ureter are depressed by NO. The precise mechanism is not clearly 
understood, however, since L-NNA does not affect phenylephrine or 5-HT 
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responses in the present study, it would appear neither α1-adrenoceptor 
nor 5-HT receptor stimulation causes NO release. 
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CHAPTER 3: 
Characterization of the 5-HT receptor 
subtype in the porcine ureter 
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3.1 Introduction 
 
5-Hydroxytryptamine (5-HT) is a well-known mono-amine transmitter that 
not only plays significant roles in the central nervous system but also in 
the regulation of smooth muscle contractions in several systems including 
in the gastrointestinal, vascular and urinary systems (Nichols and Nichols, 
2008). In mammals, 5-HT is synthesised biologically via two enzymatic 
steps: firstly, ring hydroxylation of the amino acid tryptophan by tryptophan 
hydroxylase, which is the rate-limiting step, and secondly, side chain 
decarboxylation by aromatic amino acid decarboxylase (Nichols and 
Nichols, 2008).  
 
 
 
 
Figure 3.1 Structure of 5-HT (Nichols and Nichols, 2008)  
 
 
The receptors for 5-HT are typically classified according to their primary 
signalling mechanism into four subtypes: the 5-HT2 (A, B, C) receptors acting 
via phospholipase C activation, 5-HT4, 5-HT6, and 5-HT7 receptors via 
activation of adenylyl cyclase, 5-HT1 (A, B, D, E, F) and 5-HT5 (A, B) via adenylyl 
cyclase inhibition and 5-HT3, a ligand-gated ion channel (Nichols and 
Nichols, 2008).  
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Figure 3.2 Diagrammatic representation of 5-HT receptor subtypes and 
their second messenger pathways. 
 
 
5-HT is primarily found in platelets, the gastrointestinal tract and brain and 
is capable of stimulating smooth muscle contraction and/or relaxation in 
various tissues including the intestine, vasculature and urinary bladder 
(Klarskov and Horby-Petersen, 1986, Kim and Camilleri, 2000, 
Mohammad-Zadeh et al., 2008). 5-HT can have both pre- and post-
junctional actions in the mammalian urinary tract, where it can have direct 
actions on smooth muscle cells or indirect effects on the autonomic 
intramural neurons (Hernandez et al., 2003). 5-HT can stimulate 
micturition in intact animals and has excitatory actions in human detrusor 
strips (Klarskov and Horby-Petersen, 1986, Corsi et al., 1991). In addition 
to this, there is also evidence that 5-HT can modulate peripheral 
sympathetic neurotransmission through inhibition of noradrenaline release 
via pre-junctional 5-HT1-like receptors, which have now been 
characterized as a mixture of 5-HT1B, 5-HT1D and 5-HT7 (Saxena et al., 
1998). Although this is the primary mechanism, there is also evidence that 
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5-HT can enhance adrenergic neurotransmitter release via facilitatory pre-
junctional 5-HT1A receptors (Cohen et al., 1999).  
 
While the mammalian urinary bladder and lower urinary tract have been 
shown to respond to 5-HT with contraction, in many studies in the human 
and pig  (Todd and Mack, 1969, Ambache and Zar, 1970, Long and 
Nergardh, 1978), others have proposed the opposite effect; a relaxation 
(Klarskov and Horby-Petersen, 1986). 5-HT induces contraction of the 
detrusor smooth muscle cells by enhancement of cholinergic transmission 
through mechanisms involving neural 5-HT3 receptors in the rabbit (Chen, 
1990) and guinea-pig (Messori et al., 1995). Besides that, there are also 
reports suggesting the role of ketanserin-sensitive muscular 5-HT2 
receptors in 5-HT-evoked contractile response in human (Klarskov and 
Horby-Petersen, 1986) and dog (Cohen, 1990) urinary bladder.  The 
presence of pre-junctional modulation by 5-HT in the lower urinary tract 
has also been demonstrated in numerous species, including the human 
(Tonini et al., 1994), pig (Sellers et al., 2000) and monkey (Waikar et al., 
1994) bladder via 5-HT4 receptors, whose activation results in potentiation 
of cholinergic contractile responses. Experimental studies in animals have 
demonstrated that spinal reflex circuits involved in voiding function exhibit 
a dense serotogenic innervation and multiple 5-HT receptors (Khaled and 
Elhilali, 2003). Expression of several subtypes of 5-HT receptor including 
5-HT2A, 5-HT2B, 5-HT4 and 5-HT7 has been demonstrated in the rat urinary 
bladder; particularly, 5-HT2 receptors, being involved in 5-HT induced 
contractile responses (Sakai et al., 2013). 
  
In the ureter, findings have been less complex than in the bladder, where 
in all species examined thus far, 5-HT has been found to produce an 
excitatory action only and does not induce relaxation of smooth muscle 
cells. In vivo studies have also demonstrated that intravenous 
administration of 5-HT and 2,5-dimethoxy-4-iodoamphetamine (DOI), a 5-
HT2A/2C receptor agonist, increase ureteral contraction frequency of the pig 
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ureter in a concentration-dependent manner (Hauser et al., 2002). 
Generally, in vitro studies have demonstrated that 5-HT can increase both 
phasic and tonic contractions in isolated ureter from dog  (Klarskov and 
Horby-Petersen, 1986), human (Gidener et al., 1999, Gidener et al., 1995) 
and pigs (Hernandez et al., 2003). In the pig intravesical ureter, it was 
suggested that the 5-HT2A receptor is the subtype involved in mediating 5-
HT-induced contractile tone (Hernandez et al., 2003). However, responses 
to 5-HT in the pig intravesical ureter were different to those observed in 
the pig distal ureter, since 5-HT produced only an increase in contractile 
tone in the intravesical ureter and did not trigger bursts of phasic activity 
(as reported in Chapter 2) (Hernandez et al., 2003). Thus, a complete 
pharmacological characterization of the 5-HT receptor subtype/s involved 
in 5-HT-stimulated responses in the distal ureter has not yet been 
accomplished.  
 
Furthermore, the regulation of smooth muscle contraction by 5-HT and its 
receptors has been associated with disorders of the lower urinary tract, 
including the bladder. Normal bladder function requires proper co-
ordination of detrusor relaxation during the filling phase and contraction 
during micturition. In the rat urinary bladder, it was shown that 5-HT-
induced bladder contractile responses are enhanced approximately 3-fold 
after partial bladder outlet obstruction (Sakai et al., 2013, Michishita et al., 
2015). Additionally, it has been suggested that 5-HT modulation of 
cholinergic responses could be altered in bladder dysfunction. An 
increased 5-HT4 receptor-mediated response in detrusor smooth muscle 
strips from patients with hyper-reflexic bladders has been demonstrated 
(Sellers et al., 2000), highlighting 5-HT4 receptor antagonists as a possible 
therapeutic treatment for bladder voiding defects associated with 
hypercontractility. In addition to this, mRNA expression for 5-HT2A and 5-
HT2B receptors in the detrusor muscle and subserosal layer of the bladder 
was also found to be up-regulated in bladder hyperactivity and also in 
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partial bladder outlet obstruction (Sakai et al., 2013, Michishita et al., 
2015).  
 
Similar to the bladder, ureteral peristalsis is also dependent on the normal 
functioning of ureteral smooth muscle contraction. In the rabbit distal 
ureter, induced partial or complete ureterovesical junction obstruction 
enhanced contractile responses to 5-HT, the latter producing twelve-fold 
greater augmentation than partial obstruction and signifying an apparent 
sensitization of the ureter to 5-HT in this disorder (Yalcin et al., 2013).   
 
Ageing has been shown to increase the risk of ureteral calculus 
development (Hess, 2003). Whilst research on age-related changes in 5-
HT contractile mechanism in the urinary tract is not readily available, there 
are observed changes in other organ systems involving smooth muscle 
contraction. In the gastrointestinal system, where 5-HT plays a vital role, 
immunohistochemical studies have indicated a decrease in 5-HT 
expressing enterochromaffin cells and attenuated serotogenic signalling, 
in 24-month old rats compared to 3- and 12-month old rats (Keating et al., 
2015). Similarly, esophageal smooth muscle relaxation in response to 5-
HT was also demonstrated to be significantly reduced with ageing in 
isolated tissue strips from rats (Tugay et al., 2003). Additionally, the 
inhibitory effect of 5-HT via 5-HT2 receptors in the rat vas deferens was 
also found to gradually decrease with increasing age of the rats (Moritoki 
et al., 1986). These reports suggest possible alterations of the 5-HT 
systems across the various physiological systems with ageing. However, 
in contrast, no alteration with age was observed in tracheal smooth muscle 
contractile response to 5-HT in guinea pigs, although a possible 
explanation for this is the small range of age (3-4weeks vs 4-8weeks old) 
that was examined (Cox and Cohen, 1994).  
 
In our preliminary data (Chapter 2), it was observed that contractile 
responses of isolated distal ureter to 5-HT in older animals were 
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depressed in comparison to tissues from younger animals. In addition, it 
was found that 5-HT exerts a major contractile effect in the ureteral wall, 
as it was able to produce approximately 3-fold greater contractions that 
muscarinic receptor stimulation (Chapter 2). Therefore, this leads to the 
possibility of 5-HT contractile mechanisms being a target for future drug 
development, and a potential use in medical expulsive therapy for 
treatment of ureteral stones. While it has been well established by 
numerous studies that 5-HT can produce contraction of ureteral smooth 
muscle, the receptor subtype mediating these contractions has not been 
distinctly characterized. Therefore, the aim of this study was to perform a 
full pharmacological analysis to functionally characterize the 5-HT receptor 
subtype/s mediating 5-HT-induced contractile responses in porcine 
isolated distal ureter. Furthermore, our study also investigated the effect of 
age on these responses, using tissues from two age groups: young (3 
months) and old (24 months) pigs. 
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3.2 Methods and Materials 
 
Tissue preparation and in vitro functional studies were performed as 
described in Chapter 2. For the first part of the study, isolated ureteral 
tissue strips were paired and were exposed to either increasing doses of 
5-HT (5.88 x 10-8 – 5.88 x 10-4 M) or the 5-HT2 agonist α-methyl-5-HT 
(6.57 x 10-8 – 1.97 x 10-4 M) and responses compared. In the second part 
of the study, isolated tissues were paired, with one strip used as a control 
strip, while the other was incubated for 20 minutes with one of the various 
5-HT receptor subtype antagonists listed in Table 3.1, before being 
subjected to increasing concentrations of 5-HT. In addition to this, 
antagonist experiments with ketanserin (10 – 100nM) were repeated using 
the agonist α-methyl-5-HT. Concentrations that were chosen for the 
various 5-HT antagonists are based on literature values that have been 
shown to block the respective 5-HT receptor subtypes as shown in Table 
3.1. 
 
Paired student’s t-tests were performed on studies with two groups while 
two-way ANOVA was used for studies involving more than two groups.   
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3.3 Results 
 
Porcine ureteral strips were allowed to equilibrate to a mean passive 
tension of 1.10g ± 0.33g (n=276). Spontaneous contractions developed 
during equilibration period in 41 of 276 isolated distal ureteral strips (15%). 
Current literature suggests that the most likely candidate that sets 
spontaneous contractions in the ureter are ‘atypical’ smooth muscle cells, 
which are found in the proximal ureter and not in the distal ureter (Lang 
and Klemm, 2005). Electrical and mechanical activities are initiated by 
these spontaneously active cells in the pelvi-calyceal region of the renal 
pelvis and conducted to distal regions in the ureter that are not normally 
active unless driven by pacemakers (Berridge, 2008). Therefore, it is 
suggested that the spontaneous contractions that developed in 15% of 
distal ureter preparations are due to pacemaker signals before dissection 
that are still present. To further validate this suggestion, these 
spontaneous contractions usually disappear at the end of the incubation 
period. 
 
When subjected to increasing doses of 5-HT and the 5-HT2 selective 
agonist α-methyl-5HT, all ureteral strips from both age groups developed 
bursts of phasic contractions. Increasing doses of 5-HT and α-methyl-5-HT 
also resulted in an increase in frequency of phasic activity. No significant 
differences were found between 5-HT and α-methyl-5-HT contractile 
responses in isolated distal ureter from either older or younger animals 
(Figure 3.3 and 3.4).  
 
Ketanserin (10 – 100nM), a selective 5-HT2A antagonist, produced a 
significant rightward shift of the 5-HT concentration-response curve 
(Figures 3.5a, 3.6a, 3.7a and 3.8a). In addition to this, maximal contractile 
responses to 5-HT expressed as AUC and frequency were depressed in 
the presence of ketanserin (Figures 3.5a, 3.6a, 3.7a and 3.8a). Max 
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responses could not always be obtained but a comparison of the slopes of 
the concentration-response curves in each group was performed and 
there was no significant difference in any data group (p>0.05), suggesting 
competitive antagonism. Using EC40 values for responses (expressed as 
AUC and frequency), Schild plots were developed for tissues from both 
age groups (Figures 3.5b, 3.6b, 3.7b and 3.8b). The slopes of the Schild 
plots were not significantly different from unity, again suggesting a 
competitive antagonism, except for the frequency of phasic contractions in 
tissues from older animals, where the slope was significantly steeper than 
unity (Fig 3.8b). pA2 values were also estimated by extracting the x-
intercept of Schild linear regressions. These values are stated in Table 3.2 
below. 
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Contractile Responses to 5-HT and α-Methyl-5HT 
 
 
  
 
Figure 3.3 Concentration-response curves for 5-HT and α-methyl-5-HT in 
the distal ureter from young pigs in isolated smooth muscle strips. 
Responses are expressed as percentage of maximal response for AUC 
(a) and frequency (b). Results are presented as mean ± SEM of 4 
preparations for each group. 
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Figure 3.4 Concentration-response curves for 5-HT and α-methyl-5-HT in 
the distal ureter from old pigs in isolated smooth muscle strips. Responses 
are expressed as percentage of maximal response for AUC (a) and 
frequency (b). Results are presented as mean ± SEM of 4 preparations for 
each group. 
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Effect of Ketanserin on 5-HT Induced Contractile 
Responses in Ureter from Young Pigs 
 
 
 
 
Figure 3.5 Concentration-response curves for 5-HT in the presence and 
absence of ketanserin (10 – 100nM) in isolated distal ureter from young 
pigs (a), with corresponding Schild plots for ketanserin (b). Responses are 
expressed as % of maximal response for AUC. Results are presented as 
mean ± SEM of 8 preparations for each group.  
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Figure 3.6 Concentration-response curves for 5-HT in the presence and 
absence of ketanserin (10 – 100nM) in isolated distal ureter from young 
pigs (a), with corresponding Schild plots for ketanserin (b). Responses are 
expressed as % of maximal frequency. Results are presented as mean ± 
SEM of 8 preparations for each group.  
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Effect of Ketanserin on 5-HT-induced Contractile 
Responses in Ureter from Old Pigs 
 
 
 
Figure 3.7 Concentration-response curves for 5-HT in the presence and 
absence of ketanserin (10 – 100nM) in isolated distal ureter from old pigs 
(a), with corresponding Schild plots for ketanserin (b). Responses are 
expressed as % of maximal response for AUC. Results are presented as 
mean ± SEM of 8 preparations for each group.  
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Figure 3.8 Concentration-response curves for 5-HT in the presence and 
absence of ketanserin (10 – 100nM) in isolated distal ureter from old pigs 
(a), with corresponding Schild plots for ketanserin (b). Responses are 
expressed as % of maximal response for frequency. Results are 
presented as mean ± SEM of 8 preparations for each group.  
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Effect of Ketanserin on α-Methyl-5-HT-induced Contractile 
Responses in Ureter from Young Pigs 
 
 
 
 
Figure 3.9 Concentration-response curves for α-methyl-5-HT in the 
presence and absence of ketanserin (10 – 100nM) in isolated distal 
ureter from young pigs (a), with corresponding Schild plots for ketanserin 
(b). Responses are expressed as % of maximal response for AUC. 
Results are presented as mean ± SEM of 8 preparations for each group.  
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Figure 3.10 Concentration-response curves for α-methyl-5-HT in the 
presence and absence of ketanserin (10 – 100nM) in isolated distal 
ureter from young pigs (a), with corresponding Schild plots for ketanserin 
(b). Responses are expressed as % of maximal response for frequency. 
Results are presented as mean ± SEM of 8 preparations for each group.  
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Effect of Ketanserin on α-Methyl-5-HT-induced Contractile 
Responses in Ureter from Old Pigs 
 
 
 
 
Figure 3.11 Concentration-response curves for α-methyl-5-HT in the 
presence and absence of ketanserin (10 – 100nM) in isolated distal 
ureter from old pigs (a), with corresponding Schild plots for ketanserin (b). 
Responses are expressed as % of maximal response for AUC. Results 
are presented as mean ± SEM of 8 preparations for each group.  
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Figure 3.12 Concentration-response curves for α-methyl-5-HT in the 
presence and absence of ketanserin (10 – 100nM) in isolated distal 
ureter from old pigs (a), with corresponding Schild plots for ketanserin (b). 
Responses are expressed as % of maximal response for frequency. 
Results are presented as mean ± SEM of 8 preparations for each group.  
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Ketanserin (10 – 100nM) was also effective in producing a rightward shift 
of concentration-response curves to α-methyl-5-HT in tissues from both 
age groups (Figures 3.9a, 3.10a, 3.11a and 3.12a). A comparison of 
concentration-response curve slopes also found no significant difference, 
supporting a competitive antagonism. Slopes of Schild plots were not 
significantly different from unity, also, supporting competitive antagonist 
mechanism at a single receptor subtype. pA2 estimates are shown in 
Table 3.2 below.  
 
 
Table 3.2 Affinity estimates for ketanserin with 5-HT 
and α-methyl-5-HT (*p<0.05 vs 5-HT-induced 
frequency of responses in young pig) 
Agonist Animal age Response pA2 estimate 
5-HT 
Young 
AUC 8.67 
Frequency 8.42 
Old 
AUC 8.09 
Frequency 7.69* 
α-
methyl-
5-HT 
Young 
AUC 8.41 
Frequency 8.80 
Old 
AUC 8.41 
Frequency 8.53 
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Effects of 5-HT Receptor Antagonists (Methiothepin, RS-
10221, GF109203X, GR-113808, SB699551, and SB269970) 
on 5-HT-induced Contractile Reponses  
 
The 5-HT receptor antagonists RS-102221 (30nM, 5-HT2C selective), 
ondansetron (30nM, 5-HT3 selective), SB 699551 (10nM, 5-HT5 selective), 
SB 399885 (100nM, 5-HT6 selective) and SB 269970 (10nM, 5-HT7 
selective)  did not affect maximal contractile responses to 5-HT (Figures 
3.15 - 3.18 and 3.21 - 3.26) and pEC50 for 5-HT were similar to control 
values (Table 3.3), in isolated tissues from both older and younger 
animals. 
 
The non-selective 5-HT receptor antagonist methiothepin (10nM) 
significantly reduced maximal AUC responses to 5-HT in ureters from 
younger animals (Figure 3.13a, paired student’s t-test, p<0.005) but not in 
older animals (Figure 3.14a, p>0.05). This effect was not observed for 5-
HT responses expressed as frequency of phasic contractions (Figure 
3.13b). Additionally, methiothepin also significantly shifted curves to the 
right and depressed pEC50 values for 5-HT-induced contractile responses 
expressed as AUC in tissues from the younger animals but not in tissues 
from older animals (Table 3.3). 
 
Comparatively, GR-113808, a selective 5-HT4 antagonist (100nM) reduced 
maximal responses to 5-HT when expressed as AUC in tissues from older 
animals (Figure 3.20a, paired student’s t-test, p<0.05) but not in younger 
animals (Figure 3.19a). Maximal responses to 5-HT expressed as 
frequency of phasic contractions were unaltered by GR-113808 (Figures 
3.19b and 3.20b). pEC50 values were also unaffected by 100nM GR-
113808 (Table 3.3). 
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Figure 3.13 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT antagonist methiothepin (10nM) in isolated distal ureter 
from young pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.14 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT antagonist methiothepin (10nM) in isolated distal ureter 
from old pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.15 Concentration-response curves for 5-HT in the presence and 
absence of  5-HT2C antagonist RS-102221 (30nM) in isolated distal ureter 
from young pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.16 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT2C antagonist RS-102221 (30nM) in isolated distal ureter 
from old pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.17 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT3 antagonist ondansetron (30nM) in isolated distal 
ureter from young pigs. Responses are expressed as % of maximal 
response for AUC (a) and frequency (b). Results are presented as mean ± 
SEM of 8 preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs 
control). 
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Figure 3.18 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT3 antagonist ondansetron (30nM) in isolated distal 
ureter from old pigs. Responses are expressed as % of maximal response 
for AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.19 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT4 antagonist GR-113808 (100nM) in isolated distal ureter 
from young pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.20 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT4 antagonist GR-113808 (100nM) in isolated distal ureter 
from old pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.21 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT5 antagonist SB699551 (10nM) in isolated distal ureter 
from young pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.22 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT5 antagonist SB699551 (10nM) in isolated distal ureter 
from old pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.23 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT6 antagonist SB399885 (100nM) in isolated distal ureter 
from young pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.24 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT6 antagonist SB399885 (100nM) in isolated distal ureter 
from old pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.25 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT7 antagonist SB269970 (10nM) in isolated distal ureter 
from young pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Figure 3.26 Concentration-response curves for 5-HT in the presence and 
absence of 5-HT7 antagonist SB269970 (10nM) in isolated distal ureter 
from old pigs. Responses are expressed as % of maximal response for 
AUC (a) and frequency (b). Results are presented as mean ± SEM of 8 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs control). 
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Table 3.3 (1) pEC50 values for 5-HT in the presence and absence of 
antagonists (continued on following page). 
Antagonist Group Response 
pEC50 
Absent Present 
10nM 
methiothepin 
(non-selective) 
Young 
AUC 5.26 ± 0.05 4.72 ± 0.05* 
Frequency 5.51 ± 0.09 5.19 ± 0.10 
Old 
AUC 5.34 ± 0.06 5.60 ± 0.24 
Frequency 5.80 ± 0.15 5.83 ± 0.12 
30nM RS-
10221 
(5-HT2c) 
Young 
AUC 5.27 ± 0.08 5.29 ± 0.07 
Frequency 5.58 ± 0.16 5.53 ± 0.14 
Old 
AUC 5.01 ± 0.17 4.98 ± 0.31 
Frequency 5.29 ± 0.22 5.42 ± 0.13 
30nM 
ondansetron 
(5-HT3) 
Young 
AUC 5.22 ± 0.08 5.15 ± 0.12 
Frequency 5.39 ± 0.10 5.36 ± 0.14 
Old 
AUC 5.27 ± 0.12 5.12 ± 0.12 
Frequency 5.45 ± 0.21 5.14 ± 0.13 
100nM 
GR-113808 
(5-HT4) 
Young 
AUC 5.00 ± 0.12 5.08 ± 0.09 
Frequency 5.19 ± 0.17 5.19 ± 0.16 
Old 
AUC 5.37 ± 0.10 5.23 ± 0.12 
Frequency 5.73 ± 0.36 5.63 ± 0.44 
10nM 
SB 699551 
(5-HT5) 
Young 
AUC 4.84 ± 0.15 4.77 ± 0.21 
Frequency 4.90 ± 0.18 5.01 ± 0.22 
Old 
AUC 4.84 ± 0.19 5.22 ± 0.21 
Frequency 5.28 ± 0.18 5.65 ± 0.28 
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Table 3.3 (2) pEC50 values of 5-HT in the presence and absence of 
antagonists (continued from previous page). 
Antagonist Group Response 
pEC50 
Absent Present 
100nM 
SB 399855 
(5-HT6) 
Young 
AUC 4.92 ± 0.15 4.98 ± 0.12 
Frequency 5.10 ± 0.22 5.09 ± 0.26 
Old 
AUC 5.01 ± 0.25 4.93 ± 0.10 
Frequency 5.20 ± 0.16 5.17 ± 0.08 
10nM 
SB 269970 
(5-HT7) 
Young 
AUC 5.11 ± 0.11 5.21 ± 0.05 
Frequency 5.31 ± 0.08 5.51 ± 0.12 
Old 
AUC 4.98 ± 0.12 5.12 ± 0.20 
Frequency 5.00 ± 0.21 5.09 ± 0.17 
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3.4 Discussion 
 
Previously, it has been demonstrated in the majority of studies, that 5-HT 
stimulates contraction of smooth muscle in isolated ureteral strips in 
various species (Gidener et al., 1995, Gidener et al., 1999, Hernandez et 
al., 2003). In the current study, similarly, it was observed that 5-HT was 
able to concentration-dependently increase contractile activity when 
expressed as AUC or frequency in the distal ureter from older and younger 
pigs. This is in agreement with most other findings in tissues from pig and 
human (Gidener et al., 1995, Gidener et al., 1999, Hernandez et al., 2003) 
but not with a study performed in isolated rabbit ureter, where 5-HT did not 
induce any contractile response (Yalcin et al., 2013). 5-HT was able to 
concentration-dependently increase contractile responses in the porcine 
isolated distal ureter, which supports a study in the porcine intravesical 
ureter, where similar results were observed (Hernandez et al., 2003). 
However, in that study, 5-HT preferentially increased contractile tone. 
While phasic contractions developed in the presence of 5-HT, the 
frequency of these phasic contractions was not related by 5-HT, unlike in 
the present study (Hernandez et al., 2003). In addition to this, these 
authors found that phasic contractions were abolished during 5-HT-evoked 
increases in ureteral tone (Hernandez et al., 2003). Our data did not 
indicate any significant increase in baseline tone upon addition of either 5-
HT or α-methyl-5-HT, at any concentration. This observed difference could 
be explained on the basis of experimental protocol, including tissue strips 
suspension methods, which was not specified in their report. Also, a 
difference in the ureteral region used may explain the difference in finding. 
The intravesical ureter region that was utilised in their experiment was 
proposed to be the ureteral component which acts as the sphincter to 
control movement of urine into the bladder (Blok et al., 1985, Hernandez 
et al., 1999, Prieto et al., 1997). The ureteral region utilised in the present 
study was the distal ureter which is located proximal to the intravesical 
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ureter. Thus, it is suggested that 5-HT may play different, region specific 
roles – more related to the closure of the ureteral tube at the intravesical 
ureter to prevent vesicoureteral reflux, whereas at the distal region 5-HT 
receptor stimulation plays a significant role in development of phasic 
contractions for ureteral peristalsis. 
 
In the present study, isolated tissues showed similar responsiveness to 
both 5-HT and α-methyl-5-HT (a 5-HT2 selective agonist), and also in 
tissues from both age groups. This supports other reports where α-methyl-
5-HT was also shown to be potent in stimulating contractile responses in 
pig intravesical ureter, although no comparisons to 5-HT-mediated 
contractile responses were performed in those studies (Hernandez et al., 
2003, Humphrey, 1984).   
 
Ketanserin, the selective 5-HT2A antagonist, was capable of shifting 
concentration-response curves at 10 – 100nM, suggesting the role for 5-
HT2A in mediation of 5-HT-induced contractions. The slopes of Schild plots 
for ketanserin with both 5-HT and α-methyl-5-HT were not significantly 
different from unity in tissues from the younger animals, suggesting that 5-
HT2A is the sole receptor subtype responsible for these 5-HT-induced 
contractions. Additionally, in tissues from the younger animals, affinity 
estimates from antagonism of responses by ketanserin were comparable 
to values reported at the 5-HT2A receptor in the literature (8.7) (Bonhaus et 
al., 1995). In tissues from young animals, there was a slight rightward shift 
of the 5-HT concentration-response curve in the presence of methiothepin 
(10nM), suggesting again, the involvement of the 5-HT2A receptor subtype. 
While methiothepin is generally a non-selective 5-HT antagonist, its affinity 
is highest at the 5-HT2A receptor subtype (Hoyer et al., 1994).  
Furthermore, the lack of effect on 5-HT concentration response curves by 
all other 5-HT receptor antagonists, also suggests that effects of 5-HT are 
mediated via activation of the 5-HT2A receptor in isolated ureter from 
younger animals. 
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In 5-HT-induced frequency responses in tissues from the older animals, 
competitive antagonism by ketanserin was not observed. The Schild plot 
slope was significantly greater than unity indicating additional actions of 
ketanserin on 5-HT-stimulated frequency responses in ureters from the 
older animals. The affinity estimate of 7.69 obtained from the intercept of 
the Schild plot for frequency responses is most likely not reflective of the 
true affinity value for ketanserin. Additionally, the affinity estimate for AUC 
responses to 5-HT in tissues from the older animals was low (8.0) 
compared to affinity value for in the literature (Bonhaus et al., 1995) and 
the affinity estimate from younger animals. Additionally, the rightward shift 
of the 5-HT response curves in the tissues from the younger animals when 
incubated with methiothepin (10nM), was not observed in the older 
animals. This suggests the possibility of methiothepin having another 
unidentified action on the frequency of phasic contractions in the ureter of 
older animals in response to 5-HT, masking the effects of 5-HT2A receptor 
subtype inhibition. Affinity estimates for ketanserin at 5-HT2A receptors 
with α-methyl-5-HT stimulation in older animals were also comparable to 
values (8.7) found in the literature (Bonhaus et al., 1995), indicating that 
the additional effect of methiothepin is unlikely to be via 5-HT2B or 5-HT2C 
receptor subtypes. This is further supported by the lack of inhibition of 5-
HT contractile response by the 5-HT2C selective antagonist, RS-10221 
(30nM). Although there was a decrease in maximal response in the 
presence of GR-113808, a selective 5-HT4 receptor antagonist,  it would 
be imprecise to deduce that this is the additional functional receptor 
subtype in the older animals, as there was no significant change in pEC50 
values in the presence of this antagonist. Therefore, we suggest that in the 
younger animals, the 5-HT-induced contractile response is due to 
stimulation of the 5-HT2A receptor subtype, whilst in the older animals, 5-
HT2A receptor is responsible for the contractile effect of 5-HT and the 
stimulation of 5-HT on another receptor could cause smooth muscle 
relaxation. This is also a possible explanation for our preliminary results, 
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where 5-HT contractile responses were depressed in isolated tissues from 
older animals (Chapter 2). 
 
In the isolated human (Gidener et al., 1999) and pig ureter (Hernandez et 
al., 2003), it has been shown that a slight contractile response develops in 
response to 5-CT, a selective 5-HT1A receptor subtype agonist. We did not 
perform any selective antagonist experiments to investigate 5-HT1 
receptors due to the lack of availability of selective 5-HT1 antagonists. In 
the latter study, there was a lack of effect on the 5-CT-induced responses 
by selective 5-HT1A/1B antagonist, indicating that these receptors are not 
involved in the 5-CT-induced tone and the response maybe could be due 
to activation of a different mechanism (Hernandez et al., 2003).  
 
Despite functional studies showing the significant role of 5-HT in ureteral 
contractility, there is still no agreement as to whether 5-HT is released 
endogenously in the ureter. Identifying the source of 5-HT in the ureter is 
an essential task for further understanding of the physiological role of 5-
HT-induced ureteral contraction. However, this is proving a difficult task, 
as to our knowledge, the existence of 5-HT-containing or 5-HT-producing 
neurons has not yet been reported. It is presumed that platelets and mast 
cells might be the source of 5-HT in the ureter, as 5-HT-containing 
enterochromaffin cells that are found in the gut have not been identified in 
the ureter (Theoharides et al., 1982, Nocito et al., 2007, Ripoche, 2011).  
 
It was previously demonstrated in the rabbit ureter that 5-HT-stimulated 
contractile responses are enhanced in the presence of ureteral obstruction 
(Yalcin et al., 2013). In the situation where intra-ureteral pressure may 
increase due to the presence of calculi, it is possible that capillaries could 
be damaged, leading to leakage of blood. Besides this, increased vascular 
permeability secondary to inflammation caused by ischemia could also 
occur, leading to blood leakage. In either case, 5-HT present in platelets 
and free 5-HT in plasma could permeate ureteral tissue. Mast cells, 
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playing a major role in the inflammatory process have been observed in all 
layers of the ureteral wall in the porcine ureter under normal conditions 
(Jerde et al., 2000, Vodenicharov et al., 2005). It is suggested that mast 
cells present in the ureter are most likely involved in maintaining local 
homeostasis and also play an important role in regulation of ureter motility 
through the release of transmitters including histamine and 5-HT in 
inflammatory circumstances. While our preliminary data (Chapter 2) 
demonstrated the lack of response of isolated ureteral strips to increasing 
concentrations of histamine, it is possible that this mast cell regulatory 
mechanism occurs via 5-HT. Additionally, there is also the possibility of an 
up-regulation of 5-HT2A receptors in the ureter in obstructed states (Yalcin 
et al., 2013), although this requires study of receptor expression for 
confirmation. 
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3.5 Conclusion 
 
To our knowledge, this is the first report to pharmacologically characterize, 
with Schild plots, the 5-HT receptor subtype/s mediating ureteral 
contractile responses to 5-HT. We are also the first to determine the age-
related changes in these contractions. Although further studies are 
required to confirm changes in receptor expression, our functional 
characterization suggests that in younger animals, the 5-HT2A receptor 
subtype is solely responsible for 5-HT-stimulated contractile responses of 
the isolated distal ureter. In older animals, we suggest that the 5-HT2A 
receptor also plays a mediatory role, but the role appears to be more 
complicated than in the younger animals. In the literature, the 5-HT 
receptor-mediated pathway seems to be upregulated following ureteral 
obstruction, and therefore, this system could prove to be an effective 
target for treatment of ureteral calculi (Yalcin et al., 2013). Additionally, 
urinary side effects are not common in the prescription of 5-HT 
antagonists. However, there are rare reports of urinary retention as a side 
effect of this class of drugs (Verhamme et al., 2008). 
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CHAPTER 4: 
The role of Rho-kinase pathway in 
ureteral responses 
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4.1 Introduction 
 
Normal ureteral contractility relies on effective contraction and relaxation 
of the smooth muscle cells which constitute the bulk of the ureteral wall. 
Skeletal and cardiac muscle cells are regulated by calcium through the 
tropomyosin-troponin complex. However, the contraction and relaxation of 
smooth muscle cells of the urinary tract is mediated by the enzymes 
myosin light chain kinase (MLCK) and its counteracting enzyme, myosin 
light chain phosphatase (MLCP), involved in myosin light chain (MLC) 
phosphorylation and dephosphorylation respectively (Zhang and DiSanto, 
2011). It is well established that the changes in intracellular calcium as a 
trigger for contraction plays a significant role in various smooth muscle-
related diseases and disorders. Consequently, the ability to manipulate 
and identify other aspects of intracellular signalling regulation of myosin 
activity and degree of muscle tone is under investigation. 
 
It has been known since 1946, that calcium is the intracellular trigger for 
smooth muscle contraction, and that this is activated by an elevation of 
intracellular cytosolic calcium, [Ca2+]i (Heilbrunn and Wiercinski, 1947).  
However, more recent research has demonstrated clearly that smooth 
muscle contraction can occur even in the absence of changes in [Ca2+]i. 
The major mechanism through which this occurs is the inhibition of smooth 
muscle MLCP via a guanine nucleotide-binding protein (G-protein)-
coupled mechanism involving the enzyme Rho-kinase (ROCK). This 
process currently is defined as the ‘calcium sensitization’ pathway (Zhang 
and DiSanto, 2011, de Godoy and Rattan, 2011). The vital hallmark of 
calcium sensitization is the ability of smooth muscle to sustain contractile 
responses in the presence of low [Ca2+]i  (Kitazawa and Somlyo, 1991), 
but it has been shown that this pathway is also able to induce contraction 
of smooth muscle without necessarily altering [Ca2+]i (Litten et al., 1987, de 
Godoy and Rattan, 2011). Since then, research has highlighted the 
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relevance of calcium sensitization which depends on the type of 
stimulation experienced by the myocyte (e.g. stimulation via different 
receptors). 
 
The major enzyme involved in the calcium sensitization pathway is the 
ROCK enzyme and there are presently two known isoforms of ROCK, 
ROCK-II (ROCKα) and ROCK-I (ROCKβ). Currently, the complete 
functional differences between these isoforms have still not been 
elucidated (Zhang and DiSanto, 2011, de Godoy and Rattan, 2011). 
ROCK is a specific enzyme activated via G-protein coupled receptors by 
the monomeric GTP-binding protein RhoA (Christ and Andersson, 2007). 
The Rho-proteins belong to the Ras superfamily of GTPases and there are 
three isoforms: RhoA, RhoB and RhoC (Rossman et al., 2005). Although 
these three isoforms appear to share approximately 80% amino acid 
homology, their cellular functions seem to be distinct with the most studied 
being RhoA (Sah et al., 2000). It is the RhoA isoform that is involved in 
smooth muscle contraction, but it is important to note that it has additional 
functions including regulation of cellular processes involving stress fiber 
formation, cell proliferation, migration and apoptosis (Arner and Pfitzer, 
1999, Sah et al., 2000).  
 
The binding of RhoA to ROCK causes a conformational change in the 
enzyme and also its subsequent autophosphorylation, increasing ROCK 
activity (Amano et al., 2000, Chen et al., 2002). Smooth muscle 
contraction is achieved by phosphorylation of MLCP by ROCK. MLCP is 
comprised of three subunits MYPT1, PP1c, and a small subunit whose 
function is still unclear (Borman et al., 2002).  MYPT1 has been shown to 
be ubiquitously expressed, with a significantly higher concentration in 
smooth muscle cells (Christ and Andersson, 2007). Inhibition of MLCP is 
achieved by the phosphorylation of its MYPT1 subunit, which is a crucial 
substrate for ROCK (Kimura et al., 1996, Schmidt et al., 1999). The 
phosphorylation of MYTP1 subsequently suppresses PP1c activity, 
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inhibiting MLCP action and hence, results in a maintenance of MLC 
phosphorylation (Somlyo and Somlyo, 2000, Feng et al., 1999). Besides 
that, ROCK has also been suggested to be able to further increase 
calcium sensitization by phosphorylation of a PKC-potentiated 
phosphatase inhibitor, CPI-17. CPI-17 is a downstream target of PKC, 
which subsequently plays a vital role in smooth muscle contraction (Li et 
al., 1998).  
  
In light that ROCK is able to stimulate smooth muscle contraction, a 
number of ROCK inhibitors have been developed and used as an effective 
approach to manipulate calcium sensitivity in smooth muscles. With the 
utilization of high throughput screening structural data is under minute 
investigation to identify a set of potential ROCK inhibitors (Takami et al., 
2004). The two most researched ROCK inhibitors are Y-27632 and fasudil 
(HA-1077). Initially, fasudil was characterised as an intracellular Ca2+ 
antagonist (Asano et al., 1989, Satoh et al., 2001) whereas Y-27632 was 
developed as a smooth muscle relaxant and it was only later shown to 
dampen ROCK activity (Ishizaki et al., 2000, Uehata et al., 1997). These 
ROCK inhibitors have been shown to be effective in relieving symptoms of 
several diseases including vasospastic angina (Shimokawa, 2002, Hirooka 
and Shimokawa, 2005), renal disease (Sharpe and Hendry, 2003, Jan 
Danser, 2004) and pulmonary hypertension (Nagaoka et al., 2005, Abe et 
al., 2004).  
 
Within the lower urinary tract, there have been many studies to determine 
the critical role of ROCK in normal bladder function. Similar to the ureter, 
the normal function of the bladder is also dependent on coherent 
mediation of detrusor smooth muscle contraction and relaxation.  While it 
was initially believed that M3 receptor stimulation induced contraction 
purely via phosphoinositide hydrolysis (Andersson et al., 1991, Harriss et 
al., 1995), it was later suggested that ROCK activation was also involved 
(Jezior et al., 2001). In the rat detrusor, it was found that Y-27632 and 
166 
 
fasudil both inhibited contractions evoked by carbachol but without 
affecting KCl-induced contractions (Wibberley et al., 2003). In line with 
this, a study on the human detrusor confirmed that carbachol-induced 
contractions mediated by M3 receptors are largely depend on Ca2+ entry 
through nifedipine-sensitive channels together with activation of the ROCK 
pathway (Schneider et al., 2004). Furthermore, inhibition of each of these 
pathways was equally effective in inhibiting carbachol-induced contractile 
responses (Kirschstein et al., 2014). Besides that, Y-27632 also 
demonstrated the ability to suppress spontaneous tone and responses to 
the P2X receptor agonist α,β-methylene-ATP of the rabbit urinary bladder 
(Wibberley et al., 2003). 
 
In contrast to the research into the significance of ROCK activity in bladder 
smooth muscle contraction, only a limited number of studies have focused 
on its importance in the ureter. In the normal rat ureter, it was shown that 
Y-27632, fasudil and H-1152 (another ROCK inhibitor) were all able to 
significantly decrease phasic contractions and Ca2+ transients (Shabir et 
al., 2004). This indicates that ROCK inhibition could modulate phasic 
contractions in the absence of calcium changes, which suggests a role for 
ROCK in calcium sensitization in the ureteral smooth muscle. However, 
this was not evident in the guinea-pig ureter, indicating there are species 
differences (Shabir et al., 2004). Furthermore, rho-kinase inhibitors fasudil 
and Y-27632 were shown to inhibit spontaneous contractions in the 
isolated guinea-pig and sheep ureter but not in the rat ureter (Levent and 
Buyukafsar, 2004, Shabir et al., 2004) In addition to this, another study on 
the sheep ureter demonstrated the presence of both isoforms of ROCK, 
ROCK-I and ROCK-II, and its mediation of agonist- and electrical field 
stimulated(EFS)-induced contractions as well as spontaneous contractile 
activity (Levent and Buyukafsar, 2004). Immunohistochemistry and 
immunoblotting studies showed the presence of both ROCK isoforms in 
the human ureter, and functional analysis supports this, where 
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spontaneous and EFS-induced contractile responses were depressed by 
Y-27632 in a concentration-dependent manner (Hong et al., 2005). 
 
It has been proposed that ROCK-mediated contractile mechanisms could 
be extensively altered in response to pathological insults. For instance, in 
bladders of rabbits with chemically induced diabetes, upregulation of 
ROCK and CPI-17 was evident, resulting in an increase in MLC 
phosphorylation in the detrusor muscle, which was depressed by Y-27632 
(Chang et al., 2006). Furthermore, in the male rabbit and rat bladder, an 
elevation in expressions of ROCK-I and ROCK-II was observed several 
weeks post experimental bladder outlet obstruction (Lin et al., 2008, 
Takahashi et al., 2009). In both these studies, it was also demonstrated 
that there was an increase in the sustained component of the detrusor 
contraction, especially in agonist-induced contractions to phenylephrine 
and carbachol (Lin et al., 2008, Takahashi et al., 2009). Similar to bladder 
outlet obstruction, unilateral ureteral obstruction was also shown to 
enhance expressions of ROCK-I and ROCK-II in the rabbit ureter in 
comparison to expression in non-obstructed ureters (Turna et al., 2007). 
To further support this finding, functional analysis revealed that contractile 
responses induced by electrical field stimulation, KCl, phenylephrine and 
carbachol in ureteral strips from rabbits with ureteral obstruction were 
significantly enhanced in comparison to those from control rabbits (Turna 
et al., 2007). Furthermore, Y-27632 was able to significantly suppress 
these contractile responses in both unilaterally obstructed and control 
ureters from the rabbit and also reduced contractions in the obstructed 
ureter to control levels (Turna et al., 2007).  
 
In addition to alterations seen with pathology, ageing has been shown to 
alter contractile response in the detrusor strips of the bladder. With 
regards to the ROCK pathway, it was found that in the adult guinea pig 
bladder, agonist-induced contractions of detrusor strips were sensitive to 
blockade with Y-27632, whilst this inhibitor had a negligible effect on 
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tissue strips from older animals, thus suggesting the possibility of 
alteration in ROCK expression and/or activity with age (Gomez-Pinilla et 
al., 2008).  Furthermore, in the human bladder, there was a strong 
correlation between inhibition of carbachol-induced contractions by Y-
27632 with age, suggesting that ROCK-mediated carbachol-induced 
contractions are strongly age-dependent and may play a major role in 
ageing patients (Kirschstein et al., 2014).  
 
In the literature, there are no studies reporting on the effect of age in the 
ROCK pathway in the ureter. It is well established that the α1-adrenergic 
receptor plays a major role in mediation of smooth muscle contraction in 
the ureter and as a G-protein coupled receptor, we hypothesised that the 
ROCK pathway may play some part in the regulation of ureteral smooth 
muscle contraction mediated by stimulation of this receptor. In addition to 
this, in previous chapters (Chapters 2 and 3), we have also discovered 
that 5-HT is an effective agonist to stimulate smooth muscle contraction in 
the ureter and, verified that 5-HT2A is the receptor subtype modulating this 
contractile response in both old and young pigs.  The receptor subtype, 5-
HT2A is also a G-protein coupled receptor and therefore, ROCK may also 
play a role in 5-HT-induced smooth muscle contractile response. The aim 
of this study was, therefore, to investigate the effect of the ROCK 
inhibitors, Y-27632 and fasudil, on phenylephrine- and 5-HT-stimulated 
contractile responses of isolated distal ureter from young and old animals, 
to determine if there are any changes in the ROCK pathways related to 
ageing. In addition to this, we also studied the levels of ROCK activity in 
the presence and absence of aforementioned agonists. 
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4.2 Methods and Materials 
 
Tissue preparation and in vitro functional studies were performed as 
described in Section 2.1. For the first part of the experiment, isolated 
ureteral tissue strips were paired where one strip acted as the control 
while the other was incubated for 30 minutes with one of the following 
concentrations of ROCK inhibitors: 10µM Y-27632, 10µM fasudil, 30µM 
fasudil, before addition of the EC50 concentration of phenylephrine (30µM) 
or 5-HT (10µM) (this concentration is termed low dose in the chapter). 
After 5 minutes, the tissue strips were washed with fresh warm (37°C) 
Krebs solution and following a 10-minute washout period, the pre-
determined dose that produced a maximal contraction response of 
phenylephrine (300µM) or 5-HT (100µM) was added and contractile 
response was again measured (this concentration is termed high dose in 
the chapter). The ROCK inhibitor was present throughout the experiment. 
Each ureteral tissue strip was exposed to maximum of one antagonist and 
one agonist each. The contractile responses were measured as area 
under the curve and frequency. 
 
For the second part of the study, a ROCK activity assay (Cell BioLabs, 
Inc) was performed on isolated distal ureteral tissue strips that were 
freshly homogenised with a RIPA lysis buffer system (Santa Cruz 
Biotechnology, Inc). The assay kit is an enzyme immunoassay developed 
for detection of specific phosphorylation of MYPT1 at Thr696 by ROCK. The 
plate provided with the kit is pre-coated with a recombinant MYPT1. The 
substrate wells are incubated with active ROCK standards or tissue lysate, 
and the phosphorylated MYPT1 is detected by an anti-phospho-MYPT1 
antibody which is then visualised with a substrate solution for detection 
with UV spectrophotometry at 450nm. A standard curve utilizing known 
amounts of active ROCK-II standard was produced and used to determine 
the amount of active ROCK-II present in tissue lysate samples (Fig 4.1).  
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Figure 4.1 Representative standard linear regression of known amounts 
of active ROCK-II standard measured at 450nm. 
 
 
The assay was performed by strictly following manufacturer’s instructions 
(see Appendix 2) and using tissue lysates if isolated ureter from the distal 
region of both age groups: young and old, in the presence and absence of 
low or high doses of phenylephrine or 5-HT (similar concentrations to 
functional experiment). Samples were analysed in duplicates.  
 
Paired student’s t-tests were performed on studies with two groups while 
two-way ANOVA was used for studies involving more than two groups.   
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4.3 Results 
 
All porcine ureteral strips were allowed to equilibrate to a passive tension 
of 1.19 ± 0.06 (n=72). Spontaneous contractions were developed during 
the equilibration period in 8 of 74 ureteral preparations (10.8%). When 
subjected to phenylephrine and 5-HT (both low and high doses), all 
ureteral strips from both age groups triggered bursts of phasic contractions 
in tissue strips. The frequency of phasic activity was increased upon 
addition of the high dose of phenylephrine (300µM) and 5-HT (100µM).  
 
 
Effect of Y-27632 (10µM) on Phenylephrine-Induced 
Ureteral Responses 
Pre-incubation with ROCK inhibitor Y-27632 (10µM) significantly 
depressed phenylephrine-induced contractions when responses were 
expressed as AUC at both low and high doses in isolated ureteral strips 
from both old and young animals (Fig 4.2a and 4.3a, paired t-test, 
p<0.005). Inhibition levels at maximum AUC contraction were relatively 
enhanced in the older animals (67.4 ± 5.0% vs 79.5 ± 4.1%, young vs old, 
unpaired t-test, p<0.05). The frequency of phenylephrine-induced 
contractions was only significantly inhibited by 10µM Y-27632 at high dose 
phenylephrine in ureteral strips from older animals (Fig 4.3b, paired t-test, 
p<0.001). Thus, maximum inhibition on frequency of contractions by Y-
27632 (10µM) was significantly greater in older animals in comparison to 
younger animals (21.4 ± 5.3% vs 56 ± 9.1%, young vs old, unpaired t-test, 
p<0.05).  
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Figure 4.2 The effect of Y-27632 (10μM) on contractile responses to low 
and high doses of phenylephrine in porcine ureteral strips from young 
animals. Responses are represented as mean ± SEM percentage of 
maximal response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
***p<0.001 vs control). 
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Figure 4.3 The effect of Y-27632 (10μM) on contractile responses to low 
and high doses of phenylephrine in porcine ureteral strips from old 
animals. Responses are represented as mean ± SEM percentage of 
maximal response in AUC (a) and frequency (b) (n = 8, *p<0.05, **p<0.01, 
***p<0.001 vs control). 
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Effect of Y-27632 (10µM) on 5-HT-Induced Ureteral 
Responses 
Y-27632 (10µM) was able to inhibit 5-HT-induced contractions at both low 
and high doses in both age groups (Figs 4.4a and 4.5a, paired t-test, 
p<0.05). Similar to phenylephrine-induced contractions, maximal inhibition 
by 10µM Y-27632 of 5-HT contractions expressed as AUC was greater in 
tissues from the older animals (66.6 ± 7.1% vs 82.6 ± 4.8%, young vs old, 
unpaired t-test, p<0.05). The frequency of 5-HT-stimulated contractile 
responses to both low and high doses was significantly inhibited by Y-
27632 (10µM) in older animals (Fig 4.5b, paired t-test, p<0.001) but only at 
the high dose in tissues from the younger animals (Fig 4.4b, paired t-test, 
p<0.05). Y-27632 (10µM) had no effect on frequency responses to low 
dose of 5-HT (Fig 4.4b, p>0.05). Similar to contractions expressed as 
AUC, maximal inhibition by the ROCK inhibitor on contraction frequency 
was also significantly enhanced in tissues from the older animals 
compared to the younger animals (46.9 ± 7.1% vs 63.4 ± 4.3%, old vs 
young, unpaired t-test, p<0.05).  
 
 
Comparison of Y-27632 (10µM) Effect on Phenylephrine- 
and 5-HT-Induced Ureteral Responses 
When comparing the effects of Y-27632 on the two different agonists, 
phenylephrine and 5-HT, inhibition levels were generally similar and the 
only difference was that inhibition of frequency in tissues from the younger 
animals was greater upon stimulation by low dose 5-HT in comparison to 
low dose phenylephrine (21.4 ± 5.2% vs 46.9 ± 7.2%, phenylephrine vs 5-
HT, unpaired t-test, p<0.05). 
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Figure 4.4 The effect of Y-27632 (10μM) on contractile responses to low 
and high doses of 5-HT in porcine ureteral strips from young animals. 
Responses are represented as mean ± SEM percentage of maximal 
response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
***p<0.001 vs control). 
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Figure 4.5 The effect of Y-27632 (10μM) on contractile responses to low 
and high doses of 5-HT in porcine ureteral strips from old animals. 
Responses are represented as mean ± SEM percentage of maximal 
response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Effect of Fasudil (10µM) on Phenylephrine-Induced Ureteral 
Responses 
Pre-incubation with the ROCK inhibitor fasudil (10µM) significantly 
reduced contractions to high dose of phenylephrine expressed as AUC in 
isolated ureteral strip from both age groups (Figs 4.6a and 4.7a, d, paired 
t-test, p<0.05) but only in tissues from the younger animals at the low dose 
(Fig 4.6a, paired t-test, p<0.05). At the low dose of phenylephrine, 
contractile responses expressed as AUC in the isolated ureter from older 
animals were not significantly altered in the presence of fasudil (10µM) 
(Fig 4.7a, p>0.05). Inhibition by 10µM fasudil at maximal phenylephrine-
induced contractile responses was similar in both age groups (56.9 ± 6.2% 
vs 62.6 ± 5.3%, young vs old, p>0.05). Also, fasudil (10µM) had no effect 
on the frequency of phenylephrine-induced contractions in tissues from the 
younger animals (Fig 4.6b, p>0.05) while in the older animals, only 
frequency at the high dose of 5-HT was inhibited (Fig 4.7b, paired t-test, 
p<0.005). Accordingly, inhibition of max frequency responses by fasudil 
(10µM) was greater in tissues from older animals (6.2 ± 6.2% vs 28.1 ± 
4.4%, young vs old, unpaired t-test, p<0.05).  
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Figure 4.6 The effect of fasudil (10μM) on contractile responses to low 
and high doses of phenylephrine in porcine ureteral strips from young 
animals. Responses are represented as mean ± SEM percentage of 
maximal response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Figure 4.7 The effect of fasudil (10µM) on contractile responses to low 
and high doses of phenylephrine in porcine ureteral strips from old 
animals. Responses are represented as mean ± SEM percentage of 
maximal response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Effect of Fasudil (10µM) on 5-HT-Induced Ureteral 
Responses 
Fasudil (10µM) depressed contractile responses to low and high dose of 
5-HT when expressed as AUC in ureteral strips from both old and young 
animals (Fig 4.8a and 4.9a paired t-test, p<0.05) and inhibition at high 
dose 5-HT of AUC contraction was similar in both age groups (58.1 ± 2.4% 
vs 55.7 ± 4.6%, young vs old, p>0.05). The frequency of 5-HT-induced 
contractions was also significantly inhibited by fasudil (10µM) (Fig 4.8b 
and 4.9b, paired t-test, p<0.05) except for responses to low dose 5-HT in 
tissues from the older animals (Fig 4.9b, p>0.05). Inhibition levels at high 
dose 5-HT on frequency of contractions were also similar between age 
groups (44.0 ± 5.6% vs 33.7 ± 6.5%, young vs old, p>0.05).  
 
 
Comparison of Fasudil (10µM) Effect on Phenylephrine- 
and 5-HT-Induced Ureteral Responses 
When comparing the effects of the presence of fasudil (10µM) on the two 
agonists, phenylephrine and 5-HT, inhibition levels were similar. The only 
exception was similar to that observed with Y-27632 (10µM) where 
frequency responses to low dose 5-HT were inhibited more than 
responses to low dose phenylephrine in tissues from the young animals 
(6.2 ± 6.2% vs 44.0 ± 56%, phenylephrine vs 5-HT, unpaired t-test, 
p<0.05). 
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Figure 4.8 The effect of fasudil (10µM) on contractile responses to low 
and high doses of 5-HT in porcine ureteral strips from young animals. 
Responses are represented as mean ± SEM percentage of maximal 
response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Figure 4.9 The effect of fasudil (10µM) on contractile responses to low 
and high doses of 5-HT in porcine ureteral strips from old animals. 
Responses are represented as mean ± SEM percentage of maximal 
response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Effect of Fasudil (30µM) on Phenylephrine-Induced Ureteral 
Responses 
The functional experiments in this section were then performed with a 
higher concentration of the second ROCK inhibitor, fasudil (30µM). Pre-
incubation with fasudil (30µM) significantly reduced contractions to high 
and low dose phenylephrine expressed as AUC in isolated ureteral strips 
from both age groups (Figs 4.10a and 4.11a, paired t-test, p<0.001) at 
both low and high doses of phenylephrine. Inhibition of contractile 
responses by fasudil (30µM) at high dose phenylephrine were similar in 
tissues from both age groups (81.9 ± 3.0% vs 78.7 ± 3.2%, young vs old, 
p>0.05). It was also observed that fasudil (30µM) was effective in inhibiting 
frequency of phenylephrine-induced contractions at high and low doses in 
tissues from both older and younger animals (Figs 4.10b and 4.11b, paired 
t-test, p<0.05). Additionally, inhibition of frequency responses to high dose 
phenylephrine was similar in both age groups (40.9 ± 5.2% vs 29.9 ± 
4.84%, young vs old, p>0.05).  
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Figure 4.10 The effect of fasudil (30µM) on contractile responses to low 
and high doses of phenylephrine in porcine ureteral strips from young 
animals. Responses are represented as mean ± SEM percentage of 
maximal response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Figure 4.11 The effect of fasudil (30µM) on contractile responses to low 
and high doses of phenylephrine in porcine ureteral strips from old 
animals. Responses are represented as mean ± SEM percentage of 
maximal response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Effect of Fasudil (30µM) on 5-HT-Induced Ureteral 
Responses 
Fasudil (30µM) suppressed contractile responses to low and high dose of 
5-HT expressed as AUC in ureteral strips from both old and young animals 
(Figs 4.12a and 4.13b, paired t-test, p<0.001). Inhibition of AUC 
contraction by fasudil (30µM) at high dose 5-HT was similar in both age 
groups (77.1 ± 4.1% vs 79.3 ± 2.6%, young vs old, p>0.05). The frequency 
of 5-HT-induced contractions was also significantly inhibited by fasudil 
(30µM) (Figs 4.12b and 4.13b, paired t-test, p<0.005). The degree of 
inhibition on high dose 5-HT-stimulated frequency responses was 
significantly greater in tissues from older animals in comparison to 
younger animals (45.6 ± 5.3% vs 65.5 ± 4.3%, young vs old, unpaired t-
test, p<0.05).  
 
Comparison of Fasudil (30µM) Effect on Phenylephrine- 
and 5-HT-Induced contractions 
When comparing the effects of pre-incubation with fasudil (30µM) on the 
two agonists, phenylephrine and 5-HT, inhibition levels were mostly 
similar. The only exception was that in tissues from the older animals, 
frequency contractile responses stimulated by high dose 5-HT was 
inhibited more than frequency responses to high dose phenylephrine (29.9 
± 4.8% vs 65.5 ± 4.3%, phenylephrine vs 5-HT, unpaired t-test, p<0.05). 
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Figure 4.12 The effect of fasudil (30µM) on contractile responses to low 
and high doses of 5-HT in porcine ureteral strips from young animals. 
Responses are represented as mean ± SEM percentage of maximal 
response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Figure 4.13 The effect of fasudil (30µM) on contractile responses to low 
and high doses of 5-HT in porcine ureteral strips from old animals. 
Responses are represented as mean ± SEM percentage of maximal 
response in AUC (a) and frequency (b) (n = 6, *p<0.05, **p<0.01, 
p*<0.001 vs control). 
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Comparison of ROCK Inhibitor Potencies on 
Phenylephrine-Induced Responses 
The inhibitory effects on contractile responses to high dose phenylephrine 
by the ROCK inhibitors Y-27632 (10µM) and fasudil (10µM) were similar 
across all measurements (AUC and frequency) in isolated ureteral strips 
from the younger animals (Fig 4.14, p>0.05). While this was also observed 
in contractions expressed as AUC in tissues from the older animals, 
inhibition by fasudil (10µM) on contractile response to both agonists 
expressed as frequency was significantly lower than inhibition by Y-27632 
(10µM) (Fig 4.14, two-way ANOVA, p<0.005).   
 
Upon increasing the concentration of fasudil (30µM), inhibition of 
frequency responses was still significantly greater with Y-27632 (10µM) in 
tissues from the older animals (Fig 4.14, two-way ANOVA, p<0.005). 
Besides that, the inhibitory effect on contractile responses expressed as 
AUC in tissues from older animals was not significantly changed in the 
presence of fasudil at the higher concentration (30µM) in comparison to 
the lower concentration of fasudil (30µM). However, in the tissues from the 
younger animals, inhibition by fasudil (30µM) on phenylephrine-induced 
contractions expressed as AUC and frequency were both significantly 
increased in comparison to the lower concentration of fasudil (10µM) (Fig 
4.14, two-way ANOVA, p<0.05). In this age group also, inhibition of 
contraction frequency by fasudil (30µM) was enhanced to the point where 
it was significantly greater than inhibition by 10µM Y-27632 (Fig 4.14, two-
way ANOVA, p<0.05). 
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Figure 4.14 Percentage inhibition of phenylephrine-induced (300µM) 
contractile responses by ROCK inhibitors, Y-27632 (10µM) and fasudil 
(10µM and 30µM) expressed as AUC and frequency. Responses are 
represented as a mean percentage inhibition ± SEM (n=6, *p<0.05 vs 
10µM Y-27632, ^p<0.05 vs 10µM fasudil). 
 
 
 
 
 
 
 
 
 
 
 
A U C  (yo ung ) F R Q  (yo ung ) A U C  (o ld ) F R Q  (o ld )
0
2 0
4 0
6 0
8 0
1 0 0
%
  
In
h
ib
it
io
n
 o
f 
m
a
x
P
E
 c
o
n
tr
a
c
ti
o
n
10 M  Y -27632
10 M  fa sud il
30 M  fa sud il^ ^
^ ^ ^
*
**
**
191 
 
Comparison of ROCK Inhibitor Potencies on 5-HT-Induced 
Responses 
The inhibitory effects on contractile responses to high dose 5-HT by the 
ROCK inhibitors Y-27632 (10µM) and fasudil (10µM) were similar across 
all measurements (AUC and frequency) in isolated ureteral strips from the 
younger animals (Fig 4.15, p>0.05). In contrast, these similarities were not 
observed in tissues from older animals as inhibition of responses by 
fasudil (10µM) expressed as both AUC and frequency were significantly 
lesser in comparison to Y-27632 (10µM) (Fig 4.15, two-way ANOVA, 
p<0.005).   
 
Upon increasing the concentration of fasudil (30µM), inhibition of AUC and 
frequency responses in the older animals were significantly greater than 
the lower concentration (10µM) (Fig 4.15, two-way ANOVA, p<0.005). 
Additionally, the inhibition at the higher concentration of fasudil (30µM) 
was similar to Y-27632 (10µM) (Fig 4.5, p>0.05). In tissues from the 
younger animals, the inhibitory effect of responses expressed as AUC was 
increased by the higher concentration of fasudil (30µM) in comparison to 
the lower concentration (10µM) (Fig 14.5, two-way ANOVA, p<0.05). 
However, this increase was not observed in responses expressed as AUC 
(Fig 14.5, p>0.05). Also, inhibition of both AUC and frequency responses 
by fasudil (30µM) was indifferent to inhibition by Y-27632 (10µM) in the 
younger group (Fig 14.5, p>0.05). 
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Figure 4.15 Percentage inhibition of 5-HT-induced contractile responses 
(100µM) by ROCK inhibitors, Y-27632 (10µM) and fasudil (10µM and 
30µM) expressed as AUC and frequency. Responses are represented as 
a mean percentage inhibition ± SEM (n=6, *p<0.05 vs 10µM Y-27632, 
^p<0.05 vs 10µM fasudil). 
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Rho-kinase Activity 
Using the standard curve for ROCK-II sample (Fig 4.1), active ROCK 
levels in samples of tissue lysates from different groups was determined. 
As seen in Figure 4.16, basal levels of active ROCK were found to be 
similar in old and young groups and were not elevated following agonist 
stimulation with either phenylephrine or 5-HT. The only changes in ROCK 
activity that were observed between tissues from old and young animals 
with greater ROCK activity in tissues from old group at high dose 5-HT 
(100µM) and lower levels in tissues from younger animals after low dose 
of phenylephrine (30µM) (Fig 4.16, two-way ANOVA, p<0.05). 
 
 
 
Figure 4.16 Active rho-kinase levels at basal, low and high doses of 
phenylephrine- and 5HT-induced states in isolated porcine ureteral 
smooth muscle in old and young animals. Responses are represented as 
mean ± SEM (*p<0.05 vs basal, ^p<0.05 vs old) of 3 determinations, each 
performed in duplicate. 
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4.4 Discussion 
 
Effect of Rock Inhibitors on Agonist-Induced Contractions 
The present study sought to investigate the importance of the ROCK 
pathway in agonists-induced contractile responses of the distal ureter. The 
results demonstrate the ability of phenylephrine and 5-HT to activate the 
ROCK pathway in the ureter and therefore, confirmed previous reports 
suggesting a role for of the calcium sensitization pathway in ureteral 
contractions (Levent and Buyukafsar, 2004, Shabir et al., 2004, Shabir et 
al., 2013). 
 
The two agonist concentrations that were chosen for the organ bath 
experiments were determined based on previous concentration-response 
curves produced in respective age groups for the two agonists. The low 
dose represents EC50 where contractile responses were 50% of its 
maximum response, while the high dose was the concentration producing 
the maximal contractile response (100%).  
 
The main finding in our functional study was that both ROCK inhibitors Y-
27632 and fasudil were able to suppress phenylephrine- and 5-HT-
induced contractions in the porcine distal ureter. Involvement of ROCK 
activation in α1-adrenoceptor-dependent ureteral stimulation has been 
characterised in sheep ureter (Levent and Buyukafsar, 2004). Based on 
our current knowledge of the literature, we are the first to demonstrate the 
activation of ROCK in response to 5-HT stimulation. Therefore, based on 
our functional studies, we confirmed that ROCK significantly contributes to 
phenylephrine- and 5-HT-stimulated contractile responses in the porcine 
distal ureter. 
 
In addition to these major findings, interestingly, we also found that there 
were differences in inhibition induced by the two ROCK inhibitors, Y-27632 
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and fasudil at similar concentration in the different age groups. We 
demonstrated that the inhibition of agonist response by Y-27632 (10µM) 
was more effective for than fasudil (10µM) for both phenylephrine and 5-
HT-induced contractions, but only in ureters from older animals and not in 
those from young pigs. This decreased degree of inhibition with fasudil 
(10µM) for phenylephrine was only observed in frequency response and 
not AUC responses. This raises the question as to whether there are 
different pathways involved in the mediation of tonic and phasic α1-
adrenoceptor mediated contraction in tissues from the older animals. 
 
Increasing the dose of fasudil from 10µM to 30µM (3-fold) produced an 
increase in inhibition equivalent to the level produced by Y-27632 (10µM), 
but this was only apparent in frequency of 5-HT-stimulated concentrations 
and not in phenylephrine-induced responses. Also, upon increasing the 
fasudil concentration (30µM), the inhibitory effect was significantly 
increased in the ureters from younger animals for both phenylephrine and 
5-HT, indicating that there could be potential differences in efficacy of 
each ROCK inhibitor for different age groups. To further prove this point, 
we also observed that the inhibitory effects of Y-27632 (10µM) on 
contractile responses expressed as AUC and frequency to both agonists 
were significantly greater in isolated ureter from older animals in 
comparison to the younger animals. 
 
In a study of the human detrusor, it was found that inhibitory effects by 
fasudil and Y-27632 on carbachol-induced contractions were dose-
dependent and comparison between contractions in increasing doses was 
performed (Kirschstein et al., 2014). Similar to our study, this study reports 
a greater inhibitory effect of Y-27632 on carbachol-induced contractions in 
comparison to fasudil (Kirschstein et al., 2014). This could be explained by 
the possibility that Y-27632 is not as specific for ROCK as we expected as 
it can directly inhibit phosphorylation of CPI-17 by purified PKCδ at the 
same concentration required to inhibit ROCK (Eto et al., 2001). This 
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possible additional action of Y-27632 also results in suppression of 
smooth muscle contraction (Li et al., 1998).  Because inhibition of 
phenylephrine-stimulated contraction frequency was greater by Y-27632 
than fasudil (both low and high concentrations) in the older animals, one 
suggestion would be that this specific agonist-mediated contraction is 
mediated by both ROCK and CPI-17 inhibition. However, at the same 
time, ROCK has also been proposed to have the capability of 
phosphorylating CPI-17 (Li et al., 1998). Thus, it is difficult to verify if 
inhibition of CPI-17 was due to ROCK pathway inhibition or due to the 
action of Y-27632 and further investigation is still required to accurately 
confirm whether CPI-17 phosphorylation is involved in modulation of 
ureteral smooth muscle contractions. Nevertheless, it is undeniable that 
our results indicate that the effectiveness of ROCK inhibitors might be 
age-related and also agonist-related in older animals which proves to be 
more complex than anticipated.   
 
Basal and Agonist-Induced Rho-kinase Activity 
Our findings show that there was an overall dissimilarity between basal 
ROCK activity and agonist-induced activity in tissue lysate of distal ureter 
from both age groups (only significantly lower in 100µM 5-HT in tissue 
lysate from young animals). Upon addition of ROCK inhibitors to tissue 
strips, there was no decrease in baseline tone, but this does not 
necessarily indicate that there was no ROCK activity present at basal 
levels since baseline was set to a very low tension (approximately 1g). 
 
Regrettably, we did not have sufficient numbers of tissue strips for each 
group (control and inhibitor) that developed spontaneous contractions to 
statistically determine if ROCK inhibitors had inhibitory effects on basal 
frequency responses. However, several studies have shown that ROCK 
inhibitors are capable of inhibiting spontaneous contractions of the ureter 
in various species including rat (Shabir et al., 2004), sheep (Levent and 
Buyukafsar, 2004), and human (Hong et al., 2005). These studies suggest 
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that ROCK might be activated without the stimulation of agonists, 
supporting our assay results. 
 
Several studies on the bladder have demonstrated that ROCK expression 
and ROCK activity might increase with age (Gomez-Pinilla et al., 2011, 
Kirschstein et al., 2014). In younger animals in comparison to older 
animals, we found ROCK activity was lower for low dose phenylephrine 
(30µM). The opposite was observed with high dose 5-HT (100µM) where 
younger animals had greater ROCK activity. While we acknowledge that 
conclusions cannot be drawn as these alterations are only observed at 
one concentration and not the other, these findings suggest again, that 
alterations of ROCK activity occur with ageing.  
 
Interestingly, our previous data on the effects of age on agonist-stimulated 
contractions (Chapter 2) demonstrated an increase in contractile 
responses to phenylephrine and carbachol in older animals and greater 5-
HT-stimulated contractions in younger animals. In addition to this, it has 
been shown in the human bladder that mediation of carbachol-induced 
contractions via the ROCK pathway is positively correlated with age 
(Kirschstein et al., 2014). Our findings indicate that changes in the role of 
the ROCK pathway with age could be dependent on the agonist being 
studied.  
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4.5 Conclusion 
 
Currently, nifedipine, a calcium channel blocker is one of the drugs 
clinically used to treat ureteral calculi (Osorio et al., 2008). However, 
nifedipine has been shown to result in various significant adverse effects 
including nausea, vomiting, dizziness and flushing (Singh et al., 2007, 
Osorio et al., 2008). Therefore, the discovery of the calcium sensitization 
pathway in smooth muscle contraction opens the window for the possibility 
of a new therapeutic target for drug development. Supporting results from 
previous ROCK studies in ureters from various species, our studies further 
support the view that the ROCK pathway plays a major role in normal 
ureteral function. There is evidence that ROCK is up-regulated in ureteral 
obstruction (Turna et al., 2007) and thus, it could be an interesting target 
for drugs aimed at increasing ureteral stone expulsion rate and reducing 
ureteral colic by relieving ureteral pressure. We also demonstrated that 
ROCK inhibitors might have altered effects with ageing. This discovery 
could be vital in prescribing specific treatments for specific age groups. 
However, it is clear that further studies are needed to further elucidate the 
mechanisms through which α1-adrenoceptor and 5-HT stimulation induces 
the ROCK activation. Additionally, it will also be beneficial to clarify the 
potential of utilising ROCK inhibitors therapeutically in vivo and in clinical 
settings as a part of medical expulsive therapy. 
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CHAPTER 5: 
The effect of urothelium-derived 
inhibitory factor and adenosine 
triphosphate on ureteral contractile 
responses 
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5.1 Introduction 
 
The urothelium is a stratified epithelium that lines the inner parts of the 
renal pelvis, ureters, urinary bladder and part of the urethra. The 
urothelium can be divided into three layers composed of different cell 
types; the outermost, middle and innermost layers (Figure 5.1). The 
outermost layer of the urothelium is made up of umbrella cells which are 
large, flattened and firmly interlocked by tight junctions. The middle layer is 
made up of interstitial cells, while the innermost layer is composed of 
smaller basal cells that are separated by the basal lamina from the 
suburothelial lamina propria (Jost et al., 1989). Although the number of 
intermediate layers might vary between species, it is well known that these 
three layers of cells are present in most species, including human and pig 
(Winder et al., 2014). 
 
Until recently, the urothelium has always been considered to function 
solely as a barrier against the contents of the urine. While this role still 
proves true, today, many dynamic qualities of the urothelium have been 
well recognised. It has been shown that the urothelium is able to release 
signalling molecules acting at different receptor subtypes within the 
urothelium and also able to modify afferent neuronal activity and detrusor 
smooth muscle function (Lazzeri, 2006, Birder and Andersson, 2013). 
There is limited reported research on the urothelium in the ureter. Since 
the vast majority of studies on the urothelium revolve around the urinary 
bladder, it is tempting to assume that the urothelial lining of the ureter will 
most likely have similar morphology and functionality, especially in the 
distal ureter as it is closest to the bladder.  
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Figure 5.1 Urinary bladder wall of the mouse, including a schematic 
representation of the urinary bladder wall. The urothelium is composed of 
superficial umbrella cells, intermediate cells, and basal cells. Beneath the 
urothelium there is suburothelial connective tissue, which is called the 
lamina propria. It is composed of various types of cells including 
fibroblasts, interstitial cells, and myofibroblasts and also afferent nerve 
terminals. The outermost layer is the detrusor smooth muscle cell layer 
(Winder et al., 2014). 
 
 
One of the most significant and novel functions of the urothelium is its 
ability to act as a mechanosensory conductor (Ferguson et al., 1997, 
Andersson, 2002). It has been shown that upon distension of the bladder 
wall, the stretching of the urothelium occurs, leading to the release of 
several signalling molecules (Olsen et al., 2011). Among these signalling 
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molecules are acetylcholine, NO and prostaglandins, but the one that 
appears to play an important role is adenosine-5’-triphosphate (ATP) and 
has been most characterised (Yoshida et al., 2006, Andersson and 
Persson, 1994).  
  
ATP is well-known as a multifunctional ubiquitous biological molecule, 
acting as the main intracellular energy source for all living cells and also 
an extracellular signalling molecule. ATP has been predominantly 
associated with the activation of afferent signalling and the stimulation of 
purinergic receptors on afferent nerve terminals is now well-accepted as a 
mechanosensory mechanism (Apostolidis et al., 2005). In the urinary 
bladder, it has been shown that it is a signalling molecule with a vital role 
in filling of bladder sensation (Burnstock, 2014).  
 
 
 
 
 
Figure 5.2 Structure of ATP. ATP consists of an adenine attached to a 
ribose sugar, which is attached to three phosphate groups. 
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The formation of ATP is an energetically unfavourable phosphorylation 
reaction where a phosphate group is added to adenosine diphosphate 
(ADP).  Most ATP molecules in cells are produced in the mitochondria via 
oxidative phosphorylation while a small amount is produced in the cytosol 
via glycolysis. While ATP is abundant in the cell cytoplasm (2-5mM), there 
is a higher concentration of ATP (100mM) stored in synaptic vesicles of 
neurons (Winder et al., 2014) 
 
It has always been assumed that extracellular ATP is only sourced in 
damaged or dying cells until recently. It is now apparent that ATP can be 
released from many different cell types including peripheral and central 
neurons and also many non-neuronal cell types during mechanical 
deformation including shear stress, stretch, hypoxia, osmotic swelling and 
stimulation by agents (Bodin and Burnstock, 2001, Boudreault and 
Grygorczyk, 2004). It was first suggested that ATP is released from 
epithelial cells lining structures that are viewed as ‘sacs’ (bladder and 
lungs) or ‘tubes’ (ureter, gut) (Burnstock, 1999). 
 
ATP is a highly charged molecule and cannot readily cross plasma 
membranes, thus physiological release requires the participation of an 
active transport mechanism. While theories on actual transport 
mechanisms involved in the release of ATP are still contradictory, there is 
compelling evidence that in neurons, the mechanism involves exocytotic 
vesicles (Novak, 2003). On the other hand, in non-neuronal cells like red 
blood cells and epithelial cells, several other mechanisms (on top of 
vesicle transport) have been proposed including the ATP-binding cassette 
transporters (Burnstock, 2007, Demolombe and Escande, 1996) and 
transport via connexin or pannexin channels (Stout et al., 2002, Timoteo et 
al., 2014). In the urothelium, the pathways underlying release of ATP are 
mostly attributable to vesicular exocytosis (Wang et al., 2005) and 
pannexin hemichannel conductive efflux (Timoteo et al., 2014, Negoro et 
al., 2013) although there is still no consensus on this. Regardless of the 
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transport mechanism, it is agreed that the urothelium has the capability to 
release ATP into both mucosal and serosal compartments of the urinary 
bladder wall (Ferguson et al., 1997, Lewis and Lewis, 2006) and can thus, 
play an autocrine function (Wang et al., 2005) and/or act in a local 
paracrine manner to influence afferent nerves, interstitial cells and 
myofibroblasts or detrusor muscle contractility (Cockayne et al., 2000, Sui 
et al., 2014). 
 
It is hypothesised that the initiation of ATP release from epithelial cells is 
the deformation of these cells (Burnstock, 1999).  In the urinary bladder, 
the release is thought to be caused by stretching of the urothelium during 
the filling of the bladder. This increases the tension in the apical layer of 
umbrella cells and therefore an increase in apical surface area of these 
cells, which is suggested to result in the activation of mechanotransduction 
pathways, via stretch-activated release of ATP from the urothelial cells 
(Ferguson et al., 1997, Cheng et al., 2011, Dunning-Davies et al., 2013, 
Wang et al., 2005).  In several animal models, it has been reported that 
the amount of ATP released during distension was proportional to the 
extent of distension (Ford and Cockayne, 2011, Vlaskovska et al., 2001). 
The actual cell type/s in the urothelium responsible for the release of ATP 
is still unidentified but it was demonstrated that the umbrella cells, 
intermediate and basal subtypes were equally effective in ATP generation 
(McLatchie and Fry, 2015).  
 
Upon the release of ATP extracellularly, it can act as an autocrine or 
paracrine signal, modulating cell functions via activation of purinergic 
receptors located on the plasma membrane of cells. The two purinergic 
receptor types are P1 receptors, which are selective for adenosine, formed 
during the breakdown of ATP (also known as adenosine receptors) and P2 
receptors, which are selective ATP and ADP (Burnstock, 2007). P2 
receptors are further classified into two families: the P2X and P2Y family. 
Currently, there are seven known P2X receptor subtypes and eight P2X 
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receptor isoforms (North, 2002, Shaver, 2001). While results from several 
studies regarding P2 receptor expression in the urinary bladder are 
conflicting, it appears that the urothelium expresses all seven P2X 
receptor subtypes and several P2Y receptor subtypes including P2Y1, 
P2Y2, and P2Y4 (Khandelwal et al., 2009, Shabir et al., 2013).  
 
Expression of both P2X and P2Y purinergic receptors are specifically 
located at the afferent nerve fibres and interstitial cells/myofibroblasts 
situated near the bladder luminal surface. The sensitivity of these cells to 
ATP suggests that the basolateral ATP release could also affect their 
functions (Birder and de Groat, 2007). P2Y receptors are thought to be 
involved in the mediation of further ATP release in the native bladder 
mucosa. UTP, a P2Y receptor selective agonist, was shown to significantly 
increase ATP release and in contrast, α,β-methylene ATP (α,β-meATP), a 
selective P2X1 and P2X3 agonist, had no significant release of ATP in the 
bladder mucosa (Sui et al., 2014). 
 
It is suggested that in the urothelium, stimulation of P2X2 and P2X3 
receptors present on the urothelium by ATP released from the apical and 
basolateral urothelial surfaces induced stretch-induced exocytosis and 
endocytosis (Wang et al., 2005). It is proposed that in the urothelial cells, 
exocytosis and endocytosis may modulate the composition of receptors 
present and absent at the plasma membrane of urothelial cells (Winder et 
al., 2014). In addition to this, it is also hypothesised that stimulation of 
P2X3 receptors on suburothelial sensory nerve fibres by ATP from the 
basolateral surface of the urothelium during bladder filling plays an 
important role in the relaying of information regarding the degree of 
bladder filling to the central nervous system (Cockayne et al., 2000). In 
support of this hypothesis, it was shown in knockout mice without P2X2, 
P2X3 or P2X2/P2X3 receptor subunits, there is limited activation of bladder 
afferent nerve terminals and reduced micturition frequencies and 
increased bladder volume capacities (increased voiding volume) in 
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comparison to control mice. Despite this, in the knockout mice, ATP 
release from the bladder urothelium is unaltered (Cockayne et al., 2005).   
 
Although limited research on the urothelium of ureter is available, studies 
on the guinea pig (Knight et al., 2002) and human (Calvert et al., 2008) 
ureter demonstrated an intraluminal pressure-dependent release of ATP 
from the urothelium.  It is proposed that the transport mechanism of 
urothelial ATP release appears to involve vesicular exocytosis and maybe 
ABC transporters in the guinea pig ureter (Knight et al., 2002). 
Interestingly, the release of ATP only occurred at a certain intraluminal 
pressure threshold and this threshold was comparable to pressure 
threshold in ureteric model mimicking obstructing calculi with the insertion 
of an inflated balloon where ureteral colic is experienced (Risholm, 1954, 
Calvert et al., 2008). 
 
Another interesting note is that the P2X3 homomultimer and P2X2/3 
heteromultimer receptor subtypes have been identified on nociceptive 
sensory neurons and therefore have been associated with the sensation of 
pain (Burnstock and Wood, 1996, Chen et al., 1995, Lewis et al., 1995). It 
is proposed that ATP released acting as a signal for distension of 
structures could act on P2X2/3 receptors on the subepithelial sensory 
nerves to convey information to the central nervous system pain centres 
(Burnstock, 1999). This has been exhibited in urinary bladder of various 
species (Ferguson et al., 1997, Vlaskovska et al., 2001) and also in the 
guinea pig ureter (Rong and Burnstock, 2004). This is further supported by 
evidence that P2X3 receptors are present on occasional nerve bundles in 
the subepithelial plexus of the rat (Lee et al., 2000) and human (Calvert et 
al., 2008) ureter. These findings suggest a significant role of ATP where 
distension of ureteral wall by calculi and increased intraluminal might 
stimulate its release, and therefore stimulation of this nociception pathway. 
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With relation to this, the urothelium has been implicated in a number of 
lower urinary tract disorders including, cyclophosphamide-induced cystitis 
and interstitial cystitis/painful bladder syndrome, where increased 
urothelial ATP release has been shown, in addition to the altered 
sensitivity of afferent nerve terminals (Jost et al., 1989, Ferguson et al., 
1997). There is also indication that expression of P2X2 and P2X3 receptors 
is upregulated in the bladder of patients with interstitial cystitis (Tempest et 
al., 2004).  
 
In addition to disease, urothelial ATP release mechanisms have also been 
shown to be altered with ageing. Altered ATP and acetylcholine 
bioavailability and increased P2X3 receptor expression at the urothelium 
was demonstrated in the aging mouse bladder (Daly et al., 2014). 
Furthermore, intrinsic ATP release in guinea pig mucosal preparations 
was also significantly enhanced in tissues from older animals (Sui et al., 
2014).   
 
Much has been discussed regarding the urothelium’s role in transducing 
and integrating sensory signals, especially via urothelial ATP release, for 
the nervous system to encode for relay to the central nervous system.  
Besides this notable function, it is also apparent that the urothelium can 
affect the contractility of the underlying smooth muscle layers. In addition 
to chemical diffusion between the urothelium and smooth muscle layers, it 
is suggested that gap junctions in the myofibroblasts could also be a 
mechanism for long-distance spread of signals from the urothelium to the 
detrusor smooth muscle (Brading, 2006).   
 
Many have shown that the removal of urothelium significantly enhances 
detrusor smooth muscle contractility to a range of contractile agents 
(Pinna et al., 1992, Maggi et al., 1987, Levin et al., 1995, Murakami et al., 
2007). In the pig urinary bladder, it was demonstrated that detrusor 
smooth muscle contractions to carbachol were inhibited in strips denuded 
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of urothelium in the presence of a second strip with a functional 
urothelium, indicating the release of a diffusible inhibitory agent from the 
urothelium upon activation of muscarinic stimulation (Hawthorn et al., 
2000). This was also further confirmed when these responses were 
potentiated following the removal of urothelium from previously intact 
bladder strips (Hawthorn et al., 2000). This inhibitory agent is yet to be 
identified and is termed the urothelium-derived inhibitory factor (UDIF). 
Besides muscarinic stimulation, it was suggested that β-adrenoceptor 
stimulation also induces the release of UDIF (Murakami et al., 2007). The 
presence of UDIF has also been demonstrated in the rat ureter, where 
stimulation by various agonists including carbachol, bradykinin, 
angiotensin II, neurokinin A and vasopressin were enhanced in 
urothelium-free tissue strips (Mastrangelo and Iselin, 2007). These 
findings indicate that UDIF depresses muscle contractility by either 
metabolization or inactivation of agonists, acting as a barrier to diffusion 
and penetration of agonist, or by releasing subsequent agents that 
reduced muscle contractility (Birder et al., 2012).  
 
Several possible inhibitory pathways have been studied and prime 
amongst these is NO, which have been well-known to cause relaxation of 
smooth muscle cells by activation of soluble guanylate cyclase. However, 
NOS and sGC inhibitors both did not have any effect on this urothelial-
derived inhibition, suggesting that NO cannot be UDIF (Hawthorn et al., 
2000). Other likely pathways that have been shown to induce smooth 
muscle relaxation including the COX activity, P2Y receptors and GABA 
receptors, were also rejected as UDIF because inhibition of these 
pathways did not alter urothelium depressant effect  (Hawthorn et al., 
2000).  
 
It was shown in the urinary bladder that P2X and P2Y receptors are 
present and can be activated by neural and urothelial ATP to induce 
contractions and relaxation, respectively (Hernandez et al., 1999). While 
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P2Y receptors have been ruled out as the inhibitory pathway for UDIF in 
the bladder, ATP is broken down into adenosine by ectoATPases and 
nucleotidases, which are present in the surroundings of the nerve terminal 
(Cusack and Hourani, 1984) and this can stimulate the adenosine 
receptors which can affect smooth muscle contractility. Smooth muscle 
adenosine receptors have been shown to generally cause relaxation 
where all four subtypes are G-protein coupled receptors A1 and A3 are 
coupled to inhibitory G-protein while the activation of A2A and A2B receptors 
stimulates adenylyl cyclase (Burnstock and Kennedy, 1985, Collis and 
Hourani, 1993, Alexander et al., 1994, Fredholm et al., 1994). In a study of 
the porcine intravesical ureter, it was proposed that A2B-receptor could be 
responsible for the mediation of smooth relaxation induced by NANC 
transmission (Hernandez et al., 1999).  
 
The aim of this study was to determine the effect of the urothelium, and 
ATP, on ureteral smooth muscle contraction to α-adrenoceptor and 5-HT 
receptor stimulation and whether this effect is altered with age. In addition 
to this, we were also interested in determining the receptor through which, 
if any ATP effect is mediated.  
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5.2  Methods and Materials 
 
Tissue preparation and in vitro functional studies were performed as 
stated in Section 2.1. For the first part of the study, isolated ureteral tissue 
strips were paired where one strip had intact urothelium while the other, 
urothelium was removed. Contractile responses to phenylephrine (7.48 x 
10-8 – 7.48 x 10-4 M) and 5-HT (5.88 x 10-8 – 5.88 x 10-4 M) were 
compared in the absence and presence of urothelium. In the second part 
of the study, 1mM exogenous ATP was added into the organ baths 
containing isolated denuded ureteral strips and was incubated for 30 
minutes before contractile responses to phenylephrine (7.48 x 10-8 – 7.48 
x 10-4 M) and 5-HT (5.88 x 10-8 – 5.88 x 10-4 M) were recorded. These first 
two sets of experiments were performed in tissues from both age group: 
young (20 weeks) and old (56 weeks).  
 
In the third part of this study, we utilised adenosine receptor antagonist 8-
phenyltheophylline (8-PT), the P2 receptor antagonist suramin, and ATP 
hydrolysis enzyme apyrase (which is responsible for ATP hydrolysis into 
adenosine monophosphate and inorganic phosphate). Each antagonist 
was incubated with denuded tissue strips, together with ATP, or tissues 
with intact urothelium for 30 minutes before contractile responses to 
phenylephrine (7.48 x 10-8 – 7.48 x 10-4 M) were recorded. In addition to 
this, a combination of suramin and 8-PT was incubated with denuded 
tissues together with exogenous ATP and intact tissue strips. Contractile 
responses to agonists are expressed as AUC (g s) and frequency (Hz). 
 
Paired student’s t-tests were performed on studies with two groups while 
two-way ANOVA was used for studies involving more than two groups.   
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5.3 Results 
 
Effect of Urothelium on Agonist-Induced Ureteral 
Responses 
Contractile responses expressed as AUC and frequency to phenylephrine 
were enhanced in tissues denuded of urothelium, in both age groups 
(p<0.005, paired t-test, n=6, Figures 5.3 and 5.4). The inhibitory effect of 
the urothelium on maximal phenylephrine-induced contractile response 
expressed as AUC was similar in tissues from both age groups (31.7 ± 
5.0% vs 30.0 ± 5.8%, young vs old). This was also observed for responses 
when expressed as maximum frequency of contractions (22.3 ± 3.6% vs 
27.4 ± 5.7%, young vs old). The potency (pEC50) of phenylephrine was not 
significantly different in intact and denuded tissues from younger animals 
(p>0.05, Table 5.1). However, potency of phenylephrine was greater in the 
presence of urothelium in tissues from older animals (p<0.05, paired t-test, 
n=6, Table 5.1). 
 
Maximum contractility in response to 5-HT stimulation in isolated ureteral 
strips, expressed as AUC, was decreased in the presence of urothelium in 
tissues from both old and young animals (p<0.001, paired t-test, n=6, 
Figures 5.5a and 5.6a). Inhibition of contractile response expressed as 
AUC at maximal 5-HT concentration was greater in tissues from older 
animals (29.7 ± 5.6% vs 40.4 ± 2.1%, young vs old, unpaired t-test, 
p<0.05).  Maximum frequency of contractions in response to 5-HT was 
significantly depressed only in tissues from older animals (p<0.001, paired 
t-test, n=6, Figure 5.6b) and consequently, percentage of inhibition of 
maximum frequency was greater in older animals (9.6 ± 4.5 vs 39.3 ± 6.1, 
young vs old, unpaired t-test, p<0.005). Potency of 5-HT was similar in 
both intact and denuded smooth muscle strips in both age groups (p>0.05, 
Table 5.1). 
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The degree on inhibition of contractile responses by the urothelium (AUC 
and frequency) was not significantly different between the two agonists, 
phenylephrine and 5-HT. The only observed significant difference was that 
in tissues from the younger animals, maximum frequency was not inhibited 
by the presence of urothelium in response to 5-HT but was depressed by 
the urothelium in response to phenylephrine. 
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Figure 5.3 Concentration-response curves for phenylephrine in isolated 
distal ureter from young pigs with intact and denuded urothelium. 
Responses are expressed as % of denuded tissue maximal response for 
AUC (a) and frequency (b). Results are represented as mean ± SEM of 6 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs intact). 
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Figure 5.4 Concentration-response curves for phenylephrine in isolated 
distal ureter from old pigs with intact and denuded urothelium. 
Responses are expressed as % of denuded tissue maximal response for 
AUC (a) and frequency (b). Results are represented as mean ± SEM of 6 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs intact). 
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Figure 5.5 Concentration-response curves for 5-HT in isolated distal 
ureter from young pigs with intact and denuded urothelium. Responses 
are expressed as % of denuded tissue maximal response for AUC (a) and 
frequency (b). Results are represented as mean ± SEM of 6 preparations 
for each group (*p<0.05, **p<0.01, ***p<0.001 vs intact). 
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Figure 5.6 Concentration-response curves for 5-HT in isolated distal 
ureter from old pigs with intact and denuded urothelium. Responses are 
expressed as % of denuded tissue maximal response for AUC (a) and 
frequency (b). Results are represented as mean ± SEM of 6 preparations 
for each group (*p<0.05, **p<0.01, ***p<0.001 vs intact). 
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Effect of ATP on Agonist-Induced Ureteral Responses 
Maximum contractile responses expressed as AUC to phenylephrine were 
significantly reduced in the presence of ATP in denuded strips for both age 
groups (p>0.005, paired t-test, n=6, Figure 5.7a and 5.8a). The inhibition 
induced by ATP at the maximal phenylephrine concentration was 
significantly greater in tissues from the older animals (33.4 ± 5.6% vs 45.4 
± 3.3%, young vs old, unpaired t-test, p<0.05). Maximum frequency of 
contraction in response to phenylephrine was also reduced in the 
presence of ATP in tissues from both age groups (p<0.05, Figures 5.7b 
and 5.8b). This inhibitory effect of ATP on maximal contraction frequency 
was also greater in the older animals (22.3 ± 4.7% vs 41.7 ± 2.8%, young 
vs old, unpaired t-test, p<0.005). The potencies of both phenylephrine and 
Table 5.1 pEC50 values for AUC for responses to phenylephrine 
and 5-HT in the pig distal ureter in the presence and absence of 
urothelium. Results are expressed as mean ± SEM, * vs intact 
Agonist Group n pEC50 
Phenylephrine 
Young 
Intact 6 4.99 ± 0.19 
Denuded 6 5.40 ± 0.12 
Old 
Intact 6 4.31 ± 0.19 
Denuded 6 4.90 ± 0.15* 
5-HT 
Young 
Intact 6 4.15 ± 0.68 
Denuded 6 4.65 ± 0.09 
Old 
Intact 5 4.82 ± 0.27 
Denuded 5 5.40 ± 0.15 
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5-HT were not significantly different in the presence and absence of ATP 
in both age groups (p>0.05, n=6, Table 5.2). 
 
Maximum contractility to 5-HT stimulation in isolated ureteral strips 
expressed as AUC was attenuated in the presence of ATP in tissues from 
both old and young animals (p<0.001, paired t-test, n=6, Figures 5.9a and 
5.10a) and this inhibition was similar in both age groups (22.8 ± 4.9% vs 
26.3 ± 4.7%, young vs old). ATP significantly depressed maximum 
frequency of contractions in response to 5-HT only in tissues from the 
older animals (p<0.05, paired t-test, n=6, Fig 5.10b).  Hence, the 
percentage of inhibition on frequency response was greater in tissues from 
the older group (10.9 ± 5.4% vs 23.2 ± 4.2%, young vs old, unpaired t-test, 
p<0.05). 
 
In tissues from the younger animals, inhibition of contractions by ATP at 
maximal contraction expressed as AUC was similar for both agonists, 
phenylephrine and 5-HT (p>0.05). However, maximal frequency was 
unaffected by ATP when stimulated with 5-HT, but was significantly 
decreased by ATP in phenylephrine-induced contractile responses. In the 
older animals, the inhibitory effect of ATP was greater on phenylephrine-
induced contractile responses in comparison to 5-HT-induced responses, 
expressed as both AUC (p<0.05, unpaired t-test) and frequency (p<0.005, 
unpaired t-test). 
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Figure 5.7 Concentration-response curves for phenylephrine in isolated 
distal ureter from young pigs in the presence and absence of ATP (1mM). 
Responses are expressed as % of control tissue maximal response for 
AUC (a) and frequency (b). Results are represented as mean ± SEM of 6 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001  vs ATP). 
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Figure 5.8 Concentration-response curves for phenylephrine in isolated 
distal ureter from old pigs in the presence and absence of ATP (1mM). 
Responses are expressed as % of control tissue maximal response for 
AUC (a) and frequency (b). Results are represented as mean ± SEM of 6 
preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs ATP). 
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Figure 5.9 Concentration-response curves for 5-HT in isolated distal 
ureter from young pigs in the presence and absence of ATP (1mM). 
Responses are expressed as % of maximal response for AUC (a) and 
frequency (b). Results are represented as mean ± SEM of 6 preparations 
for each group (*p<0.05, **p<0.01, ***p<0.001 vs ATP). 
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Figure 5.10 Concentration-response curves for 5-HT in isolated distal 
ureter from old pigs in the presence and absence of ATP (1mM). 
Responses are expressed as % of maximal response for AUC (a) and 
frequency (b). Results are represented as mean ± SEM of 6 preparations 
for each group (*p<0.05, **p<0.01, ***p<0.001 vs ATP). 
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Table 5.2 pEC50 values for AUC for responses to phenylephrine 
and 5-HT in the pig distal ureter in the presence and absence of 
ATP (1mM). Results are expressed as mean ± SEM. 
Agonist Group n pEC50 
Phenylephrine 
Young 
Control 6 4.96 ± 0.12 
ATP (1mM) 6 4.89 ± 0.24 
Old 
Control 6 4.37 ± 0.08 
ATP (1mM) 6 4.28 ± 0.09 
5-HT 
Young 
Control 6 4.29 ± 0.08 
ATP (1mM) 6 4.27 ± 0.14 
Old 
Control 5 5.04 ± 1.19 
ATP (1mM) 5 5.19 ± 0.87 
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Comparison of Inhibitory Effect by ATP and the Urothelium 
When comparing the inhibition induced by exogenous ATP and the 
urothelium, it was found that the inhibition was similar for both on both 
agonist-induced maximal contractions in the younger animals. However, in 
tissues from the older animals, urothelium inhibition of phenylephrine-
induced contraction was lower in comparison to the inhibition by ATP, for 
responses expressed as both AUC and frequency (unpaired t-test, p<0.05, 
Table 5.3). The opposite was demonstrated for 5-HT-stimulated maximal 
contractions, where the inhibitory effect of ATP was greater than the 
inhibitory effect of the urothelium (unpaired t-test, p<0.05, Table 5.3). 
 
 
 
 
Table 5.3 Percentage of inhibition by urothelium and ATP (1mM) at 
maximal contractile response (expressed as AUC and frequency) to 
phenylephrine and 5-HT in the pig distal ureter. Results expressed as 
mean ± SEM, * p<0.05 vs ATP . 
Agonist Group Urothelium (%) ATP (%) 
Phenylephrine 
Young 
AUC 31.7 ± 5.0 33.4 ± 5.6 
Frequency 22.3 ± 3.6 22.3 ± 4.7 
Old 
AUC 30.0 ± 5.8* 45.4 ± 3.3 
Frequency 27.4 ± 5.7* 41.7 ± 2.8 
5-HT 
Young 
AUC 29.7 ± 5.6 22.8 ± 4.9 
Frequency 9.6 ± 4.5 10.9 + 5.4 
Old 
AUC 40.4 ± 2.1* 26.3 ± 4.7 
Frequency 39.3 ± 6.1* 23.2 ± 4.2 
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Effect of Apyrase and ATP Receptor Antagonists on 
Phenylephrine-Induced Ureteral Responses in Young 
Animals 
Apyrase (2u/ml) enhanced phenylephrine-induced contractile responses, 
expressed as both AUC and frequency, in intact isolated distal ureteral 
strips from younger animals (paired t-test, p<0.005, Figure 5.11). This 
excitatory effect of apyrase on contraction to phenylephrine was not 
observed in tissues that were denuded of urothelium (p>0.05, Figure 
5.12). The inhibition of phenylephrine-induced contractile responses of 
denuded tissues by pre-incubation with ATP (1mM) was nullified in the 
presence of apyrase and this was observed for both AUC and frequency 
of contraction (paired t-test, p<0.001, Figure 5.13). There was no 
significant difference in contractile responses in the presence of suramin 
(100µM) and/or 8-phenyltheophylline (10µM) in intact or denuded tissues 
and in the presence and absence of ATP (Figures 5.14, 5.15 and 5.16). 
The potency (pEC50) of phenylephrine was similar in these studies (Table 
5.4 and 5.5). 
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Figure 5.11 Concentration-response curves for phenylephrine in isolated 
distal ureter (intact) from young pigs in the presence and absence of 
apyrase (2units/ml). Responses are expressed as % of maximal 
response for AUC (a) and frequency (b). Results are represented as mean 
± SEM of 6 preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs 
apyrase). 
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Figure 5.12 Concentration-response curves for phenylephrine in isolated 
distal ureter (denuded) from young pigs in the presence and absence of 
apyrase (2units/ml). Responses are expressed as % of maximal 
response for AUC (a) and frequency (b). Results are represented as mean 
± SEM of 6 preparations for each group (*p<0.05, **p<0.01, ***p<0.001 vs 
apyrase). 
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Figure 5.13 Concentration-response curves for phenylephrine with ATP 
(1mM) in isolated distal ureter (denuded) from young pigs in the presence 
and absence of apyrase (2units/ml). Responses are expressed as % of 
maximal response for AUC (a) and frequency (b). Results are represented 
as mean ± SEM of 6 preparations for each group (*p<0.05, **p<0.01, 
***p<0.001 vs apyrase). 
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Table 5.4 pEC50 values for AUC for contractile 
responses to phenylephrine in the pig distal ureter 
in the presence and absence of apyrase (2u/ml). 
Results are expressed as mean ± SEM. 
Group n pEC50 
Intact 
Control 6 4.92 ± 0.15 
Apyrase 6 4.84 ± 0.06 
Denuded 
Control 6 5.06 ± 0.22 
Apyrase 6 5.02 ± 0.12 
Denuded + 
ATP (1mM) 
Control 5 4.97 ± 0.10 
Apyrase 5 4.91 ± 0.10 
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Figure 5.14 Concentration-response curves for phenylephrine in isolated 
distal ureter (intact) from young pigs in the presence and absence of 
suramin (100µM) and/or 8-phenyltheophylline (10µM). Responses are 
expressed as % of maximal response for AUC (a) and frequency (b). 
Results are represented as mean ± SEM of 5 preparations for each group 
(*p<0.05, **p<0.01, ***p<0.001 vs apyrase). 
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Figure 5.15 Concentration-response curves for phenylephrine in isolated 
distal ureter (denuded) from young pigs in the presence and absence of 
suramin (100µM) and/or 8-phenyltheophylline (10µM). Responses are 
expressed as % of maximal response for AUC (a) and frequency (b). 
Results are represented as mean ± SEM of 5 preparations for each group 
(*p<0.05, **p<0.01, ***p<0.001  vs apyrase). 
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Figure 5.16 Concentration-response curves for phenylephrine with ATP 
(1mM) in isolated distal ureter (denuded) from young pigs in the presence 
and absence of suramin (100µM) and/or 8-phenyltheophylline (10µM). 
Responses are expressed as % of maximal response for AUC (a) and 
frequency (b). Results are represented as mean ± SEM of 5 preparations 
for each group (*p<0.05, **p<0.01, ***p<0.001 vs apyrase). 
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Table 5.5 pEC50 values for AUC for contractile responses 
to phenylephrine in the pig distal ureter in the presence 
and absence of suramin (100µM) and 8-
phenyltheophylline (100µM). Results are expressed as 
mean ± SEM. 
Group n pEC50 
Intact 
Control 5 4.73 ± 0.19 
Suramin 5 4.51 ± 0.18 
8-PT 5 4.40 ± 0.17 
Combination 5 4.55 ± 0.39 
Denuded 
Control 5 4.72 ± 0.16 
Suramin 5 4.79 ± 0.13 
8-PT 5 4.78 ± 0.15 
Combination 5 4.69 ± 0.18 
Denuded + 
ATP (1mM) 
Control 5 4.62 ± 0.14 
Suramin 5 4.61 ± 0.11 
8-PT 5 4.63 ± 0.15 
Apyrase 5 4.36 ± 0.18 
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5.4 Discussion 
 
Presence of Urothelium-Derived Inhibitory Factor in 
Porcine Distal Ureter 
There is limited research on the urothelium of the ureter, and therefore it is 
tempting to speculate on the basic functionality and morphology of the 
urothelium in the ureter based on studies in the bladder, especially the 
distal ureter as it extends from the bladder. In the bladder, the stimulation 
of muscarinic receptors releases a factor from the urothelium that inhibits 
the underlying smooth muscle. This is supported by studies showing 
detrusor contractile responses to muscarinic receptor stimulation being 
enhanced upon removal of the urothelium (Hawthorn et al., 2000, Levin et 
al., 1995). Hawthorne et al. (2000) showed the release of a diffusible 
inhibitory agent by the urothelium, which is currently labelled the 
urothelium-derived inhibitory factor (UDIF). UDIF has also been shown 
following stimulation of α-adrenoceptors, but not histamine receptor 
(Templeman et al., 2002). Based on our previous functional studies in the 
porcine distal ureter (Chapter 2), the α-adrenergic and 5-HT system 
appear to play the major roles in the control of ureteral smooth muscle 
contraction thus were the focus of this study. Our findings show enhanced 
phenylephrine and 5-HT-induced contractile responses upon removal of 
the urothelium, which confirms the hypothesis that, similar to the bladder, 
the urothelium of the ureter significantly modulates contractility. 
 
These results also support findings from a previous study in the rat ureter, 
where contractility was shown to be urothelium-dependently inhibited 
(Mastrangelo and Iselin, 2007). However, one disparity between our 
results and the latter study was that spontaneous contractions were also 
enhanced upon urothelium removal in the rat ureter, whilst in our study, 
development of spontaneous activity was unaltered in the porcine ureter. 
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Due to tachyphylaxis, none of these experiments were conducted in the 
same preparation and, therefore, the percentage of tissues that exhibit 
spontaneous contractions were always compared between two separate 
denuded and intact tissues. These were similar between the two groups 
(15% denuded vs 17% intact). Although the authors did not specify the 
region of ureter utilised, none of the rat ureteral strips with intact 
urothelium developed spontaneous activity, leading to the speculation that 
it was not the proximal ureter and was perhaps more likely mid or distal 
ureter. Thus, the contrasting results are perhaps not due to regional 
differences. We suspect that the most likely explanation behind this is 
simply differences between species.  
 
Our results also suggest that the inhibitory effect of the urothelium was 
similar for both α-adrenoceptor and 5-HT receptor stimulation. 
Interestingly, in the rat ureter, stimulation of smooth muscle strips by 
norepinephrine did not induce any contractions in both intact and 
urothelium-free preparations, even in the presence of β-adrenergic system 
inhibition (Mastrangelo and Iselin, 2007). This is contradictory to our 
results where the presence of the urothelium produced a significant 
reduction in contractile responses to α-adrenoceptor stimulation, as 
expected since α-adrenoceptor agonists are generally known as the 
classic group of contractile agents in the ureteral smooth muscle, in 
several species including rat, porcine and human (Lang et al., 2002). 
Additionally, a separate study also did not detect any modification of 5-HT 
stimulated contractile responses upon removal of urothelium in the 
isolated porcine intravesical ureter (Hernandez et al., 2003). Therefore, to 
our knowledge, we are the first to demonstrate the release of an inhibitory 
factor from the urothelium upon α-adrenoceptor and 5-HT receptor 
stimulation in the porcine distal ureter. In the bladder, this has been 
termed UDIF, as it is as yet unidentified. We attempted to investigate 
whether ATP is the inhibitory factor in ureter. 
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Effect of ATP on Agonist-Induced Contractile Responses  
Since there is much evidence for urothelial ATP release, the autocrine and 
paracrine effects of ATP have been thoroughly researched in the bladder 
of various species. However, similar to many other mechanisms, very little 
research on the effect of ATP has been directed to ureter. UDIF has been 
shown not to be ATP in the bladder, but there are studies on the effect of 
purines on ureteral smooth muscle receptors in the ureter (Hernandez et 
al., 1999). 
 
In the detrusor smooth muscle, it has been identified that ATP can induce 
both relaxation and contraction, via P2Y and P2X receptors respectively, 
but the latter is reported to play a more significant role by majority of 
studies (Santoso et al., 2010). Also in the detrusor muscle, the relaxant 
effect of ATP was demonstrated in urothelium-denuded strips (McMurray 
et al., 1998). In the present study, we have shown for the first time, a 
functional effect of ATP on phenylephrine- and 5-HT-induced contractions 
in isolated porcine distal ureteral smooth muscle without urothelium, 
suggesting that ATP exerts an inhibitory effect directly on the ureteral 
smooth muscle strips. While it is appealing to speculate that this relaxatory 
effect of ATP is definitely attributed to P2Y receptors, it is vital to be aware 
that local factors, in particular breakdown by nucleotidases into adenosine, 
could be involved in the regulation of smooth muscle contraction and 
therefore, we further investigated this. 
 
 
Comparison of Inhibition by Urothelium-Derived Inhibitory 
Factor and ATP 
When comparing between the inhibition induced by ATP and that induced 
by the urothelium in tissues from the younger animals, it appears that the 
presence of ATP renders the ability of denuded strips to response similarly 
to phenylephrine and 5-HT as if the urothelium was intact (ie. a similar 
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inhibition was seen between ATP and presence of the urothelium). The 
ATP concentration that was used was sufficient to make up for the loss of 
inhibition by the urothelium. This supports the idea that ATP may be the 
inhibitory factor released from the urothelium.   
 
Control of ATP release from the urothelium in the bladder is well 
established, and several agents are involved (Andersson, 2015). 
Stimulation of muscarinic receptors M1, M2 and M3 in the urothelium were 
able to trigger urothelial release of ATP (Kullmann et al., 2008).  This was 
further explored in a separate study where it was found that carbachol and 
an M2 receptor preferential agonist oxtremorine stimulated ATP release. 
This release was antagonised by methoctramine, an M2 receptor selective 
antagonist, suggesting that this muscarinic receptor subtype plays a 
significant role in neurotransmitter-induced ATP release from the bladder 
mucosa (Sui et al., 2014). This is in similarity to UDIF release, where 
stimulation of muscarinic receptor and α-adrenoceptor cause release of 
UDIF from the urothelium. While receptor expression on the urothelium of 
the ureter has not yet been investigated, it is possible that the stimulation 
of the urothelium by major neurotransmitters of the ureter (α-adrenoceptor 
agonists and 5-HT) could induce release of ATP from the urothelium. 
Although this is purely a speculation and still requires further inquisition, it 
provides further weight to the suggestion that ATP might be UDIF in the 
ureter. It is also important to keep in mind that the stimulation of P2Y 
receptors by ATP in the urothelium represents an important feedback 
mechanism to amplify further ATP release (Sui et al., 2014). Therefore, 
besides intrinsic ATP release from the urothelium, exogenous ATP has 
also been suggested to be able to stimulate the release of more ATP from 
the urothelium which in turn could produce more inhibition of smooth 
muscle contraction (Hawthorn et al., 2000, Levin et al., 1995).  
 
In the older animals, it was demonstrated that the inhibition by ATP was 
greater than that induced by the urothelium for α-adrenoceptor-stimulated 
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contractions and vice versa for 5-HT-stimulated contractions. There have 
been many reports on the changes that urothelium undergoes with ageing, 
reflecting the ageing process and the fact that older individuals are more 
prone to bladder disorders (Nelson and Dannefer, 1992, Caremel et al., 
2010). Some noteworthy changes with ageing that have been exhibited in 
the bladder urothelium are a significant increase in urothelial ATP release 
(Sui et al., 2014) and increased sensitivity to ATP and enhanced 
expression of P2X receptor (Daly et al., 2014). In addition to this, 
contractility in response to ATP in the aged rat bladder was also found to 
be significantly greater than in younger rats (Saito et al., 1993).  Therefore, 
we suggest that findings we have presented here for ureters from older 
animals may be a result there could also be alterations that occur with 
ageing in urothelial mediator release. This supports a change in factors 
released from urothelium with age and could not be solely ATP. 
 
 
Effect of Apyrase and Purinergic Antagonists on 
Urothelium-Derived Inhibitory Factor and ATP Inhibitory 
Effect  
Due to the differences found between the inhibition induced by ATP and 
UDIF in the tissues from older animals, our subsequent experiments were 
performed only in the younger animals. We used apyrase to promote the 
breakdown of ATP into adenosine monophosphate and inorganic 
phosphate.  It was observed that the presence of apyrase significantly 
enhanced phenylephrine-induced contractions in isolated tissues with 
intact urothelium, and that there was no effect of apyrase on ureteral 
tissues denuded of urothelium. Neither suramin nor 8-PT was able to 
produce a similar effect. Additionally, the inhibitory effect of presence of 
ATP on phenylephrine-induced contraction in denuded tissues was also 
reversed by apyrase but not by suramin and/or 8-PT. These findings 
suggest the possibility of urothelial release of ATP which inhibits smooth 
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muscle contractions through a mechanism other than those blocked by 
suramin and/or 8-PT. 
 
The use of suramin was proven to be ineffective in diminishing the 
inhibitory effect of UDIF or ATP in the ureteral tissues. Although, there are 
currently no reports demonstrating the expression of P2X and P2Y 
receptors on the ureter, this expression has been shown for both the 
urothelium and smooth muscle of the bladder (Birder and de Groat, 2007, 
Sui et al., 2014). Suramin is a non-selective P2 receptor antagonist and 
inhibits both P2X and P2Y receptors at the same time. However, these 
receptors are responsible for contraction and relaxation respectively and 
thus, simultaneous inhibition could prove a complication in the present 
study. 
 
The agonist that was used in this part of the study was phenylephrine, 
which is thought to induce smooth muscle contraction via activation of 
phospholipase C, and subsequently, IP3-induced Ca2+ release from the 
sarcoplasmic reticulum. Previous findings have shown that ATP exerts an 
inhibitory effect on muscarinic-mediated contractions in the distal colon via 
inhibition of intracellular Ca2+ release (Hurley et al., 1993, Jorgensen et al., 
1995, Soslau et al., 1995, Fukushi, 1999, MacMillan et al., 2012). While 
the contractions developed in the ureteral tissues in our studies were α-
adrenoceptor-mediated responses, it is proposed that the phospholipase 
C pathway involved is similar to muscarinic stimulation. In the distal colon, 
the mechanism through which ATP induced its inhibitory effect was further 
examined and it was suggested that ATP is capable of suppressing IP3-
evoked Ca2+ in the distal colon (MacMillan et al., 2012). This suppression 
was shown to not involve activation of phospholipase C but via the 
activation G-protein-coupled receptor, P2Y1 (MacMillan et al., 2012). Thus, 
we suggest the prospect of ATP release by the urothelium in the ureteral 
tissues which induces inhibition of contractile responses via suppression 
of IP3-evoked intracellular Ca2+ release. 
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5.5  Conclusion 
 
The identification of urothelium-derived inhibitory factor (UDIF) may 
provide a new target for pharmacologically mediated therapeutic 
intervention in the lower urinary tract, including the distal ureter where 
ureteral calculi frequently lodge. Since its discovery, it has proven a 
challenge to establish the identity of UDIF. In this study, we were able to 
identify ATP as a possible candidate for UDIF in isolated ureter from the 
younger animals. While the mechanism by which this occurs still needs to 
be studied in more detail, we propose that urothelially-released ATP 
inhibits the contractile response via inhibition of IP3-evoked Ca2+ release. 
In addition, we showed that with age, UDIF is altered and could involve 
more than just ATP. While further studies are still required, especially with 
age, we deem these findings significant, as they provide an insight into 
UDIF. 
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CHAPTER 6: 
General discussion 
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6.1 General Discussion 
 
Aim 
The overall aim of this project was to further elucidate the mechanisms 
controlling ureteral motility by filling in the gaps in the current research on 
the pharmacology and physiology of the ureter. This objective was 
undertaken with a purpose to identify novel targets for development of 
suitable drugs for medical expulsive treatment of ureteral calculi. Medical 
expulsive treatment can be administered to patients with smaller calculi 
and also as an adjunct to less invasive treatment modalities. Successful 
medical expulsive treatment is achieved when ureteral colic is alleviated 
and the rate of stone passage through the ureter is increased.  
 
While the pathophysiology of renal colic is not completely understood, it is 
thought that increased intraluminal pressure within the ureteric tube 
significantly amplifies pain (Rose and Gillenwater, 1973). The ureter is 
made up of smooth muscle cells that can contract or relax on various 
stimulations. This is most likely the main mechanism controlling changes 
in intraluminal pressure. Therefore, this thesis was focused on the 
investigation of mechanisms involved in ureteral smooth muscle 
contraction. 
 
 
Experimental Model 
Due to the inability to obtain a sufficient number of human ureteral tissues, 
the experimental model that was utilised in this thesis was the porcine 
ureter. In in vitro studies, porcine tissues are frequently used as a model of 
human tissues. While comparison between human and porcine isolated 
ureters have not been specifically performed, multiple studies have 
reported the similarities between the porcine and human with respect to 
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the physiology and anatomy of the lower urinary tract. These include 
resemblance in urodynamic and structural characteristics, and neural 
control (Sibley, 1984, Crowe and Burnstock, 1989, Parsons et al., 2012). 
By optimization of the methodology, we were able to achieve a standard 
protocol that was utilised throughout all studies of this thesis. Tissue strips 
were suspended longitudinally due to the likelihood of both circular and 
longitudinal smooth muscle cells of the ureter being involved in normal 
ureteral peristalsis. Besides that, distal ureteral strips were isolated as 
samples because calculi are most frequently lodged at the distal region 
(El-Barky et al., 2014). By considering these factors, we ensured that the 
most relevant set-up was used. 
 
Despite its resemblance with human tissues, there are limitations involved 
with the porcine model. Influences on the whole system associated with 
organ blood flow are not represented in the in vitro model. Therefore, 
responses involving the immune system and other systems upon addition 
of the various drugs are not mimicked in this model. In addition to this, the 
viability of isolated ureteral tissues is limited. This resulted in the inability 
to reproduce concentration response curves and prevented investigation 
of repeated treatments and recovery following drug incubation. However, 
the findings from this thesis have allowed for further investigations with 
other experimental methods that might fulfil the weaknesses the porcine 
model possesses like in vivo settings and eventually, clinical trials.  
 
 
Ageing and Urolithiasis 
There are many risk factors associated with urolithiasis including gender, 
race, familial history and other modifiable risk factors including diet and 
hydration (Gottlieb, 2002, Romero et al., 2010, Schade and Faerber, 2010, 
Macneil and Bariol, 2011, Nowfar et al., 2011). In this thesis, the main 
focus was age as a risk factor (Hess, 2003) due to differences that were 
observed between contractile responses in isolated ureter from younger 
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and older animals. It appears that in older animals, larger contractile 
responses are developed during α1-adrenoceptor and muscarinic receptor 
stimulation, whilst contractions to 5-HT receptor stimulation are decreased 
with age.  
 
It is suggested that the differences in contractile responses vary with 
different systems. During stimulation of α1-adrenoceptors, upregulation of 
the specific intracellular signalling pathway might be the cause for the 
differences in contractile responses with age. In contrast, the difference in 
contractile responses to stimulation of 5-HT receptors observed with age 
appears to be due to the involvement of different receptor subtypes with 
age, as was shown in Chapter 3, where pharmacological characterization 
of functional 5-HT receptor subtype/s was performed. The findings 
suggest that the 5-HT2A receptor is solely responsible for 5-HT-mediated 
contractile responses in the isolated ureter from younger animals. This 
receptor subtype also plays a mediatory role in tissues from the older 
animals, but one or more relaxatory 5-HT receptor subtype/s is involved 
with age. Hence, this could explain the decreased contractile responses to 
5-HT receptor stimulation with age. Contractile responses to muscarinic 
responses only developed in isolated ureteral tissues from older animals, 
suggesting that perhaps muscarinic receptors are expressed later with 
age. However, further molecular studies are required to confirm this. 
 
While nifedipine appears to be the less popular option for medical 
expulsive therapy, due to its various side effects, it is nevertheless a 
clinical option and has proven to be effective in increasing stone expulsion 
rate (Dellabella et al., 2005, Micali et al., 2007). This leads to the 
possibility of targeting other intracellular signalling pathways that might 
have a role in controlling ureteral smooth muscle contraction. This thesis 
was successful in showing the importance of the calcium sensitization 
pathway and Rho-kinase in the mediation of contractility of the ureter 
(Chapter 4). It was observed that the Rho-kinase pathway plays a 
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significant role in both α1-adrenoceptor and 5-HT receptor-stimulated 
ureteral responses, regardless of age. In addition to that, it was also 
observed that Rho-kinase activity is constant in the presence or absence 
of agonist (phenylephrine or 5-HT). Age-related differences in the control 
of Rho-kinase on frequency of phasic contractions were also observed 
which could be further investigated. This confirms that ROCK activity 
might alter with age in the lower urinary tract as previously reported 
(Gomez-Pinilla et al., 2011, Kirschstein et al., 2014).  
 
Lastly, it was also shown that the urothelium has a role in the ureter and 
changes in the role of urothelium might occur with age. While the 
urothelium is usually discussed in the context of the bladder (Hawthorn et 
al., 2000, Murakami et al., 2007), we hypothesised that it could also play a 
role as important in the ureter. This hypothesis was proven correct as the 
urothelium-derived inhibitory factor (UDIF) that has been reported in the 
bladder (Hawthorn et al., 2000, Murakami et al., 2007) was also detected 
in the porcine distal ureter. However, there are no current report 
comparing the morphology of urothelium between the distal ureter and 
bladder and this can be further investigated in the future. More importantly, 
we were able to identify ATP as a possible candidate for UDIF, which 
previous reports have not been able to determine. Our findings also show 
that ATP might be solely responsible for UDIF effects in younger animals 
and that this system might be more complicated with age. 
 
 
Concluding Remarks  
Although ageing may not be the most important risk factor associated with 
ureteral calculi, the findings of this thesis clearly indicate the significance 
of ageing on mechanisms controlling ureteral motility and that these need 
to be taken into account when undertaking basic studies of ureteral 
function. While further investigations with in vivo studies and human 
tissues are still required, these findings contribute to the literature on 
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physiology and pharmacology of the ureter and may aid in the discovery of 
novel targets for medical expulsive therapy. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
250 
 
 
 
 
 
 
 
 
 
 
 
 
  
251 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
252 
 
ABE, K., SHIMOKAWA, H., MORIKAWA, K., UWATOKU, T., OI, K., 
MATSUMOTO, Y., HATTORI, T., NAKASHIMA, Y., KAIBUCHI, K., 
SUEISHI, K. & TAKESHIT, A. 2004. Long-term treatment with a Rho-
kinase inhibitor improves monocrotaline-induced fatal pulmonary 
hypertension in rats. Circ Res, 94, 385-93. 
ABOUMARZOUK, O. M., KATA, S. G., KEELEY, F. X., MCCLINTON, S. & 
NABI, G. 2012. Extracorporeal shock wave lithotripsy (ESWL) versus 
ureteroscopic management for ureteric calculi. Cochrane Database Syst 
Rev, 5, CD006029. 
ABRAMS, P. H. & FENELEY, R. C. 1975. The actions of prostaglandins on the 
smooth muscle of the human urinary tract in vitro. Br J Urol, 47, 909-15. 
AGRAWAL, M., GUPTA, M., GUPTA, A., AGRAWAL, A., SARKARI, A. & 
LAVANIA, P. 2009. Prospective randomized trial comparing efficacy of 
alfuzosin and tamsulosin in management of lower ureteral stones. 
Urology, 73, 706-9. 
AIZAWA, N., IIJIMA, K., ROSENBAUM, J. S., DOWNS, T. R., IGAWA, Y., 
ANDERSSON, K. E. & WYNDAELE, J. J. 2011. Comparison of the 
effects of oestrogen deficiency and old age on primary bladder afferent 
activity and voiding behaviour in the ageing female rat. BJU Int, 108, E10-
6. 
AKMAN, T., BINBAY, M., UGURLU, M., KABA, M., AKCAY, M., YAZICI, 
O., OZGOR, F. & MUSLUMANOGLU, A. Y. 2012. Outcomes of 
retrograde intrarenal surgery compared with percutaneous 
nephrolithotomy in elderly patients with moderate-size kidney stones: a 
matched-pair analysis. J Endourol, 26, 625-9. 
AL-ANSARI, A., AL-NAIMI, A., ALOBAIDY, A., ASSADIQ, K., AZMI, M. D. 
& SHOKEIR, A. A. 2010. Efficacy of tamsulosin in the management of 
lower ureteral stones: a randomized double-blind placebo-controlled study 
of 100 patients. Urology, 75, 4-7. 
AL-UGAILY, L., THULESIUS, O. & ANGELO-KHATTAR, M. 1986. New 
evidence for prostaglandin induced motility of the ureter. Scand J Urol 
Nephrol, 20, 225-9. 
ALEXANDER, S. P., LOSINSKI, A., KENDALL, D. A. & HILL, S. J. 1994. A 
comparison of A2 adenosine receptor-induced cyclic AMP generation in 
cerebral cortex and relaxation of pre-contracted aorta. Br J Pharmacol, 
111, 185-90. 
ALI, M., ANGELO-KHATTAR, M., THULESIUS, L., FAREED, A. & 
THULESIUS, O. 1998. Urothelial synthesis of prostanoids in the ovine 
ureter. Urol Res, 26, 171-4. 
AMANO, M., FUKATA, Y. & KAIBUCHI, K. 2000. Regulation and functions of 
Rho-associated kinase. Exp Cell Res, 261, 44-51. 
AMANO, M., ITO, M., KIMURA, K., FUKATA, Y., CHIHARA, K., NAKANO, 
T., MATSUURA, Y. & KAIBUCHI, K. 1996. Phosphorylation and 
activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem, 
271, 20246-9. 
253 
 
AMBACHE, N. & ZAR, M. A. 1970. Non-cholinergic transmission by post-
ganglionic motor neurones in the mammalian bladder. J Physiol, 210, 761-
83. 
ANDERSSON, K. E. 2002. Bladder activation: afferent mechanisms. Urology, 
59, 43-50. 
ANDERSSON, K. E. 2015. Purinergic signalling in the urinary bladder. Auton 
Neurosci, 191, 78-81. 
ANDERSSON, K. E. & ARNER, A. 2004. Urinary bladder contraction and 
relaxation: physiology and pathophysiology. Physiol Rev, 84, 935-86. 
ANDERSSON, K. E., HOLMQUIST, F., FOVAEUS, M., HEDLUND, H. & 
SUNDLER, R. 1991. Muscarinic receptor stimulation of phosphoinositide 
hydrolysis in the human isolated urinary bladder. J Urol, 146, 1156-9. 
ANDERSSON, K. E. & PERSSON, K. 1994. Nitric oxide synthase and nitric 
oxide-mediated effects in lower urinary tract smooth muscles. World J 
Urol, 12, 274-80. 
ANDERSSON, K. E. & PERSSON, K. 1995. Nitric oxide synthase and the lower 
urinary tract: possible implications for physiology and pathophysiology. 
Scand J Urol Nephrol Suppl, 175, 43-53. 
ANGELO-KHATTAR, M., THULESIUS, O., NILSSON, T., CHERIAN, T. & 
JOSEPH, L. 1985. Motility of the human ureter, with special reference to 
the effect of indomethacin. Scand J Urol Nephrol, 19, 261-5. 
ANKEM, M. K., JERDE, T. J., WILKINSON, E. R. & NAKADA, S. Y. 2005. 
Third prize: Prostaglandin E(2)-3 receptor is involved in ureteral 
contractility in obstruction. J Endourol, 19, 1088-91. 
APOSTOLIDIS, A., POPAT, R., YIANGOU, Y., COCKAYNE, D., FORD, A. 
P., DAVIS, J. B., DASGUPTA, P., FOWLER, C. J. & ANAND, P. 2005. 
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve 
fibers following intradetrusor injections of botulinum toxin for human 
detrusor overactivity. J Urol, 174, 977-82; discussion 982-3. 
ARNER, A. & PFITZER, G. 1999. Regulation of cross-bridge cycling by Ca2+ in 
smooth muscle. Rev Physiol Biochem Pharmacol, 134, 63-146. 
ASANO, T., SUZUKI, T., TSUCHIYA, M., SATOH, S., IKEGAKI, I., 
SHIBUYA, M., SUZUKI, Y. & HIDAKA, H. 1989. Vasodilator actions of 
HA1077 in vitro and in vivo putatively mediated by the inhibition of 
protein kinase. Br J Pharmacol, 98, 1091-100. 
AUTORINO, R., DE SIO, M., DAMIANO, R., DI LORENZO, G., PERDONA, 
S., RUSSO, A., QUARTO, G., COSENTINO, L. & D'ARMIENTO, M. 
2005. The use of tamsulosin in the medical treatment of ureteral calculi: 
where do we stand? Urol Res, 33, 460-4. 
BARNES, P. J. 2001. Histamine and serotonin. Pulm Pharmacol Ther, 14, 329-
39. 
BARRETT, B. J. & CARLISLE, E. J. 1993. Metaanalysis of the relative 
nephrotoxicity of high- and low-osmolality iodinated contrast media. 
Radiology, 188, 171-8. 
BASAR, I., BIRCAN, K., TASAR, C., ERGEN, A., CAKMAK, F. & REMZI, D. 
1991. Diclofenac sodium and spasmolytic drugs in the treatment of 
ureteral colic: a comparative study. Int Urol Nephrol, 23, 227-30. 
254 
 
BAXTER, G., KENNETT, G., BLANEY, F. & BLACKBURN, T. 1995. 5-HT2 
receptor subtypes: a family re-united? Trends Pharmacol Sci, 16, 105-10. 
BENEDITO, S., PRIETO, D., RIVERA, L., COSTA, G. & GARCIA-
SACRISTAN, A. 1991. Mechanisms implicated in the histamine response 
of the sheep ureterovesical junction. J Urol, 146, 184-7. 
BERGMAN, E., CARLSSON, K., LILJEBORG, A., MANDERS, E., HOKFELT, 
T. & ULFHAKE, B. 1999. Neuropeptides, nitric oxide synthase and GAP-
43 in B4-binding and RT97 immunoreactive primary sensory neurons: 
normal distribution pattern and changes after peripheral nerve transection 
and aging. Brain Res, 832, 63-83. 
BERRIDGE, M. J. 2008. Smooth muscle cell calcium activation mechanisms. J 
Physiol, 586, 5047-61. 
BERTACCINI, G., ZAPPIA, L., BEZZI, E. & POTENZONI, D. 1983. Histamine 
receptors in the human ureter. Pharmacol Res Commun, 15, 157-66. 
BIERKENS, A. F., HENDRIKX, A. J., DE LA ROSETTE, J. J., STULTIENS, G. 
N., BEERLAGE, H. P., ARENDS, A. J. & DEBRUYNE, F. M. 1998. 
Treatment of mid- and lower ureteric calculi: extracorporeal shock-wave 
lithotripsy vs laser ureteroscopy. A comparison of costs, morbidity and 
effectiveness. Br J Urol, 81, 31-5. 
BIRDER, L. & ANDERSSON, K. E. 2013. Urothelial signaling. Physiol Rev, 93, 
653-80. 
BIRDER, L. A. & DE GROAT, W. C. 2007. Mechanisms of disease: involvement 
of the urothelium in bladder dysfunction. Nat Clin Pract Urol, 4, 46-54. 
BIRDER, L. A., RUGGIERI, M., TAKEDA, M., VAN KOEVERINGE, G., 
VELTKAMP, S., KORSTANJE, C., PARSONS, B. & FRY, C. H. 2012. 
How does the urothelium affect bladder function in health and disease? 
ICI-RS 2011. Neurourol Urodyn, 31, 293-9. 
BLOK, C., VAN VENROOIJ, G. E., MOKHLESS, I. & COOLSAET, B. L. 1985. 
Dynamics of the ureterovesical junction: its fluid transport mechanism in 
the pig. J Urol, 134, 175-8. 
BODIN, P. & BURNSTOCK, G. 2001. Purinergic signalling: ATP release. 
Neurochem Res, 26, 959-69. 
BONHAUS, D. W., BACH, C., DESOUZA, A., SALAZAR, F. H., 
MATSUOKA, B. D., ZUPPAN, P., CHAN, H. W. & EGLEN, R. M. 
1995. The pharmacology and distribution of human 5-
hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 
5-HT2A and 5-HT2C receptors. Br J Pharmacol, 115, 622-8. 
BONHAUS, D. W., WEINHARDT, K. K., TAYLOR, M., DESOUZA, A., 
MCNEELEY, P. M., SZCZEPANSKI, K., FONTANA, D. J., TRINH, J., 
ROCHA, C. L., DAWSON, M. W., FLIPPIN, L. A. & EGLEN, R. M. 
1997. RS-102221: a novel high affinity and selective, 5-HT2C receptor 
antagonist. Neuropharmacology, 36, 621-9. 
BORMAN, M. A., MACDONALD, J. A., MURANYI, A., HARTSHORNE, D. J. 
& HAYSTEAD, T. A. 2002. Smooth muscle myosin phosphatase-
associated kinase induces Ca2+ sensitization via myosin phosphatase 
inhibition. J Biol Chem, 277, 23441-6. 
255 
 
BOS, D. & KAPOOR, A. 2014. Update on medical expulsive therapy for distal 
ureteral stones: Beyond alpha-blockers. Can Urol Assoc J, 8, 442-5. 
BOUDREAULT, F. & GRYGORCZYK, R. 2004. Cell swelling-induced ATP 
release is tightly dependent on intracellular calcium elevations. J Physiol, 
561, 499-513. 
BRADING, A. F. 2006. Spontaneous activity of lower urinary tract smooth 
muscles: correlation between ion channels and tissue function. J Physiol, 
570, 13-22. 
BUHL, A. M., JOHNSON, N. L., DHANASEKARAN, N. & JOHNSON, G. L. 
1995. G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber 
formation and focal adhesion assembly. J Biol Chem, 270, 24631-4. 
BURNSTOCK, G. 1999. Release of vasoactive substances from endothelial cells 
by shear stress and purinergic mechanosensory transduction. J Anat, 194 ( 
Pt 3), 335-42. 
BURNSTOCK, G. 2007. Physiology and pathophysiology of purinergic 
neurotransmission. Physiol Rev, 87, 659-797. 
BURNSTOCK, G. 2014. Purinergic signalling in the urinary tract in health and 
disease. Purinergic Signal, 10, 103-55. 
BURNSTOCK, G. & KENNEDY, C. 1985. Is there a basis for distinguishing two 
types of P2-purinoceptor? Gen Pharmacol, 16, 433-40. 
BURNSTOCK, G. & WOOD, J. N. 1996. Purinergic receptors: their role in 
nociception and primary afferent neurotransmission. Curr Opin Neurobiol, 
6, 526-32. 
CAI, G., GURDAL, H., SEASHOLTZ, T. M. & JOHNSON, M. D. 1994. Age-
related changes in angiotensin II-stimulated vascular contraction and 
inositol phosphate accumulation in Fischer 344 rats. Mech Ageing Dev, 76, 
125-33. 
CALVERT, R. C., THOMPSON, C. S. & BURNSTOCK, G. 2008. ATP release 
from the human ureter on distension and P2X(3) receptor expression on 
suburothelial sensory nerves. Purinergic Signal, 4, 377-81. 
CANDA, A. E., TURNA, B., CINAR, G. M. & NAZLI, O. 2007. Physiology and 
pharmacology of the human ureter: basis for current and future treatments. 
Urol Int, 78, 289-98. 
CAREMEL, R., OGER-ROUSSEL, S., BEHR-ROUSSEL, D., GRISE, P. & 
GIULIANO, F. A. 2010. Nitric oxide/cyclic guanosine monophosphate 
signalling mediates an inhibitory action on sensory pathways of the 
micturition reflex in the rat. Eur Urol, 58, 616-25. 
CARVAJAL, J. A., GERMAIN, A. M., HUIDOBRO-TORO, J. P. & WEINER, 
C. P. 2000. Molecular mechanism of cGMP-mediated smooth muscle 
relaxation. J Cell Physiol, 184, 409-20. 
CHANG, B., MATHEW, R., PALMER, L. S., VALDERRAMA, E. & 
TRACHTMAN, H. 2002. Nitric oxide in obstructive uropathy: role of 
endothelial nitric oxide synthase. J Urol, 168, 1801-4. 
CHANG, S., HYPOLITE, J. A., DISANTO, M. E., CHANGOLKAR, A., WEIN, 
A. J. & CHACKO, S. 2006. Increased basal phosphorylation of detrusor 
smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by 
256 
 
upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol, 
290, F650-6. 
CHANG, W. C., MUROTA, S. I., NAKAO, J. & ORIMO, H. 1980. Age-related 
decrease in prostacyclin biosynthetic activity in rat aortic smooth muscle 
cells. Biochim Biophys Acta, 620, 159-66. 
CHEN, C. C., AKOPIAN, A. N., SIVILOTTI, L., COLQUHOUN, D., 
BURNSTOCK, G. & WOOD, J. N. 1995. A P2X purinoceptor expressed 
by a subset of sensory neurons. Nature, 377, 428-31. 
CHEN, H. I. 1990. Evidence for the presynaptic action of 5-hydroxytryptamine 
and the involvement of purinergic innervation in the rabbit lower urinary 
tract. Br J Pharmacol, 101, 212-6. 
CHEN, X. Q., TAN, I., NG, C. H., HALL, C., LIM, L. & LEUNG, T. 2002. 
Characterization of RhoA-binding kinase ROKalpha implication of the 
pleckstrin homology domain in ROKalpha function using region-specific 
antibodies. J Biol Chem, 277, 12680-8. 
CHENG, Y., MANSFIELD, K. J., SANDOW, S. L., SADANANDA, P., 
BURCHER, E. & MOORE, K. H. 2011. Porcine bladder urothelial, 
myofibroblast, and detrusor muscle cells: characterization and ATP 
release. Front Pharmacol, 2, 27. 
CHOU, Y. H., LI, C. C., HSU, H., CHANG, W. C., LIU, C. C., LI, W. M., KE, H. 
L., LEE, M. H., LIU, M. E., PAN, S. C. & WANG, H. S. 2011. Renal 
function in patients with urinary stones of varying compositions. 
Kaohsiung J Med Sci, 27, 264-7. 
CHRIST, G. J. & ANDERSSON, K. E. 2007. Rho-kinase and effects of Rho-
kinase inhibition on the lower urinary tract. Neurourol Urodyn, 26, 948-
54. 
CHUN, A. L., WALLACE, L. J., GERALD, M. C., WEIN, A. J. & LEVIN, R. M. 
1989. Effects of age on urinary bladder function in the male rat. J Urol, 
141, 170-3. 
CHUNG, S. D., CHEN, Y. K. & LIN, H. C. 2011. Increased risk of diabetes in 
patients with urinary calculi: a 5-year followup study. J Urol, 186, 1888-
93. 
CIVANTOS CALZADA, B. & ALEIXANDRE DE ARTINANO, A. 2001. 
Alpha-adrenoceptor subtypes. Pharmacol Res, 44, 195-208. 
COCKAYNE, D. A., DUNN, P. M., ZHONG, Y., RONG, W., HAMILTON, S. 
G., KNIGHT, G. E., RUAN, H. Z., MA, B., YIP, P., NUNN, P., 
MCMAHON, S. B., BURNSTOCK, G. & FORD, A. P. 2005. P2X2 
knockout mice and P2X2/P2X3 double knockout mice reveal a role for the 
P2X2 receptor subunit in mediating multiple sensory effects of ATP. J 
Physiol, 567, 621-39. 
COCKAYNE, D. A., HAMILTON, S. G., ZHU, Q. M., DUNN, P. M., ZHONG, 
Y., NOVAKOVIC, S., MALMBERG, A. B., CAIN, G., BERSON, A., 
KASSOTAKIS, L., HEDLEY, L., LACHNIT, W. G., BURNSTOCK, G., 
MCMAHON, S. B. & FORD, A. P. 2000. Urinary bladder hyporeflexia 
and reduced pain-related behaviour in P2X3-deficient mice. Nature, 407, 
1011-5. 
257 
 
COE, F. L., EVAN, A. & WORCESTER, E. 2005. Kidney stone disease. J Clin 
Invest, 115, 2598-608. 
COHEN, M. L. 1990. Canine, but not rat bladder contracts to serotonin via 
activation of 5HT2 receptors. J Urol, 143, 1037-40. 
COHEN, M. L., SCHENCK, K. W. & HEMRICK-LUECKE, S. H. 1999. 5-
Hydroxytryptamine(1A) receptor activation enhances norepinephrine 
release from nerves in the rabbit saphenous vein. J Pharmacol Exp Ther, 
290, 1195-201. 
COLE, R. S., FRY, C. H. & SHUTTLEWORTH, K. E. 1988. The action of the 
prostaglandins on isolated human ureteric smooth muscle. Br J Urol, 61, 
19-26. 
COLLINS, S., BOUVIER, M., LOHSE, M. J., BENOVIC, J. L., CARON, M. G. 
& LEFKOWITZ, R. J. 1990. Mechanisms involved in adrenergic receptor 
desensitization. Biochem Soc Trans, 18, 541-4. 
COLLIS, M. G. & HOURANI, S. M. 1993. Adenosine receptor subtypes. Trends 
Pharmacol Sci, 14, 360-6. 
CONSTANTINOU, C. E. & YAMAGUCHI, O. 1981. Multiple-coupled 
pacemaker system in renal pelvis of the unicalyceal kidney. Am J Physiol, 
241, R412-8. 
CORSI, M., PIETRA, C., TOSON, G., TRIST, D., TUCCITTO, G. & 
ARTIBANI, W. 1991. Pharmacological analysis of 5-hydroxytryptamine 
effects on electrically stimulated human isolated urinary bladder. Br J 
Pharmacol, 104, 719-25. 
COX, D. A. & COHEN, M. L. 1994. Age-related alterations in sensitivity of 
muscarinic and serotonergic responses of guinea pig trachea to removal of 
extracellular Ca2+. Eur J Pharmacol, 258, 265-8. 
CROWE, R. & BURNSTOCK, G. 1989. A histochemical and 
immunohistochemical study of the autonomic innervation of the lower 
urinary tract of the female pig. Is the pig a good model for the human 
bladder and urethra? J Urol, 141, 414-22. 
CUSACK, N. J. & HOURANI, S. M. 1984. Some pharmacological and 
biochemical interactions of the enantiomers of adenylyl 5'-(beta, gamma-
methylene)-diphosphonate with the guinea-pig urinary bladder. Br J 
Pharmacol, 82, 155-9. 
DALY, D. M., NOCCHI, L., LIASKOS, M., MCKAY, N. G., CHAPPLE, C. & 
GRUNDY, D. 2014. Age-related changes in afferent pathways and 
urothelial function in the male mouse bladder. J Physiol, 592, 537-49. 
DAVIDSON, M. E. & LANG, R. J. 2000. Effects of selective inhibitors of cyclo-
oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) on the 
spontaneous myogenic contractions in the upper urinary tract of the 
guinea-pig and rat. Br J Pharmacol, 129, 661-70. 
DE GODOY, M. A. & RATTAN, S. 2011. Role of rho kinase in the functional 
and dysfunctional tonic smooth muscles. Trends Pharmacol Sci, 32, 384-
93. 
DE SOUZA ROSSIGNOLI, P., YAMAMOTO, F. Z., PEREIRA, O. C. & CHIES, 
A. B. 2015. Norepinephrine responses in rat renal and femoral veins are 
reinforced by vasoconstrictor prostanoids. Vascul Pharmacol, 72, 93-100. 
258 
 
DELL'ATTI, L. 2015. Silodosin versus tamsulosin as medical expulsive therapy 
for distal ureteral stones: a prospective randomized study. Urologia, 82, 
54-7. 
DELLABELLA, M., MILANESE, G. & MUZZONIGRO, G. 2003. Efficacy of 
tamsulosin in the medical management of juxtavesical ureteral stones. J 
Urol, 170, 2202-5. 
DELLABELLA, M., MILANESE, G. & MUZZONIGRO, G. 2005. Randomized 
trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in 
medical expulsive therapy for distal ureteral calculi. J Urol, 174, 167-72. 
DEMOLOMBE, S. & ESCANDE, D. 1996. ATP-binding cassette proteins as 
targets for drug discovery. Trends Pharmacol Sci, 17, 273-5. 
DOCHERTY, J. R. 1988. The effects of ageing on vascular alpha-adrenoceptors 
in pithed rat and rat aorta. Eur J Pharmacol, 146, 1-5. 
DOCHERTY, J. R. 2010. Subtypes of functional alpha1-adrenoceptor. Cell Mol 
Life Sci, 67, 405-17. 
DOCHERTY, J. R. & O'MALLEY, K. 1983. An examination of age-related 
changes in pre- and postsynaptic alpha-adrenoceptors in the rat isolated 
vas deferens. Eur J Pharmacol, 95, 171-6. 
DODEL, R. C., HAFNER, D. & BORCHARD, U. 1996. Characterization of 
histamine receptors in the ureter of the dog. Eur J Pharmacol, 318, 395-
402. 
DUNNING-DAVIES, B. M., FRY, C. H., MANSOUR, D. & FERGUSON, D. R. 
2013. The regulation of ATP release from the urothelium by adenosine 
and transepithelial potential. BJU Int, 111, 505-13. 
EDYVANE, K. A., TRUSSELL, D. C., JONAVICIUS, J., HENWOOD, A. & 
MARSHALL, V. R. 1992. Presence and regional variation in peptide-
containing nerves in the human ureter. J Auton Nerv Syst, 39, 127-37. 
EGLEN, R. M., REDDY, H., WATSON, N. & CHALLISS, R. A. 1994. 
Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends 
Pharmacol Sci, 15, 114-9. 
EL-BARKY, E., ALI, Y., SAHSAH, M., TERRA, A. A. & KEHINDE, E. O. 
2014. Site of impaction of ureteric calculi requiring surgical intervention. 
Urolithiasis, 42, 67-73. 
ETO, M., KITAZAWA, T., YAZAWA, M., MUKAI, H., ONO, Y. & 
BRAUTIGAN, D. L. 2001. Histamine-induced vasoconstriction involves 
phosphorylation of a specific inhibitor protein for myosin phosphatase by 
protein kinase C alpha and delta isoforms. J Biol Chem, 276, 29072-8. 
EVANS, B. A., BROXTON, N., MERLIN, J., SATO, M., HUTCHINSON, D. S., 
CHRISTOPOULOS, A. & SUMMERS, R. J. 2011. Quantification of 
functional selectivity at the human alpha(1A)-adrenoceptor. Mol 
Pharmacol, 79, 298-307. 
FELSEN, D., SCHULSINGER, D., GROSS, S. S., KIM, F. Y., MARION, D. & 
VAUGHAN, E. D., JR. 2003. Renal hemodynamic and ureteral pressure 
changes in response to ureteral obstruction: the role of nitric oxide. J Urol, 
169, 373-6. 
FENG, J., ITO, M., ICHIKAWA, K., ISAKA, N., NISHIKAWA, M., 
HARTSHORNE, D. J. & NAKANO, T. 1999. Inhibitory phosphorylation 
259 
 
site for Rho-associated kinase on smooth muscle myosin phosphatase. J 
Biol Chem, 274, 37385-90. 
FERGUSON, D. R., KENNEDY, I. & BURTON, T. J. 1997. ATP is released 
from rabbit urinary bladder epithelial cells by hydrostatic pressure 
changes--a possible sensory mechanism? J Physiol, 505 ( Pt 2), 503-11. 
FERGUSON, S. S., ZHANG, J., BARAK, L. S. & CARON, M. G. 1998. 
Molecular mechanisms of G protein-coupled receptor desensitization and 
resensitization. Life Sci, 62, 1561-5. 
FERNANDES, V. S. & HERNANDEZ, M. 2016. The role of nitric oxide and 
hydrogen sulfide in urinary tract function. Basic Clin Pharmacol Toxicol. 
FETISSOF, F., DUBOIS, M. P., ARBEILLE-BRASSART, B., LANSON, Y., 
BOIVIN, F. & JOBARD, P. 1983. Endocrine cells in the prostate gland, 
urothelium and Brenner tumors. Immunohistological and ultrastructural 
studies. Virchows Arch B Cell Pathol Incl Mol Pathol, 42, 53-64. 
FOLEY, A. G., HIRST, W. D., GALLAGHER, H. C., BARRY, C., HAGAN, J. 
J., UPTON, N., WALSH, F. S., HUNTER, A. J. & REGAN, C. M. 2008. 
The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 
potentiate NCAM PSA immunolabeling of dentate granule cells, but not 
neurogenesis, in the hippocampal formation of mature Wistar rats. 
Neuropharmacology, 54, 1166-74. 
FORD, A. P. & COCKAYNE, D. A. 2011. ATP and P2X purinoceptors in urinary 
tract disorders. Handb Exp Pharmacol, 485-526. 
FREDHOLM, B. B., ABBRACCHIO, M. P., BURNSTOCK, G., DALY, J. W., 
HARDEN, T. K., JACOBSON, K. A., LEFF, P. & WILLIAMS, M. 1994. 
Nomenclature and classification of purinoceptors. Pharmacol Rev, 46, 
143-56. 
FROMM, C., COSO, O. A., MONTANER, S., XU, N. & GUTKIND, J. S. 1997. 
The small GTP-binding protein Rho links G protein-coupled receptors and 
Galpha12 to the serum response element and to cellular transformation. 
Proc Natl Acad Sci U S A, 94, 10098-103. 
FUKUSHI, Y. 1999. Heterologous desensitization of muscarinic receptors by P2Z 
purinoceptors in rat parotid acinar cells. Eur J Pharmacol, 364, 55-64. 
GARCIA-PASCUAL, A., COSTA, G., LABADIA, A., PERSSON, K. & 
TRIGUERO, D. 1996. Characterization of nitric oxide synthase activity in 
sheep urinary tract: functional implications. Br J Pharmacol, 118, 905-14. 
GIDENER, S., GUMUSTEKIN, M. & KIRKALI, Z. 1999. Pharmacological 
analysis of 5-hydroxytryptamine effects on human isolated ureter. 
Pharmacol Res, 39, 487-91. 
GIDENER, S., KIRKALI, Z. & GUVEN, H. 1995. Influence of serotonin on the 
human ureter: an in vitro pharmacological study. Urol Int, 55, 202-4. 
GIGLIO, D., RYBERG, A. T., TO, K., DELBRO, D. S. & TOBIN, G. 2005. 
Altered muscarinic receptor subtype expression and functional responses 
in cyclophosphamide induced cystitis in rats. Auton Neurosci, 122, 9-20. 
GNESSIN, E., LINGEMAN, JE, EVAN, AP 2010. Pathogenesis of renal calculi. 
Endourology, 36, 190-199. 
GOMEZ-PINILLA, P. J., GOMEZ, M. F., SWARD, K., HEDLUND, P., 
HELLSTRAND, P., CAMELLO, P. J., ANDERSSON, K. E. & POZO, M. 
260 
 
J. 2008. Melatonin restores impaired contractility in aged guinea pig 
urinary bladder. J Pineal Res, 44, 416-25. 
GOMEZ-PINILLA, P. J., POZO, M. J. & CAMELLO, P. J. 2011. Aging 
differentially modifies agonist-evoked mouse detrusor contraction and 
calcium signals. Age (Dordr), 33, 81-8. 
GOTTLIEB, S. 2002. High protein diet brings risk of kidney stones. British 
Medical Journal, 325, 1. 
GRAHAM, R. M., PEREZ, D. M., HWA, J. & PIASCIK, M. T. 1996. alpha 1-
adrenergic receptor subtypes. Molecular structure, function, and signaling. 
Circ Res, 78, 737-49. 
GRATZKE, C., UCKERT, S., REICH, O., SCHLENKER, B., TILKI, D., SEITZ, 
M. & STIEF, C. G. 2007. [PDE5 inhibitors. A new option in the treatment 
of ureteral colic?]. Urologe A, 46, 1219-23. 
GRAY, H. 1918. The ureters. Gray's Anatomy. Philadelphia: Lea & Febiger. 
GUPTA, S., LODH, B., SINGH, A. K., SOMARENDRA, K., MEITEI, K. S. & 
SINGH, S. R. 2013. Comparing the efficacy of tamsulosin and silodosin in 
the medical expulsion therapy for ureteral calculi. J Clin Diagn Res, 7, 
1672-4. 
GURDAL, H., TILAKARATNE, N., BROWN, R. D., FONSECA, M., 
FRIEDMAN, E. & JOHNSON, M. D. 1995. The expression of alpha 1 
adrenoceptor subtypes changes with age in the rat aorta. J Pharmacol Exp 
Ther, 275, 1656-62. 
GUSTIN, P., ANSAY, M. & ADVENIER, C. 1993. Effects of age and 
indomethacin on response and sensitivity of pulmonary artery to 
phenylephrine and to histamine in pigs. J Vet Pharmacol Ther, 16, 207-13. 
GYIRES, K., ZADORI, Z. S., TOROK, T. & MATYUS, P. 2009. alpha(2)-
Adrenoceptor subtypes-mediated physiological, pharmacological actions. 
Neurochem Int, 55, 447-53. 
HANNA, M. K., JEFFS, R. D., STURGESS, J. M. & BARKIN, M. 1976. 
Ureteral structure and ultrastructure. Part I. The normal human ureter. J 
Urol, 116, 718-24. 
HARRISS, D. R., MARSH, K. A., BIRMINGHAM, A. T. & HILL, S. J. 1995. 
Expression of muscarinic M3-receptors coupled to inositol phospholipid 
hydrolysis in human detrusor cultured smooth muscle cells. J Urol, 154, 
1241-5. 
HATAKE, K., WAKABAYASHI, I., KAKISHITA, E. & HISHIDA, S. 1992. 
Effect of aging on contractile response to KCl, norepinephrine and 5-
hydroxytryptamine in isolated human basilar artery. Gen Pharmacol, 23, 
417-20. 
HAUSER, D. S., MEVISSEN, M., WEISS, R., PORTIER, C. J., SCHOLTYSIK, 
G., STUDER, U. E. & DANUSER, H. 2002. Effects of ketanserin and 
DOI on spontaneous and 5-HT-evoked peristalsis of the pig ureter in vivo. 
Br J Pharmacol, 135, 1026-32. 
HAWTHORN, M. H., CHAPPLE, C. R., COCK, M. & CHESS-WILLIAMS, R. 
2000. Urothelium-derived inhibitory factor(s) influences on detrusor 
muscle contractility in vitro. Br J Pharmacol, 129, 416-9. 
261 
 
HEILBRUNN, L. V. & WIERCINSKI, F. J. 1947. The action of various cations 
on muscle protoplasm. J Cell Physiol, 29, 15-32. 
HERMANNS, T., SAUERMANN, P., RUFIBACH, K., FRAUENFELDER, T., 
SULSER, T. & STREBEL, R. T. 2009. Is there a role for tamsulosin in the 
treatment of distal ureteral stones of 7 mm or less? Results of a 
randomised, double-blind, placebo-controlled trial. Eur Urol, 56, 407-12. 
HERNANDEZ, M., BARAHONA, M. V., BUSTAMANTE, S., GARCIA-
SACRISTAN, A. & ORENSANZ, L. M. 1999. A2B adenosine receptors 
mediate relaxation of the pig intravesical ureter: adenosine modulation of 
non adrenergic non cholinergic excitatory neurotransmission. Br J 
Pharmacol, 126, 969-78. 
HERNANDEZ, M., BARAHONA, M. V., SIMONSEN, U., RECIO, P., 
RIVERA, L., MARTINEZ, A. C., GARCIA-SACRISTAN, A., 
ORENSANZ, L. M. & PRIETO, D. 2003. Characterization of the 5-
hydroxytryptamine receptors mediating contraction in the pig isolated 
intravesical ureter. Br J Pharmacol, 138, 137-44. 
HERNANDEZ, M., PRIETO, D., ORENSANZ, L. M., BARAHONA, M. V., 
GARCIA-SACRISTAN, A. & SIMONSEN, U. 1995. Nitric oxide is 
involved in the non-adrenergic, non-cholinergic inhibitory 
neurotransmission of the pig intravesical ureter. Neurosci Lett, 186, 33-6. 
HERNANDEZ, M., PRIETO, D., SIMONSEN, U., RIVERA, L., BARAHONA, 
M. V. & GARCIA-SACRISTAN, A. 1992. Noradrenaline modulates 
smooth muscle activity of the isolated intravesical ureter of the pig 
through different types of adrenoceptors. Br J Pharmacol, 107, 924-31. 
HERNANDEZ, M., SIMONSEN, U., PRIETO, D., RIVERA, L., GARCIA, P., 
ORDAZ, E. & GARCIA-SACRISTAN, A. 1993. Different muscarinic 
receptor subtypes mediating the phasic activity and basal tone of pig 
isolated intravesical ureter. Br J Pharmacol, 110, 1413-20. 
HERTLE, L. & NAWRATH, H. 1986. [Effects of drugs on the upper urinary tract 
of the human]. Urologe A, 25, 252-8. 
HESS, B. 2003. [Pathophysiology, diagnosis and conservative therapy in calcium 
kidney calculi]. Ther Umsch, 60, 79-87. 
HIROOKA, Y. & SHIMOKAWA, H. 2005. Therapeutic potential of rho-kinase 
inhibitors in cardiovascular diseases. Am J Cardiovasc Drugs, 5, 31-9. 
HOLLINGSWORTH, J. M., ROGERS, M. A., KAUFMAN, S. R., BRADFORD, 
T. J., SAINT, S., WEI, J. T. & HOLLENBECK, B. K. 2006. Medical 
therapy to facilitate urinary stone passage: a meta-analysis. Lancet, 368, 
1171-9. 
HOLMLUND, D. & SJODIN, J. G. 1978. Treatment of ureteral colic with 
intravenous indomethacin. J Urol, 120, 676-7. 
HONG, S. K., KWAK, C., CHANG JEONG, B., KIM, B. S. & KIM, H. H. 2005. 
Involvement of Rho-kinase in the contractile mechanism of human 
ureteral smooth muscle. Neurourol Urodyn, 24, 136-41. 
HOROWITZ, A., MENICE, C. B., LAPORTE, R. & MORGAN, K. G. 1996. 
Mechanisms of smooth muscle contraction. Physiol Rev, 76, 967-1003. 
HOYER, D., CLARKE, D. E., FOZARD, J. R., HARTIG, P. R., MARTIN, G. R., 
MYLECHARANE, E. J., SAXENA, P. R. & HUMPHREY, P. P. 1994. 
262 
 
International Union of Pharmacology classification of receptors for 5-
hydroxytryptamine (Serotonin). Pharmacol Rev, 46, 157-203. 
HUA, X. Y. & LUNDBERG, J. M. 1986. Dual capsaicin effects on ureteric 
motility: low dose inhibition mediated by calcitonin gene-related peptide 
and high dose stimulation by tachykinins? Acta Physiol Scand, 128, 453-
65. 
HUMPHREY, P. P. 1984. Peripheral 5-hydroxytryptamine receptors and their 
classification. Neuropharmacology, 23, 1503-10. 
HURLEY, T. W., SHOEMAKER, D. D. & RYAN, M. P. 1993. Extracellular 
ATP prevents the release of stored Ca2+ by autonomic agonists in rat 
submandibular gland acini. Am J Physiol, 265, C1472-8. 
HWANG, E. C., HWANG, I. S., YU, H. S., KIM, S. O., JUNG, S. I., KANG, T. 
W., KWON, D. D., PARK, K., RYU, S. B., KIM, M. K. & LU, J. W. 
2012. Effects of alfuzosin with methylprednisolone for spontaneous 
expulsion and pain control of lower ureteral stone. Urol Res, 40, 605-9. 
IIZUKA, K., YOSHII, A., SAMIZO, K., TSUKAGOSHI, H., ISHIZUKA, T., 
DOBASHI, K., NAKAZAWA, T. & MORI, M. 1999. A major role for the 
rho-associated coiled coil forming protein kinase in G-protein-mediated 
Ca2+ sensitization through inhibition of myosin phosphatase in rabbit 
trachea. Br J Pharmacol, 128, 925-33. 
ISELIN, C. E., ALM, P., SCHAAD, N. C., LARSSON, B., GRABER, P. & 
ANDERSSON, K. E. 1996. Nitric oxide inhibits contraction of isolated 
pig ureteral smooth muscle. J Urol, 155, 763-7. 
ISELIN, C. E., ALM, P., SCHAAD, N. C., LARSSON, B., GRABER, P. & 
ANDERSSON, K. E. 1997. Localization of nitric oxide synthase and 
haemoxygenase, and functional effects of nitric oxide and carbon 
monoxide in the pig and human intravesical ureter. Neurourol Urodyn, 16, 
209-27. 
ISELIN, C. E., NY, L., LARSSON, B., SCHAAD, N. C., ALM, P., GRABER, P., 
MOREL, D. R. & ANDERSSON, K. E. 1998. The nitric oxide 
synthase/nitric oxide and heme oxygenase/carbon monoxide pathways in 
the human ureter. Eur Urol, 33, 214-21. 
ISHIZAKI, T., UEHATA, M., TAMECHIKA, I., KEEL, J., NONOMURA, K., 
MAEKAWA, M. & NARUMIYA, S. 2000. Pharmacological properties of 
Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol, 
57, 976-83. 
ITOH, Y., KOJIMA, Y., YASUI, T., TOZAWA, K., SASAKI, S. & KOHRI, K. 
2007. Examination of alpha 1 adrenoceptor subtypes in the human ureter. 
Int J Urol, 14, 749-53. 
JAN DANSER, A. H. 2004. Blood pressure-independent effects of Rho-kinase 
inhibitors in the kidney? J Hypertens, 22, 1675-7. 
JERDE, T. J., CALAMON-DIXON, J. L., BJORLING, D. E. & NAKADA, S. Y. 
2005. Celecoxib inhibits ureteral contractility and prostanoid release. 
Urology, 65, 185-90. 
JERDE, T. J., SABAN, R., BJORLING, D. E., STEINBERG, H. & NAKADA, S. 
Y. 2000. Distribution of neuropeptides, histamine content, and 
inflammatory cells in the ureter. Urology, 56, 173-8. 
263 
 
JERDE, T. J., SABAN, R. & NAKADA, S. Y. 1999. Evaluation of ureteric 
contraction: a comparison among ring, spiral-cut and longitudinal 
segments. BJU Int, 83, 95-100. 
JEZIOR, J. R., BRADY, J. D., ROSENSTEIN, D. I., MCCAMMON, K. A., 
MINER, A. S. & RATZ, P. H. 2001. Dependency of detrusor contractions 
on calcium sensitization and calcium entry through LOE-908-sensitive 
channels. Br J Pharmacol, 134, 78-87. 
JORGENSEN, T. D., GROMADA, J., TRITSARIS, K., NAUNTOFTE, B. & 
DISSING, S. 1995. Activation of P2z purinoceptors diminishes the 
muscarinic cholinergic-induced release of inositol 1,4,5-trisphosphate and 
stored calcium in rat parotid acini. ATP as a co-transmitter in the stimulus-
secretion coupling. Biochem J, 312 ( Pt 2), 457-64. 
JOST, S. P., GOSLING, J. A. & DIXON, J. S. 1989. The morphology of normal 
human bladder urothelium. J Anat, 167, 103-15. 
KANEKO, T., MATSUSHIMA, H., MORIMOTO, H., TSUZAKA, Y. & 
HOMMA, Y. 2010. Efficacy of low dose tamsulosin in medical expulsive 
therapy for ureteral stones in Japanese male patients: a randomized 
controlled study. Int J Urol, 17, 462-5. 
KANNAN, M. S. & JOHNSON, D. E. 1995. Modulation of nitric oxide-
dependent relaxation of pig tracheal smooth muscle by inhibitors of 
guanylyl cyclase and calcium activated potassium channels. Life Sci, 56, 
2229-38. 
KARTHA, G., CALLE, J. C., MARCHINI, G. S. & MONGA, M. 2013. Impact of 
stone disease: chronic kidney disease and quality of life. Urol Clin North 
Am, 40, 135-47. 
KATOH, H., AOKI, J., YAMAGUCHI, Y., KITANO, Y., ICHIKAWA, A. & 
NEGISHI, M. 1998. Constitutively active Galpha12, Galpha13, and 
Galphaq induce Rho-dependent neurite retraction through different 
signaling pathways. J Biol Chem, 273, 28700-7. 
KEATING, C., NOCCHI, L., YU, Y., DONOVAN, J. & GRUNDY, D. 2015. 
Ageing and gastrointestinal sensory function: Altered colonic 
mechanosensory and chemosensory function in the aged mouse. J Physiol. 
KHALED, S. M. & ELHILALI, M. 2003. Role of 5-HT receptors in treatment of 
overactive bladder. Drugs Today (Barc), 39, 599-607. 
KHAN, S. R. 1997. Calcium phosphate/calcium oxalate crystal association in 
urinary stones: implications for heterogeneous nucleation of calcium 
oxalate. J Urol, 157, 376-83. 
KHANDELWAL, P., ABRAHAM, S. N. & APODACA, G. 2009. Cell biology 
and physiology of the uroepithelium. Am J Physiol Renal Physiol, 297, 
F1477-501. 
KIJVIKAI, K. & DE LA ROSETTE, J. J. 2011. Assessment of stone composition 
in the management of urinary stones. Nat Rev Urol, 8, 81-5. 
KIJVIKAI, K., HALEBLIAN, G. E., PREMINGER, G. M. & DE LA ROSETTE, 
J. 2007. Shock wave lithotripsy or ureteroscopy for the management of 
proximal ureteral calculi: an old discussion revisited. J Urol, 178, 1157-
63. 
264 
 
KIM, D. Y. & CAMILLERI, M. 2000. Serotonin: a mediator of the brain-gut 
connection. Am J Gastroenterol, 95, 2698-709. 
KIMURA, K., ITO, M., AMANO, M., CHIHARA, K., FUKATA, Y., 
NAKAFUKU, M., YAMAMORI, B., FENG, J., NAKANO, T., OKAWA, 
K., IWAMATSU, A. & KAIBUCHI, K. 1996. Regulation of myosin 
phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science, 
273, 245-8. 
KIRSCHSTEIN, T., PROTZEL, C., PORATH, K., SELLMANN, T., KOHLING, 
R. & HAKENBERG, O. W. 2014. Age-dependent contribution of Rho 
kinase in carbachol-induced contraction of human detrusor smooth muscle 
in vitro. Acta Pharmacol Sin, 35, 74-81. 
KITAZAWA, T. & SOMLYO, A. P. 1991. Modulation of Ca2+ sensitivity by 
agonists in smooth muscle. Adv Exp Med Biol, 304, 97-109. 
KLARSKOV, P. & HORBY-PETERSEN, J. 1986. Influence of serotonin on 
lower urinary tract smooth muscle in vitro. Br J Urol, 58, 507-13. 
KLEMM, M. F., EXINTARIS, B. & LANG, R. J. 1999. Identification of the cells 
underlying pacemaker activity in the guinea-pig upper urinary tract. J 
Physiol, 519 Pt 3, 867-84. 
KLUNER, C., HEIN, P. A., GRALLA, O., HEIN, E., HAMM, B., ROMANO, V. 
& ROGALLA, P. 2006. Does ultra-low-dose CT with a radiation dose 
equivalent to that of KUB suffice to detect renal and ureteral calculi? J 
Comput Assist Tomogr, 30, 44-50. 
KNIGHT, G. E., BODIN, P., DE GROAT, W. C. & BURNSTOCK, G. 2002. 
ATP is released from guinea pig ureter epithelium on distension. Am J 
Physiol Renal Physiol, 282, F281-8. 
KOBAYASHI, S., GONG, M. C., SOMLYO, A. V. & SOMLYO, A. P. 1991. 
Ca2+ channel blockers distinguish between G protein-coupled 
pharmacomechanical Ca2+ release and Ca2+ sensitization. Am J Physiol, 
260, C364-70. 
KOBAYASHI, S., TOMIYAMA, Y., MARUYAMA, K., HOYANO, Y., 
YAMAZAKI, Y. & KUSAMA, H. 2009. Effects of four different 
alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced 
contractions in isolated mouse and hamster ureters. J Smooth Muscle Res, 
45, 187-95. 
KOK, D. J. & KHAN, S. R. 1994. Calcium oxalate nephrolithiasis, a free or fixed 
particle disease. Kidney Int, 46, 847-54. 
KOK, D. J., PAPAPOULOS, S. E. & BIJVOET, O. L. 1990. Crystal 
agglomeration is a major element in calcium oxalate urinary stone 
formation. Kidney Int, 37, 51-6. 
KOMORI, S., KAWAI, M., TAKEWAKI, T. & OHASHI, H. 1992. GTP-binding 
protein involvement in membrane currents evoked by carbachol and 
histamine in guinea-pig ileal muscle. J Physiol, 450, 105-26. 
KULLMANN, F. A., ARTIM, D., BECKEL, J., BARRICK, S., DE GROAT, W. 
C. & BIRDER, L. A. 2008. Heterogeneity of muscarinic receptor-
mediated Ca2+ responses in cultured urothelial cells from rat. Am J 
Physiol Renal Physiol, 294, F971-81. 
265 
 
KUMAR, S., JAYANT, K., AGRAWAL, S. & SINGH, S. K. 2014. Comparative 
efficacy of tamsulosin versus tamsulosin with tadalafil in combination 
with prednisolone for the medical expulsive therapy of lower ureteric 
stones: a randomized trial. Korean J Urol, 55, 196-200. 
KUPELI, B., IRKILATA, L., GUROCAK, S., TUNC, L., KIRAC, M., 
KARAOGLAN, U. & BOZKIRLI, I. 2004. Does tamsulosin enhance 
lower ureteral stone clearance with or without shock wave lithotripsy? 
Urology, 64, 1111-5. 
LAERUM, E., OMMUNDSEN, O. E., GRONSETH, J. E., CHRISTIANSEN, A. 
& FAGERTUN, H. E. 1995. Oral diclofenac in the prophylactic treatment 
of recurrent renal colic. A double-blind comparison with placebo. Eur 
Urol, 28, 108-11. 
LANG, R. J., DAVIDSON, M. E. & EXINTARIS, B. 2002. Pyeloureteral motility 
and ureteral peristalsis: essential role of sensory nerves and endogenous 
prostaglandins. Exp Physiol, 87, 129-46. 
LANG, R. J., EXINTARIS, B., TEELE, M. E., HARVEY, J. & KLEMM, M. F. 
1998. Electrical basis of peristalsis in the mammalian upper urinary tract. 
Clin Exp Pharmacol Physiol, 25, 310-21. 
LANG, R. J. & KLEMM, M. F. 2005. Interstitial cell of Cajal-like cells in the 
upper urinary tract. J Cell Mol Med, 9, 543-56. 
LAZZERI, M. 2006. The physiological function of the urothelium--more than a 
simple barrier. Urol Int, 76, 289-95. 
LEE, H. Y., BARDINI, M. & BURNSTOCK, G. 2000. Distribution of P2X 
receptors in the urinary bladder and the ureter of the rat. J Urol, 163, 
2002-7. 
LEE, M. C. & BARIOL, S. V. 2011. Evolution of stone management in Australia. 
BJU Int, 108 Suppl 2, 29-33. 
LEE, S. Y., LEE, M. Y., PARK, S. H., KIM, T. H., MOON, Y. T., HAN, J. H. & 
MYUNG, S. C. 2010. NS-398 (a selective cyclooxygenase-2 inhibitor) 
decreases agonist-induced contraction of the human ureter via calcium 
channel inhibition. J Endourol, 24, 1863-8. 
LEE, Y. H., HUANG, W. C., TSAI, J. Y., LU, C. M., CHEN, W. C., LEE, M. H., 
HSU, H. S., HUANG, J. K. & CHANG, L. S. 2002. Epidemiological 
studies on the prevalence of upper urinary calculi in Taiwan. Urol Int, 68, 
172-7. 
LEVENT, A. & BUYUKAFSAR, K. 2004. Expression of Rho-kinase (ROCK-1 
and ROCK-2) and its substantial role in the contractile activity of the 
sheep ureter. Br J Pharmacol, 143, 431-7. 
LEVIN, R. M., WEIN, A. J., KRASNOPOLSKY, L., ATTA, M. A. & 
GHONIEM, G. M. 1995. Effect of mucosal removal on the response of the 
feline bladder to pharmacological stimulation. J Urol, 153, 1291-4. 
LEVY, E. M., VISCOLI, C. M. & HORWITZ, R. I. 1996. The effect of acute 
renal failure on mortality. A cohort analysis. JAMA, 275, 1489-94. 
LEWIS, C., NEIDHART, S., HOLY, C., NORTH, R. A., BUELL, G. & 
SURPRENANT, A. 1995. Coexpression of P2X2 and P2X3 receptor 
subunits can account for ATP-gated currents in sensory neurons. Nature, 
377, 432-5. 
266 
 
LEWIS, S. A. & LEWIS, J. R. 2006. Kinetics of urothelial ATP release. Am J 
Physiol Renal Physiol, 291, F332-40. 
LI, L., ETO, M., LEE, M. R., MORITA, F., YAZAWA, M. & KITAZAWA, T. 
1998. Possible involvement of the novel CPI-17 protein in protein kinase 
C signal transduction of rabbit arterial smooth muscle. J Physiol, 508 ( Pt 
3), 871-81. 
LIEU, P. K., SA'ADU, A., ORUGUN, E. O. & MALONE-LEE, J. G. 1997. The 
influence of age on isometric and isotonic rat detrusor contractions. J 
Gerontol A Biol Sci Med Sci, 52, M94-6. 
LIN, W. Y., MANNIKAROTTU, A., CHICHESTER, P., NEUMAN, P., 
JOHNSON, A., PEREZ-MARTINEZ, F. C. & LEVIN, R. M. 2008. The 
effect of chronic partial bladder outlet obstruction on corpus cavernosum 
smooth muscle and Rho-kinase in rabbits. Neurourol Urodyn, 27, 826-31. 
LITTEN, R. Z., SUBA, E. A. & ROTH, B. L. 1987. Effects of a phorbol ester on 
rat aortic contraction and calcium influx in the presence and absence of 
BAY k 8644. Eur J Pharmacol, 144, 185-91. 
LLUEL, P., PALEA, S., BARRAS, M., GRANDADAM, F., HEUDES, D., 
BRUNEVAL, P., CORMAN, B. & MARTIN, D. J. 2000. Functional and 
morphological modifications of the urinary bladder in aging female rats. 
Am J Physiol Regul Integr Comp Physiol, 278, R964-72. 
LONG, S. & NERGARDH, A. 1978. Autonomic receptor functions of the human 
ureter: an in vitro study. Scand J Urol Nephrol, 12, 23-6. 
LONGHURST, P. A., EIKA, B., LEGGETT, R. E. & LEVIN, R. M. 1992. 
Comparison of urinary bladder function in 6 and 24 month male and 
female rats. J Urol, 148, 1615-20. 
LOTAN, Y., GETTMAN, M. T., ROEHRBORN, C. G., CADEDDU, J. A. & 
PEARLE, M. S. 2002. Management of ureteral calculi: a cost comparison 
and decision making analysis. J Urol, 167, 1621-9. 
LOTAN, Y. & PEARLE, M. S. 2011. Cost-effectiveness of primary prevention 
strategies for nephrolithiasis. J Urol, 186, 550-5. 
LOWRY, P. S., JERDE, T. J., BJORLING, D. E., MASKEL, J. L. & NAKADA, 
S. Y. 2005. Obstruction alters the effect of prostaglandin E2 on ureteral 
contractility. J Endourol, 19, 183-7. 
MACDONALD, J. A., BORMAN, M. A., MURANYI, A., SOMLYO, A. V., 
HARTSHORNE, D. J. & HAYSTEAD, T. A. 2001. Identification of the 
endogenous smooth muscle myosin phosphatase-associated kinase. Proc 
Natl Acad Sci U S A, 98, 2419-24. 
MACMILLAN, D., KENNEDY, C. & MCCARRON, J. G. 2012. ATP inhibits 
Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors. J 
Cell Sci, 125, 5151-8. 
MACNEIL, F. & BARIOL, S. 2011. Urinary stone disease - assessment and 
management. Aust Fam Physician, 40, 772-5. 
MAGGI, C. A., GIULIANI, S. & SANTICIOLI, P. 1994. Multiple mechanisms in 
the smooth muscle relaxant action of calcitonin gene-related peptide 
(CGRP) in the guinea-pig ureter. Naunyn Schmiedebergs Arch Pharmacol, 
350, 537-47. 
267 
 
MAGGI, C. A., SANTICIOLI, P., PARLANI, M., ASTOLFI, M., PATACCHINI, 
R. & MELI, A. 1987. The presence of mucosa reduces the contractile 
response of the guinea-pig urinary bladder to substance P. J Pharm 
Pharmacol, 39, 653-5. 
MANDEVILLE, J. A., GNESSIN, E. & LINGEMAN, J. E. 2011. Imaging 
evaluation in the patient with renal stone disease. Semin Nephrol, 31, 254-
8. 
MANSFIELD, K. J., LIU, L., MITCHELSON, F. J., MOORE, K. H., MILLARD, 
R. J. & BURCHER, E. 2005. Muscarinic receptor subtypes in human 
bladder detrusor and mucosa, studied by radioligand binding and 
quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol, 
144, 1089-99. 
MAO, J., YUAN, H., XIE, W., SIMON, M. I. & WU, D. 1998. Specific 
involvement of G proteins in regulation of serum response factor-mediated 
gene transcription by different receptors. J Biol Chem, 273, 27118-23. 
MARCHINI, G. S., SARKISSIAN, C., TIAN, D., GEBRESELASSIE, S. & 
MONGA, M. 2013. Gout, stone composition and urinary stone risk: a 
matched case comparative study. J Urol, 189, 1334-9. 
MARQUARDT, D. L. 1983. Histamine. Clin Rev Allergy, 1, 343-51. 
MASARANI, M. & DINNEEN, M. 2007. Ureteric colic: new trends in diagnosis 
and treatment. Postgrad Med J, 83, 469-72. 
MASTRANGELO, D., BAERTSCHI, A. J., ROATTI, A., AMHERDT, M. & 
ISELIN, C. E. 2003. Nitric oxide production within rat urothelial cells. J 
Urol, 170, 1409-14. 
MASTRANGELO, D. & ISELIN, C. E. 2007. Urothelium dependent inhibition of 
rat ureter contractile activity. J Urol, 178, 702-9. 
MASTRANGELO, D., WISARD, M., ROHNER, S., LEISINGER, H. & ISELIN, 
C. E. 2000. Diclofenac and NS-398, a selective cyclooxygenase-2 
inhibitor, decrease agonist-induced contractions of the pig isolated ureter. 
Urol Res, 28, 376-82. 
MATSUMOTO, R., OTSUKA, A., SUZUKI, T., SHINBO, H., MIZUNO, T., 
KURITA, Y., MUGIYA, S. & OZONO, S. 2013. Expression and 
functional role of beta3 -adrenoceptors in the human ureter. Int J Urol, 20, 
1007-14. 
MATSUMURA, F. & HARTSHORNE, D. J. 2008. Myosin phosphatase target 
subunit: Many roles in cell function. Biochem Biophys Res Commun, 369, 
149-56. 
MATSUOKA, T. & NARUMIYA, S. 2007. Prostaglandin receptor signaling in 
disease. ScientificWorldJournal, 7, 1329-47. 
MCFADZEAN, I. & GIBSON, A. 2002. The developing relationship between 
receptor-operated and store-operated calcium channels in smooth muscle. 
Br J Pharmacol, 135, 1-13. 
MCHALE, N. G., HOLLYWOOD, M. A., SERGEANT, G. P., SHAFEI, M., 
THORNBURY, K. T. & WARD, S. M. 2006. Organization and function 
of ICC in the urinary tract. J Physiol, 576, 689-94. 
268 
 
MCLATCHIE, L. M. & FRY, C. H. 2015. ATP release from freshly isolated 
guinea-pig bladder urothelial cells: a quantification and study of the 
mechanisms involved. BJU Int, 115, 987-93. 
MCMURRAY, G., DASS, N. & BRADING, A. F. 1998. Purinoceptor subtypes 
mediating contraction and relaxation of marmoset urinary bladder smooth 
muscle. Br J Pharmacol, 123, 1579-86. 
MEAGHER, T., SUKUMAR, V. P., COLLINGWOOD, J., CRAWLEY, T., 
SCHOFIELD, D., HENSON, J., LAKIN, K., CONNOLLY, D. & GILES, 
J. 2001. Low dose computed tomography in suspected acute renal colic. 
Clin Radiol, 56, 873-6. 
MEHMET, N. M. & ENDER, O. 2015. Effect of urinary stone disease and its 
treatment on renal function. World J Nephrol, 4, 271-6. 
MESSORI, E., RIZZI, C. A., CANDURA, S. M., LUCCHELLI, A., BALESTRA, 
B. & TONINI, M. 1995. 5-Hydroxytryptamine receptors that facilitate 
excitatory neuromuscular transmission in the guinea-pig isolated detrusor 
muscle. Br J Pharmacol, 115, 677-83. 
MICALI, S., GRANDE, M., SIGHINOLFI, M. C., DE STEFANI, S. & 
BIANCHI, G. 2007. Efficacy of expulsive therapy using nifedipine or 
tamsulosin, both associated with ketoprofene, after shock wave lithotripsy 
of ureteral stones. Urol Res, 35, 133-7. 
MICHEL, M. C. 2011. beta-Adrenergic Receptor Subtypes in the Urinary Tract. 
Handb Exp Pharmacol, 307-18. 
MICHEL, M. C. & DE LA ROSETTE, J. J. 2006. alpha-blocker treatment of 
urolithiasis. Eur Urol, 50, 213-4. 
MICHISHITA, M., YANO, K., KASAHARA, K., TOMITA, K. & 
MATSUZAKI, O. 2015. Increased expression of 5-HT(2A) and 5-HT(2B) 
receptors in detrusor muscle after partial bladder outlet obstruction in rats. 
Biomed Res, 36, 187-94. 
MILLER, J. C. 2003. Urinary Tract Imaging. Radiology Rounds, 1, 1-3. 
MILLER, N. L., EVAN, A. P. & LINGEMAN, J. E. 2007. Pathogenesis of renal 
calculi. Urol Clin North Am, 34, 295-313. 
MILLER, O. F. & KANE, C. J. 1999. Time to stone passage for observed ureteral 
calculi: a guide for patient education. J Urol, 162, 688-90; discussion 690-
1. 
MILLER, O. F., RINEER, S. K., REICHARD, S. R., BUCKLEY, R. G., 
DONOVAN, M. S., GRAHAM, I. R., GOFF, W. B. & KANE, C. J. 1998. 
Prospective comparison of unenhanced spiral computed tomography and 
intravenous urogram in the evaluation of acute flank pain. Urology, 52, 
982-7. 
MINKE, B. 2006. TRP channels and Ca2+ signaling. Cell Calcium, 40, 261-75. 
MIYAOKA, R., MENDES, C., SCHENKA, A., GONZALEZ, P. G., DE NUCCI, 
G., ANTUNES, E., MONGA, M., LEVI D'ANCONA, C. A. & MONICA, 
F. Z. 2014. BAY 41-2272, a soluble guanylate cyclase stimulator, relaxes 
isolated human ureter in a standardized in vitro model. Urology, 83, 256 
e1-7. 
MOHAMMAD-ZADEH, L. F., MOSES, L. & GWALTNEY-BRANT, S. M. 
2008. Serotonin: a review. J Vet Pharmacol Ther, 31, 187-99. 
269 
 
MOHAMMED, H. & SANTER, R. M. 2001. Distribution and changes with age 
of nitric oxide synthase-immunoreactive nerves of the rat urinary bladder, 
ureter and in lumbosacral sensory neurons. Eur J Morphol, 39, 137-44. 
MOHAMMED, H. A. & SANTER, R. M. 2002. Distribution and changes with 
age of calcitonin gene-related peptide- and substance P-immunoreactive 
nerves of the rat urinary bladder and lumbosacral sensory neurons. Eur J 
Morphol, 40, 293-301. 
MORITA, T., ANDO, M., KIHARA, K. & OSHIMA, H. 1995. Relationship of 
the structure of ureteral muscularis to in vitro spontaneous contractions. 
Urol Int, 55, 123-7. 
MORITOKI, H., IWAMOTO, T., KANAYA, J., ISHIDA, Y. & FUKUDA, H. 
1986. Age-related change in serotonin-mediated prejunctional inhibition of 
rat vas deferens. Eur J Pharmacol, 132, 39-46. 
MORO, C., LEEDS, C. & CHESS-WILLIAMS, R. 2012. Contractile activity of 
the bladder urothelium/lamina propria and its regulation by nitric oxide. 
Eur J Pharmacol, 674, 445-9. 
MUNRO, D. D. & WENDT, I. R. 1993. Contractile and metabolic properties of 
longitudinal smooth muscle from rat urinary bladder and the effects of 
aging. J Urol, 150, 529-36. 
MURAKAMI, S., CHAPPLE, C. R., AKINO, H., SELLERS, D. J. & CHESS-
WILLIAMS, R. 2007. The role of the urothelium in mediating bladder 
responses to isoprenaline. BJU Int, 99, 669-73. 
MUTGI, A., WILLIAMS, J. W. & NETTLEMAN, M. 1991. Renal colic. Utility 
of the plain abdominal roentgenogram. Arch Intern Med, 151, 1589-92. 
NAGAOKA, T., FAGAN, K. A., GEBB, S. A., MORRIS, K. G., SUZUKI, T., 
SHIMOKAWA, H., MCMURTRY, I. F. & OKA, M. 2005. Inhaled Rho 
kinase inhibitors are potent and selective vasodilators in rat pulmonary 
hypertension. Am J Respir Crit Care Med, 171, 494-9. 
NAKADA, S. Y., JERDE, T. J., BJORLING, D. E. & SABAN, R. 2000. Selective 
cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better 
alternative for renal colic? J Urol, 163, 607-12. 
NAKADA, S. Y., JERDE, T. J., JACOBSON, L. M., SABAN, R., BJORLING, 
D. E. & HULLETT, D. A. 2002. Cyclooxygenase-2 expression is up-
regulated in obstructed human ureter. J Urol, 168, 1226-9. 
NAKAYAMA, H., NODA, K., HOTTA, H., OHSAWA, H. & HOSOYA, Y. 
1998. Effects of aging on numbers, sizes and conduction velocities of 
myelinated and unmyelinated fibers of the pelvic nerve in rats. J Auton 
Nerv Syst, 69, 148-55. 
NEGORO, H., LUTZ, S. E., LIOU, L. S., KANEMATSU, A., OGAWA, O., 
SCEMES, E. & SUADICANI, S. O. 2013. Pannexin 1 involvement in 
bladder dysfunction in a multiple sclerosis model. Sci Rep, 3, 2152. 
NELSON, E. A. & DANNEFER, D. 1992. Aged heterogeneity: fact or fiction? 
The fate of diversity in gerontological research. Gerontologist, 32, 17-23. 
NICHOLS, D. E. & NICHOLS, C. D. 2008. Serotonin receptors. Chem Rev, 108, 
1614-41. 
NOCITO, A., GEORGIEV, P., DAHM, F., JOCHUM, W., BADER, M., GRAF, 
R. & CLAVIEN, P. A. 2007. Platelets and platelet-derived serotonin 
270 
 
promote tissue repair after normothermic hepatic ischemia in mice. 
Hepatology, 45, 369-76. 
NORREGAARD, R., JENSEN, B. L., TOPCU, S. O., NIELSEN, S. S., 
WALTER, S., DJURHUUS, J. C. & FROKIAER, J. 2006. 
Cyclooxygenase type 2 is increased in obstructed rat and human ureter and 
contributes to pelvic pressure increase after obstruction. Kidney Int, 70, 
872-81. 
NORTH, R. A. 2002. Molecular physiology of P2X receptors. Physiol Rev, 82, 
1013-67. 
NOVAK, I. 2003. ATP as a signaling molecule: the exocrine focus. News Physiol 
Sci, 18, 12-7. 
NOWFAR, S., PALAZZI-CHURAS, K., CHANG, D. C. & SUR, R. L. 2011. The 
relationship of obesity and gender prevalence changes in United States 
inpatient nephrolithiasis. Urology, 78, 1029-33. 
OLOFSSON, B. 1999. Rho guanine dissociation inhibitors: pivotal molecules in 
cellular signalling. Cell Signal, 11, 545-54. 
OLSEN, S. M., STOVER, J. D. & NAGATOMI, J. 2011. Examining the role of 
mechanosensitive ion channels in pressure mechanotransduction in rat 
bladder urothelial cells. Ann Biomed Eng, 39, 688-97. 
ORDWAY, G. A., ESBENSHADE, T. A., KOLTA, M. G., GERALD, M. C. & 
WALLACE, L. J. 1986a. Effect of age on cholinergic muscarinic 
responsiveness and receptors in the rat urinary bladder. J Urol, 136, 492-6. 
ORDWAY, G. A., KOLTA, M. G., GERALD, M. C. & WALLACE, L. J. 1986b. 
Age-related change in alpha-adrenergic responsiveness of the urinary 
bladder of the rat is regionally specific. Neuropharmacology, 25, 1335-40. 
OSORIO, L., LIMA, E., AUTORINO, R. & MARCELO, F. 2008. Emergency 
management of ureteral stones: Recent advances. Indian J Urol, 24, 461-6. 
PACAUD, P. & BOLTON, T. B. 1991. Relation between muscarinic receptor 
cationic current and internal calcium in guinea-pig jejunal smooth muscle 
cells. J Physiol, 441, 477-99. 
PALMERO, J. L., AMOROS, A., RAMIREZ, M., PASTOR, J. C. & 
BENEDICTO, A. 2012. [Surgical therapy of lithiasis in horseshoe 
kidney]. Actas Urol Esp, 36, 439-43. 
PARK, H. K., CHOI, E. Y., JEONG, B. C., KIM, H. H. & KIM, B. K. 2007. 
Localizations and expressions of alpha-1A, alpha-1B and alpha-1D 
adrenoceptors in human ureter. Urol Res, 35, 325-9. 
PARK, Y. C., TOMIYAMA, Y., HAYAKAWA, K., AKAHANE, M., 
AJISAWA, Y., MIYATAKE, R., KIWAMOTO, H., SUGIYAMA, T. & 
KURITA, T. 2000. Existence of a beta3-adrenoceptro and its functional 
role in the human ureter. J Urol, 164, 1364-70. 
PARKER, B. D., FREDERICK, R. W., REILLY, T. P., LOWRY, P. S. & BIRD, 
E. T. 2004. Efficiency and cost of treating proximal ureteral stones: shock 
wave lithotripsy versus ureteroscopy plus holmium:yttrium-aluminum-
garnet laser. Urology, 64, 1102-6; discussion 1106. 
PARKS, J. H., COWARD, M. & COE, F. L. 1997. Correspondence between stone 
composition and urine supersaturation in nephrolithiasis. Kidney Int, 51, 
894-900. 
271 
 
PARSONS, B. A., DRAKE, M. J., GAMMIE, A., FRY, C. H. & VAHABI, B. 
2012. The validation of a functional, isolated pig bladder model for 
physiological experimentation. Front Pharmacol, 3, 52. 
PARSONS, J. K., HERGAN, L. A., SAKAMOTO, K. & LAKIN, C. 2007. 
Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol, 177, 
983-7; discussion 987. 
PATEL, C. A. & RATTAN, S. 2007. Cellular regulation of basal tone in internal 
anal sphincter smooth muscle by RhoA/ROCK. Am J Physiol Gastrointest 
Liver Physiol, 292, G1747-56. 
PEREZ, D. M., DEYOUNG, M. B. & GRAHAM, R. M. 1993. Coupling of 
expressed alpha 1B- and alpha 1D-adrenergic receptor to multiple 
signaling pathways is both G protein and cell type specific. Mol 
Pharmacol, 44, 784-95. 
PFISTER, S. A., DECKART, A., LASCHKE, S., DELLAS, S., OTTO, U., 
BUITRAGO, C., ROTH, J., WIESNER, W., BONGARTZ, G. & 
GASSER, T. C. 2003. Unenhanced helical computed tomography vs 
intravenous urography in patients with acute flank pain: accuracy and 
economic impact in a randomized prospective trial. Eur Radiol, 13, 2513-
20. 
PHADNIS, S., GARG, S. K., SHAH, M. A. & SABIR, M. 1995. Histamine H2 
receptor mediated relaxation of buffalo (Bubalus bubalus) ureter. Indian J 
Exp Biol, 33, 41-3. 
PIASCIK, M. T. & PEREZ, D. M. 2001. Alpha1-adrenergic receptors: new 
insights and directions. J Pharmacol Exp Ther, 298, 403-10. 
PICKARD, R., STARR, K., MACLENNAN, G., LAM, T., THOMAS, R., BURR, 
J., MCPHERSON, G., MCDONALD, A., ANSON, K., N'DOW, J., 
BURGESS, N., CLARK, T., KILONZO, M., GILLIES, K., SHEARER, 
K., BOACHIE, C., CAMERON, S., NORRIE, J. & MCCLINTON, S. 
2015. Medical expulsive therapy in adults with ureteric colic: a 
multicentre, randomised, placebo-controlled trial. Lancet, 386, 341-9. 
PINHEIRO, L. C. & MARTINS PISCO, J. 2012. Treatment of benign prostatic 
hyperplasia. Tech Vasc Interv Radiol, 15, 256-60. 
PINNA, C., CARATOZZOLO, O. & PUGLISI, L. 1992. A possible role for 
urinary bladder epithelium in bradykinin-induced contraction in diabetic 
rats. Eur J Pharmacol, 214, 143-8. 
POLETTI, P. A., PLATON, A., RUTSCHMANN, O. T., SCHMIDLIN, F. R., 
ISELIN, C. E. & BECKER, C. D. 2007. Low-dose versus standard-dose 
CT protocol in patients with clinically suspected renal colic. AJR Am J 
Roentgenol, 188, 927-33. 
PORPIGLIA, F., VACCINO, D., BILLIA, M., RENARD, J., CRACCO, C., 
GHIGNONE, G., SCOFFONE, C., TERRONE, C. & SCARPA, R. M. 
2006. Corticosteroids and tamsulosin in the medical expulsive therapy for 
symptomatic distal ureter stones: single drug or association? Eur Urol, 50, 
339-44. 
PREMINGER, G. M., TISELIUS, H. G., ASSIMOS, D. G., ALKEN, P., BUCK, 
C., GALLUCCI, M., KNOLL, T., LINGEMAN, J. E., NAKADA, S. Y., 
PEARLE, M. S., SARICA, K., TURK, C., WOLF, J. S., JR. & PANEL, E. 
272 
 
A. N. G. 2007. 2007 guideline for the management of ureteral calculi. J 
Urol, 178, 2418-34. 
PREUSS, J. M. & GOLDIE, R. G. 1998. The influence of age on isolated tracheal 
responsiveness to spasmogens. Eur J Pharmacol, 345, 71-7. 
PREUSS, J. M., RIGBY, P. J. & GOLDIE, R. G. 1998. Age and region-dependent 
contraction to alpha-adrenoceptor agonists in rat and guinea-pig isolated 
trachea. Br J Pharmacol, 123, 1541-8. 
PRIETO, D., BENEDITO, S., RIVERA, L., HERNANDEZ, M. & GARCIA-
SACRISTAN, A. 1990. Autonomic innervation of the equine urinary 
bladder. Anat Histol Embryol, 19, 276-87. 
PRIETO, D., HERNANDEZ, M., RIVERA, L., GARCIA-SACRISTAN, A. & 
SIMONSEN, U. 1997. Distribution and functional effects of neuropeptide 
Y on equine ureteral smooth muscle and resistance arteries. Regul Pept, 
69, 155-65. 
PRIETO, D., SIMONSEN, U., MARTIN, J., HERNANDEZ, M., RIVERA, L., 
LEMA, L., GARCIA, P. & GARCIA-SACRISTAN, A. 1994. 
Histochemical and functional evidence for a cholinergic innervation of the 
equine ureter. J Auton Nerv Syst, 47, 159-70. 
PUTNEY, J. W., JR., BROAD, L. M., BRAUN, F. J., LIEVREMONT, J. P. & 
BIRD, G. S. 2001. Mechanisms of capacitative calcium entry. J Cell Sci, 
114, 2223-9. 
RASIDOVIC, D., KEARNEY, D., BOYLE, K. M. & BUND, S. J. 2010. The 
assessment of rat ureteral pressure generation in vitro: regional 
heterogeneity and influence of distending pressure. Acta Physiol Hung, 97, 
307-15. 
RAY, A. A., GHICULETE, D., PACE, K. T. & HONEY, R. J. 2010. Limitations 
to ultrasound in the detection and measurement of urinary tract calculi. 
Urology, 76, 295-300. 
RIPOCHE, J. 2011. Blood platelets and inflammation: their relationship with liver 
and digestive diseases. Clin Res Hepatol Gastroenterol, 35, 353-7. 
RISHOLM, L. 1954. Studies on renal colic and its treatment by posterior 
splanchnic block. Acta Chir Scand Suppl, 184, 5-64. 
ROMERO, V., AKPINAR, H. & ASSIMOS, D. G. 2010. Kidney stones: a global 
picture of prevalence, incidence, and associated risk factors. Rev Urol, 12, 
e86-96. 
RONG, W. & BURNSTOCK, G. 2004. Activation of ureter nociceptors by 
exogenous and endogenous ATP in guinea pig. Neuropharmacology, 47, 
1093-101. 
ROSE, J. G. & GILLENWATER, J. Y. 1973. Pathophysiology of ureteral 
obstruction. Am J Physiol, 225, 830-7. 
ROSSMAN, K. L., DER, C. J. & SONDEK, J. 2005. GEF means go: turning on 
RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol 
Cell Biol, 6, 167-80. 
ROTH, B. L. 1994. Multiple serotonin receptors: clinical and experimental 
aspects. Ann Clin Psychiatry, 6, 67-78. 
273 
 
SAH, V. P., SEASHOLTZ, T. M., SAGI, S. A. & BROWN, J. H. 2000. The role 
of Rho in G protein-coupled receptor signal transduction. Annu Rev 
Pharmacol Toxicol, 40, 459-89. 
SAITA, A., BONACCORSI, A., MARCHESE, F., CONDORELLI, S. V. & 
MOTTA, M. 2004. Our experience with nifedipine and prednisolone as 
expulsive therapy for ureteral stones. Urol Int, 72 Suppl 1, 43-5. 
SAITO, M., KONDO, A., GOTOH, M., KATO, K. & LEVIN, R. M. 1993. Age-
related changes in the response of the rat urinary bladder to 
neurotransmitters. Neurourol Urodyn, 12, 191-200. 
SAKAI, T., KASAHARA, K., TOMITA, K., IKEGAKI, I. & KURIYAMA, H. 
2013. 5-Hydroxytryptamine-induced bladder hyperactivity via the 5-
HT2A receptor in partial bladder outlet obstruction in rats. Am J Physiol 
Renal Physiol, 304, F1020-7. 
SAKAMOTO, K., SURI, D. & RAJASEKARAN, M. 2006. Characterization of 
muscarinic receptor subtypes in human ureter. J Endourol, 20, 939-42. 
SALEM, H. K. 2009. A prospective randomized study comparing shock wave 
lithotripsy and semirigid ureteroscopy for the management of proximal 
ureteral calculi. Urology, 74, 1216-21. 
SANBORN, B. M., KU, C. Y., SHLYKOV, S. & BABICH, L. 2005. Molecular 
signaling through G-protein-coupled receptors and the control of 
intracellular calcium in myometrium. J Soc Gynecol Investig, 12, 479-87. 
SANTICIOLI, P. & MAGGI, C. A. 1998. Myogenic and neurogenic factors in the 
control of pyeloureteral motility and ureteral peristalsis. Pharmacol Rev, 
50, 683-722. 
SANTOSO, A. G., SONARNO, I. A., ARSAD, N. A. & LIANG, W. 2010. The 
role of the urothelium and ATP in mediating detrusor smooth muscle 
contractility. Urology, 76, 1267 e7-12. 
SASAKI, S., TOMIYAMA, Y., KOBAYASHI, S., KOJIMA, Y., KUBOTA, Y. 
& KOHRI, K. 2011. Characterization of alpha1-adrenoceptor subtypes 
mediating contraction in human isolated ureters. Urology, 77, 762 e13-7. 
SASSONE-CORSI, P. 2012. The cyclic AMP pathway. Cold Spring Harb 
Perspect Biol, 4. 
SATOH, S., UTSUNOMIYA, T., TSURUI, K., KOBAYASHI, T., IKEGAKI, I., 
SASAKI, Y. & ASANO, T. 2001. Pharmacological profile of hydroxy 
fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life 
Sci, 69, 1441-53. 
SAXENA, P. R., DE VRIES, P. & VILLALON, C. M. 1998. 5-HT1-like 
receptors: a time to bid goodbye. Trends Pharmacol Sci, 19, 311-6. 
SCHADE, G. R. & FAERBER, G. J. 2010. Urinary tract stones. Prim Care, 37, 
565-81, ix. 
SCHMIDT, M., VOSS, M., WEERNINK, P. A., WETZEL, J., AMANO, M., 
KAIBUCHI, K. & JAKOBS, K. H. 1999. A role for rho-kinase in rho-
controlled phospholipase D stimulation by the m3 muscarinic 
acetylcholine receptor. J Biol Chem, 274, 14648-54. 
SCHNEIDER, T., FETSCHER, C., KREGE, S. & MICHEL, M. C. 2004. Signal 
transduction underlying carbachol-induced contraction of human urinary 
bladder. J Pharmacol Exp Ther, 309, 1148-53. 
274 
 
SCHULMAN, C. C. 1975. Development of the innervation of the ureter. Eur 
Urol, 1, 46-8. 
SCOTT, P. J. & REID, J. L. 1982. The effect of age on the responses of human 
isolated arteries to noradrenaline. Br J Clin Pharmacol, 13, 237-9. 
SEITZ, C., LIATSIKOS, E., PORPIGLIA, F., TISELIUS, H. G. & ZWERGEL, 
U. 2009. Medical therapy to facilitate the passage of stones: what is the 
evidence? Eur Urol, 56, 455-71. 
SELLERS, D. J., CHESS-WILLIAMS, R. & CHAPPLE, C. R. 2000. 5-
Hydroxytryptamine-induced potentiation of cholinergic responses to 
electrical field stimulation in pig detrusor muscle. BJU Int, 86, 714-8. 
SHABIR, S., BORISOVA, L., WRAY, S. & BURDYGA, T. 2004. Rho-kinase 
inhibition and electromechanical coupling in rat and guinea-pig ureter 
smooth muscle: Ca2+-dependent and -independent mechanisms. J Physiol, 
560, 839-55. 
SHABIR, S., CROSS, W., KIRKWOOD, L. A., PEARSON, J. F., APPLEBY, P. 
A., WALKER, D., EARDLEY, I. & SOUTHGATE, J. 2013. Functional 
expression of purinergic P2 receptors and transient receptor potential 
channels by the human urothelium. Am J Physiol Renal Physiol, 305, 
F396-406. 
SHARPE, C. C. & HENDRY, B. M. 2003. Signaling: focus on Rho in renal 
disease. J Am Soc Nephrol, 14, 261-4. 
SHAVER, S. R. 2001. P2Y receptors: biological advances and therapeutic 
opportunities. Curr Opin Drug Discov Devel, 4, 665-70. 
SHEAFOR, D. H., HERTZBERG, B. S., FREED, K. S., CARROLL, B. A., 
KEOGAN, M. T., PAULSON, E. K., DELONG, D. M. & NELSON, R. C. 
2000. Nonenhanced helical CT and US in the emergency evaluation of 
patients with renal colic: prospective comparison. Radiology, 217, 792-7. 
SHEHADI, W. H. & TONIOLO, G. 1980. Adverse reactions to contrast media: a 
report from the Committee on Safety of Contrast Media of the 
International Society of Radiology. Radiology, 137, 299-302. 
SHIMOKAWA, H. 2002. Rho-kinase as a novel therapeutic target in treatment of 
cardiovascular diseases. J Cardiovasc Pharmacol, 39, 319-27. 
SHINE, S. 2008. Urinary calculus: IVU vs. CT renal stone? A critically appraised 
topic. Abdom Imaging, 33, 41-3. 
SIBLEY, G. N. 1984. A comparison of spontaneous and nerve-mediated activity 
in bladder muscle from man, pig and rabbit. J Physiol, 354, 431-43. 
SIGALA, S., DELLABELLA, M., MILANESE, G., FORNARI, S., FACCOLI, 
S., PALAZZOLO, F., PERONI, A., MIRABELLA, G., CUNICO, S. C., 
SPANO, P. & MUZZONIGRO, G. 2005. Evidence for the presence of 
alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn, 24, 
142-8. 
SIMON, J., ROUMEGUERE, T., VAESSEN, C. & SCHULMAN, C. C. 1997. 
Conservative management of ureteric stones. Acta Urol Belg, 65, 7-9. 
SINGH, A., ALTER, H. J. & LITTLEPAGE, A. 2007. A systematic review of 
medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med, 
50, 552-63. 
275 
 
SIVRIKAYA, A., CELIK, O. F., SIVRIKAYA, N. & OZGUR, G. K. 2003. The 
effect of diclofenac sodium and papaverine on isolated human ureteric 
smooth muscle. Int Urol Nephrol, 35, 479-83. 
SIVULA, A. & LEHTONEN, T. 1967. Spontaneous passage of artificial 
concretions applied in the rabbit ureter. Scand J Urol Nephrol, 1, 259-63. 
SMITH, P. P., DEANGELIS, A. & KUCHEL, G. A. 2012. Detrusor expulsive 
strength is preserved, but responsiveness to bladder filling and urinary 
sensitivity is diminished in the aging mouse. Am J Physiol Regul Integr 
Comp Physiol, 302, R577-86. 
SOMLYO, A. P. & SOMLYO, A. V. 1994. Signal transduction and regulation in 
smooth muscle. Nature, 372, 231-6. 
SOMLYO, A. P. & SOMLYO, A. V. 2000. Signal transduction by G-proteins, 
rho-kinase and protein phosphatase to smooth muscle and non-muscle 
myosin II. J Physiol, 522 Pt 2, 177-85. 
SOMMER, P., KROMANN-ANDERSEN, B., LENDORF, A., LYNGDORF, P. 
& MOLLER, P. 1989. Analgesic effect and tolerance of Voltaren and 
Ketogan in acute renal or ureteric colic. Br J Urol, 63, 4-6. 
SOSLAU, G., MCKENZIE, R. J., BRODSKY, I. & DEVLIN, T. M. 1995. 
Extracellular ATP inhibits agonist-induced mobilization of internal 
calcium in human platelets. Biochim Biophys Acta, 1268, 73-80. 
SOUCIE, J. M., THUN, M. J., COATES, R. J., MCCLELLAN, W. & AUSTIN, 
H. 1994. Demographic and geographic variability of kidney stones in the 
United States. Kidney Int, 46, 893-9. 
SPAETHE, S. M., SCAIFE, C. L., PECHOUS, P. A. & VANALSTYNE, E. L. 
1992. Effect of age on leukotriene B4 production in guinea pig whole 
blood. Biochem Pharmacol, 43, 837-43. 
STEGGALL, M. J. 2002. Urinary tract stones: cause, complications and 
treatment. Br J Nurs, 10, 1452-1456. 
STEGGALL, M. J. & OMARA, M. 2008. Urinary tract stones: types, nursing care 
and treatment options. Br J Nurs, 17, s20-3. 
STEVENS, M. J., LIPE, S. & MOULDS, R. F. 1982. The effect of age on the 
responses of human isolated arteries and veins to noradrenaline. Br J Clin 
Pharmacol, 14, 750-2. 
STIEF, C. G., UCKERT, S., TRUSS, M. C., BECKER, A. J., MACHTENS, S. & 
JONAS, U. 1996. A possible role for nitric oxide in the regulation of 
human ureteral smooth muscle tone in vitro. Urol Res, 24, 333-7. 
STOUT, C. E., COSTANTIN, J. L., NAUS, C. C. & CHARLES, A. C. 2002. 
Intercellular calcium signaling in astrocytes via ATP release through 
connexin hemichannels. J Biol Chem, 277, 10482-8. 
SUI, G., FRY, C. H., MONTGOMERY, B., ROBERTS, M., WU, R. & WU, C. 
2014. Purinergic and muscarinic modulation of ATP release from the 
urothelium and its paracrine actions. Am J Physiol Renal Physiol, 306, 
F286-98. 
SWEENEY, H. L., YANG, Z., ZHI, G., STULL, J. T. & TRYBUS, K. M. 1994. 
Charge replacement near the phosphorylatable serine of the myosin 
regulatory light chain mimics aspects of phosphorylation. Proc Natl Acad 
Sci U S A, 91, 1490-4. 
276 
 
TABNER, A. J., JOHNSON, G. D., FAKIS, A., SURTEES, J. & LENNON, R. I. 
2016. beta-Adrenoreceptor agonists in the management of pain associated 
with renal colic: a systematic review. BMJ Open, 6, e011315. 
TAINIO, H., KYLMALA, T. & HEIKKINEN, A. 1992. Peptidergic innervation 
of the normal and obstructed human pyeloureteral junctions. Urol Int, 48, 
31-4. 
TAKAHASHI, N., SHIOMI, H., KUSHIDA, N., LIU, F., ISHIBASHI, K., 
YANAGIDA, T., SHISHIDO, K., AIKAWA, K. & YAMAGUCHI, O. 
2009. Obstruction alters muscarinic receptor-coupled RhoA/Rho-kinase 
pathway in the urinary bladder of the rat. Neurourol Urodyn, 28, 257-62. 
TAKAMI, A., IWAKUBO, M., OKADA, Y., KAWATA, T., ODAI, H., 
TAKAHASHI, N., SHINDO, K., KIMURA, K., TAGAMI, Y., MIYAKE, 
M., FUKUSHIMA, K., INAGAKI, M., AMANO, M., KAIBUCHI, K. & 
IIJIMA, H. 2004. Design and synthesis of Rho kinase inhibitors (I). 
Bioorg Med Chem, 12, 2115-37. 
TEMPEST, H. V., DIXON, A. K., TURNER, W. H., ELNEIL, S., SELLERS, L. 
A. & FERGUSON, D. R. 2004. P2X and P2X receptor expression in 
human bladder urothelium and changes in interstitial cystitis. BJU Int, 93, 
1344-8. 
TEMPLEMAN, L., CHAPPLE, C. R. & CHESS-WILLIAMS, R. 2002. 
Urothelium derived inhibitory factor and cross-talk among receptors in the 
trigone of the bladder of the pig. J Urol, 167, 742-5. 
THEOHARIDES, T. C., BONDY, P. K., TSAKALOS, N. D. & ASKENASE, P. 
W. 1982. Differential release of serotonin and histamine from mast cells. 
Nature, 297, 229-31. 
THOMAS, D. R., SOFFIN, E. M., ROBERTS, C., KEW, J. N., DE LA FLOR, R. 
M., DAWSON, L. A., FRY, V. A., COGGON, S. A., FAEDO, S., 
HAYES, P. D., CORBETT, D. F., DAVIES, C. H. & HAGAN, J. J. 2006. 
SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-
phenylethyl)amino]methyl}-4 -biphenylyl)methyl]propanamide 
dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 
5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A 
receptor in guinea pig brain. Neuropharmacology, 51, 566-77. 
THOMPSON, M. D., BURNHAM, W. M. & COLE, D. E. 2005. The G protein-
coupled receptors: pharmacogenetics and disease. Crit Rev Clin Lab Sci, 
42, 311-92. 
TIMOTEO, M. A., CARNEIRO, I., SILVA, I., NORONHA-MATOS, J. B., 
FERREIRINHA, F., SILVA-RAMOS, M. & CORREIA-DE-SA, P. 2014. 
ATP released via pannexin-1 hemichannels mediates bladder overactivity 
triggered by urothelial P2Y6 receptors. Biochem Pharmacol, 87, 371-9. 
TODA, N. & SHIMIZU, I. 1987. Neuroeffector function in mesenteric arteries 
isolated from beagles of different ages. J Pharmacol Exp Ther, 240, 223-7. 
TODD, J. K. & MACK, A. J. 1969. A study of human bladder detrusor muscle. 
Br J Urol, 41, 448-54. 
TOMIYAMA, Y., MURAKAMI, M., HAYAKAWA, K., AKIYAMA, K., 
YAMAZAKI, Y., KOJIMA, M., SHIBATA, N. & AKAHANE, M. 2003a. 
277 
 
Pharmacological profile of KUL-7211, a selective beta-adrenoceptor 
agonist, in isolated ureteral smooth muscle. J Pharmacol Sci, 92, 411-9. 
TOMIYAMA, Y., WANAJO, I., YAMAZAKI, Y., MURAKAMI, M., KOJIMA, 
M. & SHIBATA, N. 2003b. Functional muscarinic cholinoceptors in the 
isolated canine ureter. Naunyn Schmiedebergs Arch Pharmacol, 367, 348-
52. 
TONINI, M., MESSORI, E., FRANCESCHETTI, G. P., RIZZI, C. A., 
CASTOLDI, A. F., COCCINI, T. & CANDURA, S. M. 1994. 
Characterization of the 5-HT receptor potentiating neuromuscular 
cholinergic transmission in strips of human isolated detrusor muscle. Br J 
Pharmacol, 113, 1-2. 
TSAI, H., BUCHHOLZ, J. & DUCKLES, S. P. 1993. Postjunctional alpha 2-
adrenoceptors in blood vessels: effect of age. Eur J Pharmacol, 237, 311-
6. 
TUGAY, M., YILDIZ, F. & GUVENC, B. H. 2003. Development changes 
esophageal smooth muscle reactivity: an in vitro study. Pharmacol Res, 
48, 473-8. 
TURNA, B., CINAR, M. G., CANDA, A. E., ORHAN, E. C., TIFTIK, N. R., 
NAZLI, O. & BUYUKAFSAR, K. 2007. Role of Rho-kinase in 
contractions of ureters from rabbits with unilateral ureteric obstruction. 
BJU Int, 100, 1166-71. 
UCHIYAMA, T. & CHESS-WILLIAMS, R. 2004. Muscarinic receptor subtypes 
of the bladder and gastrointestinal tract. J Smooth Muscle Res, 40, 237-47. 
UEHATA, M., ISHIZAKI, T., SATOH, H., ONO, T., KAWAHARA, T., 
MORISHITA, T., TAMAKAWA, H., YAMAGAMI, K., INUI, J., 
MAEKAWA, M. & NARUMIYA, S. 1997. Calcium sensitization of 
smooth muscle mediated by a Rho-associated protein kinase in 
hypertension. Nature, 389, 990-4. 
UGAILY-THULESIUS, L. & THULESIUS, O. 1988. The effects of urine on 
mast cells and smooth muscle of the human ureter. Urol Res, 16, 441-7. 
UGAILY-THULESIUS, L., THULESIUS, O., ANGELO-KHATTAR, M., 
SIVANANDASINGHAM, P. & SABHA, M. 1988. Mast cells and 
histamine responses of the ureter, ultrastructural features of cell-to-cell 
associations and functional implications. Urol Res, 16, 287-93. 
VANE, J. R. & BOTTING, R. M. 1995. A better understanding of anti-
inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and 
COX-2). Adv Prostaglandin Thromboxane Leukot Res, 23, 41-8. 
VARGIU, R., PERINU, A., TINTRUP, F., BROCCIA, F. & LISA, A. D. 2015. 
Regional differences of energetics, mechanics, and kinetics of myosin 
cross-bridge in human ureter smooth muscle. Int J Physiol Pathophysiol 
Pharmacol, 7, 34-43. 
VIGNONI, A., FIERRO, A., MORESCHINI, G., CAU, M., AGOSTINO, A., 
DANIELE, E., FOTI, G. & GROSSI, E. 1983. Diclofenac sodium in 
ureteral colic: a double-blind comparison trial with placebo. J Int Med Res, 
11, 303-7. 
VLASKOVSKA, M., KASAKOV, L., RONG, W., BODIN, P., BARDINI, M., 
COCKAYNE, D. A., FORD, A. P. & BURNSTOCK, G. 2001. P2X3 
278 
 
knock-out mice reveal a major sensory role for urothelially released ATP. 
J Neurosci, 21, 5670-7. 
VODENICHAROV, A., LEISER, R., GULUBOVA, M. & VLAYKOVA, T. 
2005. Morphological and immunocytochemical investigations on mast 
cells in porcine ureter. Anat Histol Embryol, 34, 343-9. 
WAIKAR, M. V., FORD, A. P. & CLARKE, D. E. 1994. Evidence for an 
inhibitory 5-HT4 receptor in urinary bladder of rhesus and Cynomolgus 
monkeys. Br J Pharmacol, 111, 213-8. 
WALDEN, M., LAHTINEN, J. & ELVANDER, E. 1993. Analgesic effect and 
tolerance of ketoprofen and diclofenac in acute ureteral colic. Scand J 
Urol Nephrol, 27, 323-5. 
WANAJO, I., TOMIYAMA, Y., TADACHI, M., KOBAYASHI, M., 
YAMAZAKI, Y., KOJIMA, M. & SHIBATA, N. 2005. The potency of 
KUL-7211, a selective ureteral relaxant, in isolated canine ureter: 
comparison with various spasmolytics. Urol Res, 33, 409-14. 
WANAJO, I., TOMIYAMA, Y., YAMAZAKI, Y. & KOJIMA, M. 2011. Ureteral 
selectivity of intravenous beta-adrenoceptor agonists in pig model of acute 
ureteral obstruction: comparison of KUL-7211, a selective beta2/beta3 
agonist, with isoproterenol, terbutaline, and CL-316243. Urology, 77, 
1266 e1-6. 
WANAJO, I., TOMIYAMA, Y., YAMAZAKI, Y., KOJIMA, M. & SHIBATA, 
N. 2004. Pharmacological characterization of beta-adrenoceptor subtypes 
mediating relaxation in porcine isolated ureteral smooth muscle. J Urol, 
172, 1155-9. 
WANG, C. J., HUANG, S. W. & CHANG, C. H. 2009. Adjunctive medical 
therapy with an alpha-1A-specific blocker after shock wave lithotripsy of 
lower ureteral stones. Urol Int, 82, 166-9. 
WANG, E. C., LEE, J. M., RUIZ, W. G., BALESTREIRE, E. M., VON 
BODUNGEN, M., BARRICK, S., COCKAYNE, D. A., BIRDER, L. A. & 
APODACA, G. 2005. ATP and purinergic receptor-dependent membrane 
traffic in bladder umbrella cells. J Clin Invest, 115, 2412-22. 
WANG, Q. & LARGE, W. A. 1991. Noradrenaline-evoked cation conductance 
recorded with the nystatin whole-cell method in rabbit portal vein cells. J 
Physiol, 435, 21-39. 
WEBB, R. C. 2003. Smooth muscle contraction and relaxation. Adv Physiol Educ, 
27, 201-6. 
WETTSCHURECK, N. & OFFERMANNS, S. 2002. Rho/Rho-kinase mediated 
signaling in physiology and pathophysiology. J Mol Med (Berl), 80, 629-
38. 
WHARTON, J., POLAK, J. M., PROBERT, L., DE MEY, J., MCGREGOR, G. 
P., BRYANT, M. G. & BLOOM, S. R. 1981. Peptide containing nerves in 
the ureter of the guinea-pig and cat. Neuroscience, 6, 969-82. 
WIBBERLEY, A., CHEN, Z., HU, E., HIEBLE, J. P. & WESTFALL, T. D. 2003. 
Expression and functional role of Rho-kinase in rat urinary bladder smooth 
muscle. Br J Pharmacol, 138, 757-66. 
WINDER, M., TOBIN, G., ZUPANCIC, D. & ROMIH, R. 2014. Signalling 
molecules in the urothelium. Biomed Res Int, 2014, 297295. 
279 
 
WOOLF, A. S. & DAVIES, J. A. 2013. Cell biology of ureter development. J Am 
Soc Nephrol, 24, 19-25. 
WORSTER, A., PREYRA, I., WEAVER, B. & HAINES, T. 2002. The accuracy 
of noncontrast helical computed tomography versus intravenous 
pyelography in the diagnosis of suspected acute urolithiasis: a meta-
analysis. Ann Emerg Med, 40, 280-6. 
WUEST, M., EICHHORN, B., BRAETER, M., STRUGALA, G., MICHEL, M. 
C. & RAVENS, U. 2008. Muscarinic receptor expression and receptor-
mediated detrusor contraction: comparison of juvenile and adult porcine 
tissue. Pflugers Arch, 456, 349-58. 
XINGYU, Y., GUOLIANG, T., YOUMEI, C., HONGGEN, W., YIHONG, G. & 
JUNYI, C. 2012. The effect of nitric oxide on the pressure of the acutely 
obstructed ureter. Urol Res, 40, 163-9. 
YALCIN, S., ERTUNC, M., ARDICLI, B., KABAKUS, I. M., TAS, T. S., 
SARA, Y., ONUR, R. & KARNAK, I. 2013. Ureterovesical junction 
obstruction causes increment in smooth muscle contractility, and 
cholinergic and adrenergic activity in distal ureter of rabbits. J Pediatr 
Surg, 48, 1954-61. 
YANG, M., RUAN, J., VOLLER, M., SCHALKEN, J. & MICHEL, M. C. 1999. 
Differential regulation of human alpha1-adrenoceptor subtypes. Naunyn 
Schmiedebergs Arch Pharmacol, 359, 439-46. 
YE, Z., YANG, H., LI, H., ZHANG, X., DENG, Y., ZENG, G., CHEN, L., 
CHENG, Y., YANG, J., MI, Q., ZHANG, Y., CHEN, Z., GUO, H., HE, 
W. & CHEN, Z. 2011. A multicentre, prospective, randomized trial: 
comparative efficacy of tamsulosin and nifedipine in medical expulsive 
therapy for distal ureteric stones with renal colic. BJU Int, 108, 276-9. 
YILMAZ, E., BATISLAM, E., BASAR, M. M., TUGLU, D., FERHAT, M. & 
BASAR, H. 2005. The comparison and efficacy of 3 different alpha1-
adrenergic blockers for distal ureteral stones. J Urol, 173, 2010-2. 
YONO, M., LATIFPOUR, J., YAMAMOTO, Y., IMANISHI, A. & YOSHIDA, 
M. 2008. Region and age dependent differences in alpha(1)-adrenergic 
responsiveness of rat seminal vesicle and vas deferens. Eur J Pharmacol, 
587, 291-5. 
YOSHIDA, M., INADOME, A., MAEDA, Y., SATOJI, Y., MASUNAGA, K., 
SUGIYAMA, Y. & MURAKAMI, S. 2006. Non-neuronal cholinergic 
system in human bladder urothelium. Urology, 67, 425-30. 
YOSHII, A., IIZUKA, K., DOBASHI, K., HORIE, T., HARADA, T., 
NAKAZAWA, T. & MORI, M. 1999. Relaxation of contracted rabbit 
tracheal and human bronchial smooth muscle by Y-27632 through 
inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol, 20, 1190-200. 
YUVANC, E., YILMAZ, E., TUGLU, D. & BATISLAM, E. 2015. Medical and 
alternative therapies in urinary tract stone disease. World J Nephrol, 4, 
492-9. 
ZDERIC, S. A., DUCKETT, J. W., WEIN, A. J., SNYDER, H. M., 3RD & 
LEVIN, R. M. 1990. Development factors in the contractile response of 
the rabbit bladder to both autonomic and non-autonomic agents. 
Pharmacology, 41, 119-23. 
280 
 
ZHANG, X. & DISANTO, M. E. 2011. Rho-kinase, a common final path of 
various contractile bladder and ureter stimuli. Handb Exp Pharmacol, 543-
68. 
ZHENG, Y. 2001. Dbl family guanine nucleotide exchange factors. Trends 
Biochem Sci, 26, 724-32. 
ZHOLOS, A. V. & BOLTON, T. B. 1997. Muscarinic receptor subtypes 
controlling the cationic current in guinea-pig ileal smooth muscle. Br J 
Pharmacol, 122, 885-93. 
ZHONG, H. & MINNEMAN, K. P. 1999. Activation of tyrosine kinases by 
alpha1A-adrenergic and growth factor receptors in transfected PC12 cells. 
Biochem J, 344 Pt 3, 889-94. 
ZILBERMAN, D. E., TSIVIAN, M., LIPKIN, M. E., FERRANDINO, M. N., 
FRUSH, D. P., PAULSON, E. K. & PREMINGER, G. M. 2011. Low dose 
computerized tomography for detection of urolithiasis--its effectiveness in 
the setting of the urology clinic. J Urol, 185, 910-4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
281 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
282 
 
Appendix 1 
 
AREA UNDER CURVE MEASUREMENT FOR LABCHART SOFTWARE 
(measures overall activity of tissue strips) 
 
1. On the Lab Chart trace, add a new Channel (eg. Channel 5) with the following settings: 
Source Channel > Raw Data (eg. Channel 1, Channel 2, etc) 
Calculation > Integral 
Reset > No Reset 
 
2. Label the start of baseline activity before adding drug (eg. 0.1ug baseline). * Label the 
start of activity after adding drug (eg. 0.1ug data). 
 
3. Open Data Pad. On a vacant column, set the following calculations: 
Statistics > End Value - Start Value 
Calculation Source > Integral Channel, ie. the channel added at Step 1 (eg. Channel 5)  
 
4. Under Commands, select Multiple Add to Data Pad with the following settings: 
Find Using > Comment 
Channel > Any 
Containing > Label from Step 2 (eg. 0.1ug data, 0.1ug baseline) 
Select > for > 3 minutes > after comment 
Step through > Whole file 
 
5. The values added to Data Pad after the step before is the area under curve for the 
areas selected (3 minutes before or after adding drug). To calculate the change in 
activity: 
Area under curve 3 minutes after adding drug - Area under curve 3 minutes before 
adding drug 
 
* For single dose response, every drug concentration has a different baseline. For cumulative 
dose response, the same baseline (before first dose was added) is used for all concentrations. 
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